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1D   One-dimensional 
2D   Two-dimensional 
AC   Activated carbon filtration 
AChE   Acetylcholinesterase 
AF   Aliivibrio fischeri  
AMD   Automated multiple development 
AOP   Adverse outcome pathway 
AR   Androgen receptor 
BS   Bacillus subtilis 
CAS   Chemical Abstract Service 
CHO-cells  Chinese ovary hamster-cells 
DDT   Dichlorodiphenyltrichloroethane 
DIN   German Institute for Standardization 
DNA   Deoxyribonucleic acid 
DR   Dioxin response 
DW   Drinking water 
EDA   Effect-directed analysis 
ER-α   Estrogen receptor-α 
ER-CALUX®  Estrogen receptor-chemically activated luciferase expression® 
ESI   Electrospray ionization 
Fc   Fold change 
FEA   Federal Environmental Agency 
GC   Gas chromatography 
HPLC   High-performance liquid chromatography 
HPTLC  High-performance thin-layer chromatography 




HRMS   High-resolution mass spectrometry 
ISO   International Organization for Standardization 
LC   Liquid chromatography 
MS   Mass spectrometry 
MS/MS  Tandem-mass spectrometry 
MUG   4-Methylumbelliferyl-ß-D-galactopyranoside 
MTT   3-[4,5-Dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide 
NADH   Nicotinamide adenine dinucleotide hydrogen 
NADPH  Nicotinamide adenine dinucleotide phosphate hydrogen 
NP   Normal phase 
NT   Non-target 
NTS   Non-target screening 
O3   Ozonation 
ONPG   O-Nitrophenyl-β-D-galactopyranoside 
PAH   Polycyclic aromatic hydrocarbons 
pYES   Planar yeast estrogen screen 
QSAR   Quantitative structure-activity relationship 
RP   Reversed phase 
RW   Raw water 
SPE   Solid phase extraction 
TLC   Thin-layer chromatography 
WBA   Wirkungsbezogene Analytik 
YES   Yeast estrogen screen 





Ames assay In-vitro bioassay based on genetically modified  bacterial Salmonella strains. It 
is used to detect mutagenic effects and was developed by Bruce Ames in 
1975. 
DR-LUC assay Reporter gene assay for the detection of dioxin-like effects. Dioxin response 
(DR) is mediated by the luc-gene coding for the enzyme luciferase. Luciferase 
catalyses light emission of the substrate luciferin. 
GeneBLAzer assay By binding of estrogenic substances to the estrogen receptor-α (ER-α) in the 
ER-GeneBLAzer assay, a signalling cascade starts in which the ß-lactamase is 
expressed by the bla-gene. The ß-lactamase cleaves a substrate whose change 
in fluorescence can be detected. 
H295R assay In-vitro bioassay with human H295R-adenocarcinoma cell line for the detec-
tion of non-receptor bound endocrine effects. 
HeLa-9903 Human, genetically modified adenocarcinoma cell line originally taken from 
Mrs. Henrietta Lacks in 1951. 
LacZ-reporter gene Gene of lactose-operon (lac-operon) in bacteria encoding the enzyme  
ß-galactosidase, which cleaves lactose to glucose and galactose. Additional to 
the natural substrate lactose, the enzyme also cleaves color substrates to the 
dye and galactose, such that the dye concentration can be determined photo-
metrical. 
MELN Estrogen-sensitive human breast cancer cell line containing a luciferase  
reporter gene induced through binding of compounds to the ER-α. 
Metabolic activation Many environmental substances are chemically altered in the liver of animals 
and humans by xenobiotic metabolism and thus acquire a toxicological effect. 
Bacterial cells usually do not possess enzymes of xenobiotic metabolism and 
are called metabolically not-competent. In order to simulate the processes of 
xenobiotic metabolism, exogenous enzymes are added to the bacterial cells. 
Micronucleus assay Assay for the detection of chromosome damage and damage to the spindle 
apparatus of a cell due to genotoxic effects. The determination of genotoxicity 
is carried out by the formation of micronuclei during cell division that contain 
damaged chromosome fragments. 
 
 




P53-CALUX® assay Reporter gene assay for the detection of genotoxic effects. P53 (protein, 
53 kDa) transcription factor regulates gene expression after DNA damage. In 
the assay, activation of the p53-pathway leads to expression of luciferase.  
Luciferase catalyses light emission of the substrate luciferin.  
SOS-repair system The SOS-response repairs DNA in damaged bacterial cells before the cell 
cycle continues. 
Umu assay In-vitro bioassay for the detection of genotoxic effects to a genetically modi-
fied Salmonella strain. The assay is mediated by the bacterial cell's SOS-repair 
system, which contains an umuC-gene that gave the assay its name. 
S. cerevisiae BJ3505 Genetically modified Saccharomyces yeast cell strain that carries the gene for 
the human ER-α. If estrogenic substances bind to the receptor, it triggers the 
expression lacZ-gene coding for ß-galactosidase. 
S. typhimurium TA98  Histidine-deficient mutant Salmonella strain in the Ames assay, for the  
detection of base pair substitutions.  
S. typhimurium TA100  Histidine-deficient mutant Salmonella strain in the Ames assay, which is used 
to detect frameshift mutations. A frameshift mutation is a change in the genet-
ic reading frame of the DNA sequence. 
WBA-BeReit Acronym for the research project: Wirkungsbezogene Analytik als neuer  
Ansatz zur orientierenden Bewertung organischer Spurenstoffe in Rohwasser-
ressourcen zur Trinkwassergewinnung und bei Aufbereitungsprozessen. 
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The protection of the aquatic environment and the supply of clean drinking water to people all over the 
world are central challenges of our time. Monitoring of the aquatic environment and the input of an-
thropogenic trace substances into it is therefore very important. However, since aquatic environmental 
samples often consist of complex substance mixtures, their characterization and evaluation is very 
demanding. By using generic target analysis methods, selected known anthropogenic trace substances 
can be detected and quantified very sensitively. For the detection of previously unknown substances, 
non-target analysis methods have been increasingly used in recent years. However, these methods do 
not provide information on the relevance of the anthropogenic trace substances occurring in water. In 
this context, especially all those trace substances are regarded as relevant from which a harmful effect 
on humans or water organisms is to be expected. For the detection of such effective substances, effect-
directed analysis (EDA) can be used, which specifically detect effects such as neurotoxicity or geno-
toxicity. In EDA, a bioassay is combined with a fractionation method and subsequent chemical analy-
sis, the aim being to identify the bioactive substance. The EDA detects the effect of individual sub-
stances or substance groups in a sample with the respective endpoint without the need to know the 
effective substances. The separation method used in this work is high-performance thin-layer chroma-
tography (HPTLC). After chromatography, the bioassay is performed directly on the HPTLC plate. If 
an effective zone appears in the bioassay, a prioritization strategy is used to clarify the identity of the 
substance. 
Due to the complex aquatic samples, a large number of different substances in a zone must still be 
expected despite the applied HPTLC separation, which makes it difficult to identify the effective sub-
stance. Therefore, a strategy to simplify the identification of effective substances should be developed. 
The aim was to reduce the complexity by multidimensional separation in such a way that chemical 
analysis can be used to prioritize to a few candidates in the effective fraction. 
In the first part of the work, a selective two-dimensional HPTLC separation was developed to reduce 
the number of substances in a bioactive zone. After the first separation dimension (1D) the acetylcho-
linesterase inhibition assay (AChE assay) was performed and afterwards only the effective zones were 
extracted from the HPTLC plate. The selected effective zones were separated in a second separation 
dimension (2D) and the bioassay was performed again. Here, a retardation factor-adapted separation 
with several mobile phases was applied in the 2D. Depending on the retardation factor of the effective 
zone in the 1D, a mobile phase with optimized eluent strength was used in the 2D. This procedure was 
intended to achieve an optimal separation of the samples and thus a reduction of the complexity of the 
effective zones. With this 2D separation, the peak capacity could be increased by a factor of 7 com-
pared to a 1D HPTLC gradient development. 
If real water samples are examined for their effects, an additional structural elucidation must be carried 
out to clearly identify the unknown bioactive substances. In this work, the developed 2D EDA was 
therefore connected to a high-performance liquid chromatography (HPLC) with high-resolution mass 
spectrometry (HRMS) and a non-target screening (NTS) was performed. Using three water samples 
(drinking water, surface water and purified sewage water) spiked with six effective substances, it was 




shown that the developed strategy is suitable for the identification of effective substances and that 
these can be recovered despite repeated extraction. When applying the developed methodology to real 
samples, it was also possible to assign and quantify the detected effect in several waters to the sub-
stance lumichrome and to linear alkylbenzene sulfonates. 
Genotoxicity is a crucial endpoint for the effect assessment of water samples. However, this endpoint 
with metabolic activation cannot yet be performed directly on the HPTLC plate. Since many of the 
genotoxic substances have an indirect genotoxic effect, i.e. they only acquire their activity after meta-
bolic activation; this endpoint was investigated in the present work with the umu assay in the micro-
titer plate. However, separation with HPTLC, subsequent extraction of effective zones and non-target 
analysis of the extracts, should also be performed for this assay. Therefore the umu assay in the micro-
titer plate was integrated into the existing EDA-with-HPTLC concept. 
In laboratory experiments, sodium hypochlorite was added to the drug metformin in order to simulate 
the behavior of the substance during water treatment (chlorination). The metformin sample treated 
with hypochlorite was examined with the umu assay and a genotoxic effect was detected. After 
HPTLC separation of the chlorinated sample, zones were extracted over the entire retardation range. 
When the extracted zones were examined with the umu assay, the genotoxic effect could be clearly 
assigned to one fraction. Using high-resolution mass spectrometry, the genotoxic effect could be as-
signed to an already known transformation product of metformin. The HPTLC separation and extrac-
tion of the zones from the plate led to a reduction of the possible effective candidate masses by a fac-
tor of 10 and thus to a clear prioritization in HRMS analysis. 
In the context of the present work, the project "WBA-BeReit" was also worked on, with the aim of 
showing the possibilities and the significance of the EDA for drinking water treatment. In the project, 
raw and drinking waters of different water suppliers from Germany were analyzed and the results were 
compared. Clear effect changes during the treatment of raw to drinking water were shown, but also 
when comparing the individual raw waters. Thus, it was possible to successfully use the EDA for an 
orienting evaluation of different treatment processes with regard to the change of effects during the 
treatment process of drinking water. 
 





Der Schutz der aquatischen Umwelt und die Versorgung der Menschen auf der ganzen Welt mit sau-
berem Trinkwasser sind zentrale Herausforderungen unserer Zeit. Daher ist die Überwachung der 
aquatischen Umwelt und des Eintrags von anthropogenen Spurenstoffen in diese von wichtiger Bedeu-
tung. Da aquatische Umweltproben jedoch oft aus komplexen Stoffgemischen bestehen, ist deren Cha-
rakterisierung und Bewertung sehr anspruchsvoll. Durch den Einsatz klassischer Target-
Analysemethoden können ausgewählte, bekannte anthropogene Spurenstoffe sehr empfindlich detek-
tiert und quantifiziert werden. Für die Detektion bislang unbekannter Substanzen werden in den letzten 
Jahren vermehrt Non-Target-Analysemethoden eingesetzt. Allerdings liefern diese Methoden keine 
Aussagen zur Relevanz der im Wasser vorkommenden anthropogenen Spurenstoffe. Als relevant gel-
ten in diesem Zusammenhang vor allem all jene Spurenstoffe, von denen eine schädliche Wirkung auf 
den Menschen oder im Wasser lebende Organismen zu erwarten ist. Zur Detektion solcher wirkender 
Substanzen kann die Wirkungsbezogene Analytik (WBA) verwendet werden, die gezielt Wirkungen 
wie zum Beispiel Neurotoxizität oder Gentoxizität detektiert. Bei der WBA wird ein Bioassay mit 
einer Fraktionierungsmethode und anschließender chemischer Analyse kombiniert, wobei das Ziel die 
Identifizierung der bioaktiven Substanz ist. Die WBA detektiert die Wirkung von einzelnen Substan-
zen bzw. Substanzgruppen in einer Probe mit dem jeweiligen Endpunkt, ohne dass dafür die wirken-
den Substanzen bekannt sein müssen. Als Fraktionierungsmethode wurde in dieser Arbeit die Hoch-
leistungsdünnschichtchromatographie (HPTLC) angewandt. Nach der Chromatographie wird der Bio-
assay direkt auf der HPTLC-Platte durchgeführt. Tritt im Bioassay eine wirkende Zone auf, so soll 
mithilfe einer Priorisierungsstrategie die Identität der Substanz aufgeklärt werden. 
Aufgrund der komplexen aquatischen Proben muss trotz der angewandten HPTLC-Trennung in einer 
wirkenden Zone noch immer mit einer Vielzahl verschiedener Substanzen gerechnet werden, die eine 
Identifizierung der wirkenden Substanz erschweren. Es sollte aus diesem Grund eine Strategie zur 
Vereinfachung der Identifizierung von wirkenden Substanzen entwickelt werden. Ziel war es, die 
Komplexität durch mehrdimensionale Trennung so zu verringern, dass mithilfe der chemischen Ana-
lyse auf wenige Kandidaten in der wirkenden Zone priorisiert werden kann. 
Im ersten Teil der Arbeit wurde zur Reduktion der Anzahl von Substanzen in einer bioaktiven Zone 
eine selektive zweidimensionale HPTLC-Trennung entwickelt. Nach der ersten Trenndimension (1D) 
wurde der Acetylcholinesterase-Hemmtest (AChE-Assay) durchgeführt und anschließend lediglich die 
wirkenden Zonen von der HPTLC-Platte extrahiert. Die ausgewählten wirkenden Zonen wurden in 
einer zweiten Trenndimension (2D) nochmals aufgetrennt und abermals der Bioassay durchgeführt. 
Hierbei kam in der 2D eine Retardationsfaktor-angepasste Trennung mit mehreren Fließmitteln zum 
Einsatz. Je nach dem Retardationsfaktor der wirkenden Zone in der 1D wurde in der 2D ein Fließmit-
tel mit optimierter Elutionskraft verwendet. Mit diesem Vorgehen sollte eine optimale Auftrennung 
der Proben und damit eine Reduktion der Komplexität der wirkenden Zonen erreicht werden. Die 
Peakkapazität konnte durch diese 2D-Trennung im Vergleich zu einer 1D-HPTLC-
Gradientenentwicklung um den Faktor 7 gesteigert werden. 




Wenn reale Wasserproben wirkungsbezogenen untersucht werden, muss für eine eindeutige Identifi-
zierung der unbekannten bioaktiven Substanzen zusätzlich eine Strukturaufklärung durchgeführt wer-
den. In dieser Arbeit wurde deshalb die entwickelte 2D-WBA an eine Hochleistungsflüssigkeitschro-
matographie (HPLC) mit hochauflösender Massenspektrometrie (HRMS) angebunden und ein Non-
Target-Screening (NTS) durchgeführt. Am Beispiel dreier mit sechs wirkenden Substanzen dotierter 
Wasserproben (Trinkwasser, Oberflächenwasser und gereinigtes Abwasser) konnte gezeigt werden, 
dass sich die entwickelte Strategie für die Identifizierung wirkender Substanzen eignet und dass diese 
trotz mehrmaliger Extraktion wiedergefunden werden können. Bei der Anwendung der entwickelten 
Methodik auf Realproben gelang es zudem, in mehreren Wässern die detektierte Wirkung der Sub-
stanz Lumichrome sowie linearen Alkylbenzolsulfonaten zuzuordnen und zu quantifizieren.  
Für die Beurteilung der Wirkungen von Wasserproben ist die Gentoxizität ein entscheidender End-
punkt. Allerdings kann dieser Endpunkt mit metabolischer Aktivierung bislang nicht direkt auf der 
HPTLC-Platte durchgeführt werden. Da jedoch viele der gentoxischen Substanzen indirekt gentoxisch 
wirken, ihre Aktivität also erst nach der metabolischen Aktivierung erlangen, wurde dieser Endpunkt 
im Rahmen der vorliegenden Arbeit mit dem umu-Assay in der Mikrotiterplatte untersucht. Jedoch 
sollten auch für diesen Assay eine Fraktionierung mit der HPTLC, eine anschließende Extraktion wir-
kender Zonen und Non-Target-Analyse der Extrakte erfolgen. Dazu wurde der umu-Assay in der 
Mikrotiterplatte in das bestehende WBA-mit-HPTLC-Konzept integriert. 
Im Laborexperiment wurde das Arzneimittel Metformin mit Natriumhypochlorit versetzt, um damit 
das Verhalten der Substanz während der Wasseraufbereitung (Chlorung) nachzustellen. Die mit Hy-
pochlorit umgesetzte Metforminprobe wurde mit dem umu-Assay untersucht, wobei eine gentoxische 
Wirkung detektiert werden konnte. Nach der HPTLC-Trennung der gechlorten Probe wurden an-
schließend Zonen über den gesamten Retardationsbereich extrahiert. Bei der Untersuchung der extra-
hierten Zonen mit dem umu-Assay konnte der gentoxische Effekt eindeutig einer Fraktion zugeordnet 
werden. Mittels hochauflösender Massenspektrometrie gelang es, den gentoxischen Effekt einem be-
reits beschriebenen Transformationsprodukt von Metformin nachzuweisen. Die HPTLC-Trennung und 
Extraktion der Zonen von der Platte führte zu einer Reduktion der möglichen wirkenden Kandidaten-
massen um den Faktor 10 und somit zu einer deutlichen Priorisierung bei der HRMS-Analyse.  
Im Rahmen der vorliegenden Arbeit wurde zudem das Projekt „WBA-BeReit“ bearbeitet, mit dem 
Ziel, die Möglichkeiten sowie die Aussagekraft der WBA für die Trinkwasseraufbereitung aufzuzei-
gen. Im Projekt wurden u.a. Roh- und Trinkwässer verschiedener Wasserversorger aus Deutschland 
analysiert und die Ergebnisse verglichen. Es zeigten sich deutliche Wirkungsveränderungen durch die 
Aufbereitung von Roh- zum Trinkwasser, aber auch beim Vergleich der einzelnen Rohwässer. So war 
es möglich, die WBA erfolgreich für eine orientierende Bewertung verschiedener Aufbereitungsver-
fahren hinsichtlich der Veränderung der Wirkungen über den Aufbereitungsprozess von Trinkwasser 
hinweg einzusetzen. 




3 Aims and scope 
In this thesis, EDA was applied to detect bioactive substances in different water samples. Since not all 
of the ingredients in water samples can be identified and evaluated with the analytical methods known 
to date, effect detection should be used to prioritise the relevant substances, i.e., those that cause a 
damaging effect to humans and/or to the environment. Various in-vivo and in-vitro bioassays are  
currently available to assess the effects of such substances. However, due to the numerous ingredients 
in aquatic samples, the identification of effective substances still poses a major challenge. For this  
reason, a strategy should be developed in this work to facilitate the identification of bioactive  
substances in water. As a result of identification, measures could be taken to reduce or even prevent 
the introduction of bioactive substances in the aquatic environment. 
One reason for failing identification attempts in EDA is the complexity of the samples, such that a 
large number of different substances still occur in an effective fraction. The aim of the first part of the 
work was therefore to reduce the number of substances in a fraction by increasing the peak  
capacity with two-dimensional HPTLC separation. A selective approach should be developed, in 
which only the effective zones are transferred into 2D (Publication 1). For identification of the bioac-
tive compounds, the developed 2D EDA approach should be combined with high-resolution mass 
spectrometry and a prioritization strategy was to be developed. The number of signals that could be 
responsible for the effect should be further reduced by the formation of intersections of the sample and 
the extracted zones of the 1D and 2D. Prioritisation to a few signals should facilitate the identification 
of the effective substance (Publication 3). 
In order to cover a broad effect spectrum, the endpoint genotoxicity should be added to the existing 
EDA with HPTLC concept in this thesis. The genotoxicity is of particular importance for water quality 
monitoring, as it results in very low health-related indication values of 0.1 µg/L (0.01 µg/L for  
genotoxic substances with relevant metabolism) in drinking water. Due to the fact that the metabolic 
activation of indirect genotoxic substances cannot be performed on the HPTLC plate yet, the umu 
assay for the detection of genotoxic effects should be applied in the microtiter plate. The aim of the 
current work was the development of a workflow for prior HPTLC separation to the umu assay in 
the microtiter plate and combination with HRMS, such that prioritization and identification of  
genotoxic substances gets possible with the EDA with HPTLC concept (Publication 2). 
After the method development in the first part of the work, within the research project „WBA-BeReit“, 
a real world application of EDA was performed. It should be investigated, if EDA can be used for the 
orienting evaluation of organic trace substances in raw water resources for drinking water  
extraction and treatment processes. For this purpose an initial monitoring approach for raw and 
drinking water had to be developed and different treatment processes were compared. 





4.1 Organic trace substances in the aquatic environment 
Far more than 100 million substances are registered by the Chemical Abstract Service (CAS) of the 
American Chemical Society up to 2019, and more than 100 000 were estimated to be in use presently 
[1]. Every year about 500 to 1000 new chemicals are synthesized [2]. These substances include, for 
example, pharmaceuticals, pesticides, industrial chemicals or cosmetic products, which find numerous 
applications in daily use and can thus, end up in the aquatic environment and subsequently also in raw 
water resources used for drinking water production (Table 1). 
Table 1: Examples for organic pollutants in the aquatic environment [3,4] 
Origin/Usage Class Example groups/substances 














Consumer products Surfactants 
Pharmaceuticals 
Hormones 















Transformation products formed from all the above through 
transformation processes 
Desethylatrazine, Guanyl urea 
 
Anthropogenic substances can enter the aquatic environment in different ways, such as direct sources 
like wastewater treatment plants or industrial processes. Other entry paths are non-point sources like 
agriculture or surface runoffs. The substances can be unintentionally released into the air, water or soil 
via diffuse inputs or accidents, or they can be deliberately released into the ecosystem, as in the case of 
pesticides. The different environmental areas are linked by transport and transfer processes such that 
the substances were distributed [2]. Additionally, the substances are further transformed to different 
transformation products.  
Transformation processes can take place directly in humans or animals, as is desired, with many drugs. 
Transformations in the environment and during water treatment processes, like ozonation or chlorina-




tion cause additional transformation products. The vast majority of them are lesser persistent, bioac-
cumulative and toxic than their starting substances, but there are also some exceptions. For example, 
there is nonylphenol, which is more persistent and bioaccumulative than the precursor substance 
nonylphenol polyethoxylate and moreover causes estrogenic effects [5]. Substances and their trans-
formation products are very diverse and many of the transformation products are currently not known. 
In addition, frequently nothing is known about their toxicity to the ecosystem or humans. 
For water quality assessment, however, the (eco)toxicological effects of the substances occurring is of 
particular importance, as they pose a potential risk to animal and human health. For this reason, bioan-
alytical methods for the detection of toxic effects have been increasingly used in recent years [3]. By 
using bioassays, which are able to detect different endpoints, a broad effect spectrum can be covered. 
However, if the effective substance(s) in an aquatic sample are to be identified, fractionation and 
chemical analysis are required in addition to biotesting. Then the method is named effect-directed 
analysis (EDA). 
4.2 Effect-directed analysis 
EDA was developed to identify the major toxicants in complex environmental mixtures, which pose a 
risk to the environment or to human health. There are a lot of different substances in the environment, 
but often only a few key substances are responsible for causing an effect and thus for the possible  
existing risk. Therefore, EDA combines a fractionation with biological testing and chemical analysis 
with the aim to identify the bioactive substances (Figure 1) [6]. But it is also possible to compare  
different samples with EDA without knowing the identity of the effective substances. For example, the 
effects of samples from different seasons or sampling sites can be compared. Such an effect-directed 
consideration of samples is called bioprofiling [7-9]. 
 
Figure 1: General workflow of effect-directed analysis, modified from [10]. 
The core of EDA is the biotesting, where samples are investigated regarding their toxicity to selected 
endpoints. If a sample shows an effect in the bioassay, EDA enables the separation of the sample into 
several fractions, which could be investigated with the biotesting again. In this work, HPTLC was 
used as a fractionation method for EDA. In this particular case, the bioassay is performed directly on 
the HPTLC plate and is not applied first without separation, but always after the chromatography. In 
the simplest case, the effect can be assigned to one fraction of the sample. So, the fractionation reduces 
the complexity of the sample and additionally delivers information of the physicochemical properties 



























but also by its absorption or fluorescence. The effective HPTLC zone is then further investigated with 
chemical analysis to identify the effective compound. 
4.2.1 Sample preparation 
Water samples to be investigated with EDA can differ widely, from treated sewage, surface or ground 
water up to drinking water. But the concentration of organic trace substances contained, generally is 
under the µg/L-range and so with few exceptions lies under the detection limit of the bioassays, such 
that sample enrichment becomes necessary [11]. As enrichment method for biotesting, solid phase 
extraction (SPE) is frequently used [3,12,13]. Depending on the load of the sample with organic trace 
compounds and matrix, the enrichment factor can be variably adjusted, whereby generally it ranges 
between 10 up to 10 000 [14]. Such flexible enrichment enables the detection of effects, even if the 
substances are only present in minute traces. But sample enrichment also poses challenges that should 
be considered [10]: 
 Toxicity blanks: They may occur if impurities enter the sample during the extraction process. 
Therefore, a blank extract is always required that reflects the conditions of the extraction pro-
cess. For example, a blank of the SPE cartridge helps to detect contamination of the solid 
phase material or the solvents used. 
 Detectable substances: It has to be considered, that an extraction procedure will only gather 
parts of the substances contained in the sample. Therefore often multi-layer SPE cartridges are 
used for biotesting, to gather a broad range of different substance classes. For example, C18 
solid phase materials are combined with special polymer phases that enable the targeted  
enrichment of polar substances or of acidic resp. basic substances [15]. Still, the enriched 
sample must not be representative for the original water sample, because there will always be 
substances, like metals or very polar organic substances, which could only be enriched partly 
or are completely lost during the enrichment. 
 Matrix effects: There are matrix compounds, which are also enriched with the used enrich-
ment method. These compounds generally are natural ones, like humic and fulvic acids and 
they may interact with the bioassay and cause unspecific effects [16]. But they also may bind 
substances contained in the samples and decrease their bioavailability for the bioassay. Such 
matrix effects increase with increasing enrichment factor. Clean-ups may counteract, but they 
cause the additional risk of infiltration of blank toxicity and loss of substances. 
In addition to enrichment with SPE, other enrichment methods, like vacuum concentration or freeze-
drying can also be used for EDA. By using these methods, the substance spectrum to be covered can 
be extended. Vacuum concentration and freeze-drying are well suited for the enrichment of polar and 
ionic substances which can only be enriched to a limited extent by SPE [17,18]. In the research project 
“WBA-BeReit” that was processed in this thesis, very good recoveries for selected anions, cations and 
carboxylic acids could be achieved with these methods. However, the salts contained in the samples 
were also enriched and influenced the applied chromatography. It was also shown that the achievable 
enrichment factors of approx. 50 - 100 limit the application of these methods to water samples with a 
higher content of effective substances [19]. 





The fractionation step in EDA is intended to reduce the complexity of a sample and thus the number of 
substances in a fraction that could possibly be responsible for the effect. By separating non-effective 
fractions from effective fractions, the following identification strategy can be aligned to those fractions 
that cause an effect in the bioassay. In order to develop an optimal fractionation method for the  
addressed separation problem, the following criteria must be observed [10]: 
 Recovery of toxicity: It must be ensured that toxicity is recovered after fractionation. For this 
purpose, the fractions can be combined and their effect compared with the effect of the  
original sample. 
 No toxicity of the blank: Toxicity blank values, which result from the solvent used or from 
the fractionation process, must be controlled and largely prevented. 
 Selectivity and orthogonality of separation steps: The selected fractionation of the sample 
must show sufficient selectivity for the separation problem to be solved. Orthogonal multi-
dimensional fractionations can be used to increase the separation efficiency [20]. 
 Information for toxicant identification: Fractionation can be used to obtain additional  
information about the effective substance, such as the estimation of log Kow values. Using a 
quantitative structure-activity relationship (QSAR)-analysis, the log Kow value can also  
provide additional information about the potential of the substance to cause an effect in a  
particular bioassay [21]. 
There are many different fractionation techniques, but high-performance liquid chromatography 
(HPLC) is applied most frequently in EDA [10]. HPLC enables both on-line and off-line coupling to 
the bioassay. Off-line coupling is much more common, because frequently the time frame of the  
bioassay does not coincide with that of the fractionation [10]. HPLC as a fraction method in EDA was 
for example already used for the investigation of antiandrogenic effects in surface water [22] and  
endocrine effects in hospital wastewater [23]. Generally, organic solvents and additives used for the 
fractionation are not compatible with the following bioassay and therefore have to be eliminated  
before the bioassay is carried out. This can be achieved by carefully evaporating the solvent, which 
however may result in the loss of volatile compounds [24]. 
Only a few EDA applications with preparative gas chromatography (GC) are described as far [25]. GC 
is very suitable for volatile compounds due to its separation efficiency and the sensitive detection in 
combination with mass spectrometry. There are also huge data libraries for easier identification of 
effective compounds [24]. One application example is the separation of polycyclic aromatic hydrocar-
bons (PAH) like benzo[a]pyrene and investigation with the DR-LUC-bioassay for measurement of the 
potency to activate the dioxin receptor [26]. 
High-performance thin-layer chromatography (HPTLC) also has proven to be very suitable as  
fractionation method in EDA. It enables to perform the bioassay directly on the HPTLC plate and was 
applied most frequently to plant extracts [27] and foodstuffs [28,29] but also to environmental samples 
[30]. Different types of beer were examined and compared with regard to their estrogenic effects [28]. 
Bioassay batteries that investigated different endpoints were used for sunflower leaves [31], Salvia 




miltiorrhize (sage) [32] or green tea [33]. One study investigated numerous cosmetic products, such as 
facial creams or sun creams, with a bioassay battery for their antioxidant potential, baseline toxicity, 
estrogenic and antibiotic effects [8]. Moreover HPTLC allows changes in the effects to be considered 
over time and over the application of a process, e.g. water treatment [34]. 
HPTLC as fractionation technique in EDA generally is based on an isocratic separation [8,32], that 
can be carried out quickly and with simple means and it can be easily adapted to new separation prob-
lems. With isocratic HPTLC, however, only peak capacities of 10 up to 35 can be achieved [35]. To 
minimize zone broadening and to increase peak capacity, the automated multiple development (AMD) 
is used in HPTLC. However, this gradient development is at the expense of the required time, which 
increases depending on the number of AMD separation steps applied [36]. 
Each separation technique (HPLC, GC or HPTLC) has different advantages and disadvantages for 
application in EDA. When using HPLC, a large number of different stationary phases are available for 
different fields of application and a broad substance spectrum can be captured. However, the selection 
of solvents for the mobile phase is limited and a solvent change has to be carried out before applica-
tion of the bioassay. Gas chromatography can only be used for a limited amount of substances.  
However, it provides excellent peak capacities for fractionation and very well-developed databases for 
spectrum interpretation. In HPTLC, a variety of solvents can be used for separation, such that a broad 
substances spectrum can be captured. Furthermore, the HPTLC plate is solvent-free after separation 
and can be used directly for the following bioassay, but disadvantageously the peak capacity is  
limited. 
4.2.2.1 Two-dimensional fractionation 
In EDA, the fractionation method is used to reduce the number of candidates possibly causing the 
effect for easier identification of the true effective compounds. In the case of environmental samples 
such as surface or sewage water, however, numerous substances are still present in an effective  
fraction even after fractionation. So, identification of the effective substances remains time-consuming 
and ambitious and in some cases does not succeed. For this reason, two-dimensional techniques are 
used in EDA with the aim of increasing peak capacity and thus achieving a sufficient reduction of 
complexity [20]. 
Several two-dimensional fractionation methods are already in use for EDA. For example, there is a 
two-dimensional HPLC x HPLC method that uses the acetylcholinesterase inhibition assay (AChE 
assay) for the investigation of water samples [20]. One advantage of this application is the automati-
cally performance. Both the 2D LC separation and the subsequent fractionation into a microtiter plate 
are performed completely automatically. After fractionation, the remaining solvent is evaporated from 
the microtiter plate and the bioassay is applied. By means of extremely small fractionation steps, up to 
384 fractions can be separated with this application and examined for their effects. In addition, there 
are also applications of comprehensive HPTLC x HPTLC separations in EDA [37]. Therefore, the 
HPTLC plate is rotated 90° after the 1D and then the plate is separated again with another mobile 
phase. In the study, the pYES for the detection of estrogenic effects was performed after the second 
separation dimension. Moreover heart-cut combination of HPTLC + HPLC through extraction of 
zones from the HPTLC plate is also possible [38]. Therefore, not the entire sample is transferred to the 




2D, but only a selected zone. While the bioassay for comprehensive separations is applied once after 
the 2D, the bioassay for the heart-cut application is applied only after the 1D.  
Another possibility of 2D HPTLC was presented in this work. After the separation in the 1D, the  
bioassay was used to select the effective zones. These were extracted with the TLC-MS Interface and 
transferred to a second HPTLC plate. After the second separation, the bioassay was performed again 
for the detection of effects in the 2D (Publication 1). 
4.2.2.2 Fraction collection for biotesting 
The collection of fractions for the bioassay differs, depending on the used fractionation method 
(Figure 2). In column chromatography, the fractions are usually collected with an automatic fraction 
collector, depending on a certain time frame or on chromatographic peak detection [10]. By using 
HPTLC, the collection of fractions is not necessary, because of the direct application of the bioassay 
on the plate (in-plate fractionation) [24]. However, if the bioassay cannot be performed directly on the 
HPTLC plate, the TLC-MS Interface may be used as fraction collector. When using the Interface, an 
elution head is pressed onto the zone of the HPTLC plate to be extracted and an eluent solves the 
compounds of the zone from the plate [39]. The zones can be selected according to their retardation 
factors, or the entire retardation area may be divided in small sections that can be extracted at greater 
expense. Extracted zones can be examined with bioassays in the microtiter plate (Publication 2) or 
they may be applied to the HPTLC plate and separated again (Publication 1). Then the bioassay is 
performed after a 2D HPTLC separation. In addition, fractions obtained after column chromatography 
with the fraction collector could also be applied to the HPTLC plate. The bioassay can then be  
performed on the HPTLC plate, detecting also two-dimensional separated fractions. 
 
Figure 2: Possibilities for combination of HPLC, GC and HPTLC as fractionation methods with 
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The biotesting is the key element of EDA, because it is used to determine the effects of the sample in a 
concentration dependent manner [10] and it gives biological relevance to the results [24]. The success 
of the EDA depends on the selection of suitable bioassays, which on the one hand must be relevant for 
the risk assessment and on the other hand should also be compatible with the samples to be examined. 
The selection of suitable bioassays shall be based on the following criteria [40]: 
 Required sample volume: The volume required to perform the bioassay must be within a 
range that makes it possible to examine enriched sample extracts. The extracts are usually 
available with a volume of approximately 1 - 10 mL. 
 Tolerance to solvent residuals: Due to the enrichment and separation of the samples, solvent 
residues must be expected, which must not negatively influence the bioassay. 
 Acceptable time exposure: The separation into several fractions increases the effort for the 
analysis of a sample. Thus, the bioassay must be within an acceptable time frame for this 
analysis. 
 Sufficient sensitivity: The bioassay has to be sufficiently sensitive to detect relevant  
substances. Due to the low concentrations of organic trace substances in samples, enrichment 
generally is required for biotesting. 
Bioassays can be performed at the molecular, cellular (in-vitro) or whole organism (in-vivo) level. 
Various biotesting systems are available, whereby in-vivo assays are still used as standard in 
toxicology, because of their high relevance and their predictive power for (eco)toxicological effects. 
Through the use of intact organisms, both toxicokinetic and toxicodynamic aspects are taken into  
account with in-vivo bioassays [40]. However, in-vitro bioassays allow a higher throughput and thus 
the investigation of a larger sample number with lower costs compared to in-vivo bioassays. In  
addition, ethical aspects for avoiding experiments on living organisms speak against the widespread 
use of in-vivo bioassays (Figure 3). 
 






























































So far, the transferability of effects, measured with an in-vitro bioassay, to complex systems such as 
mammals is still a major challenge. There are approaches, like the Adverse Outcome Pathway (AOP) 
concept, that shall facilitate the translation of mechanistic data into meaningful outcomes for environ-
mental monitoring [41,42]. A bioassay that is used for environmental monitoring should meet two 
criteria: it has to be sensitive enough to detect chemicals of environmental concern and the measured 
results should be related to relevant responses in organisms. So, the AOP concept can also be used to 
select appropriate bioassays for EDA [43]. Cell-based bioassays cannot replace regulatory in-vivo 
bioassays, but they can provide additional information for risk assessment and substance prioritization 
[43]. They are extremely divers in their range of endpoints (Figure 4) and some of them have standard-
ized protocols, such as the ISO (International Organization for Standardization) or DIN (German  
Institute for Standardization) guidelines. 
4.2.3.1 Endpoints for investigation of aquatic samples 
There are many different effects in the aquatic environment, so a single bioassay is not sufficient for 
the risk assessment of such a complex sample. Therefore, generally a bioassay battery (more than 3 
different bioassays) is applied in EDA [3]. The battery should be designed in such a way that it can 
detect the effects usually occurring in environmental samples (Figure 4), including specific and non-
specific endpoints [44]. In addition, bioassay batteries must be applicable in routine, which is why the 
selection of applied bioassays is focused on the most important environmental effects [12]. These  
include the induction of the xenobiotic metabolism, endocrine disruption and adaptive stress response 
[43]. Other important endpoints for the assessment of water quality are genotoxicity and neurotoxicity 
[45]. An overview of important effects in environmental analysis is shown in Figure 4. 
 
Figure 4: Overview of important effects in environmental analysis that can be recorded with bioassays 
[46]. 
Taking into account the reasons given above, to cover a broad effect spectrum with relevant endpoints 
and also to select bioassays that can be combined with the used enrichment and fractionation methods, 
the following five endpoints, each gathered with an in-vitro bioassay, were applied in the present 
work: 
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A substantial endpoint for monitoring of aquatic samples, which is also crucial for determination of 
limit values, is the genotoxicity [47]. Substances with a demonstrated genotoxic effect are allocated in 
drinking water to levels of ≤ 0.1 µg/L according to the health-related indicator value concept of Feder-
al Environmental Agency (FEA) in Germany [48]. Genotoxic substances with a human relevant  
metabolism even get health-related indicator values of 0.01 µg/L in drinking water. Different in-vitro 
bioassays are available for the detection of genotoxic effects, such as the Ames assay, the micronucle-
us assay or the umu assay. The Ames assay with Salmonella typhimurium tester strains TA98 and 
TA100 with and without exogenous metabolic activation, is applied most frequently in water analysis 
[49]. The genetically modified strains carry mutations, which prevent the bacteria to grow without the 
addition of histidine to the growth media. Only bacteria that come in contact to mutagenic substances 
and therefore mutate back can grow on a histidine deficiency culture medium. The number of mutant 
colonies is counted and determines the mutagenic effect of the sample. In the micronucleus assay, 
occurrence of mutagenic substances is measured through appearance of micronuclei in Chinese ovary 
hamster (CHO) cells [50]. Micronuclei are small membrane bound DNA fragments that occur through 
deficient cell division. The cells are visually scored for the presence of micronuclei. Another bioassay 
that is frequently used is the umu assay with genetically modified Salmonella typhimurium 
TA1535/pSK1002 cells [51]. Presence of genotoxic substances leads to DNA damage, which triggers 
the expression of the umuC-gene, a part of the SOS-repair system. However, the umuC-gene is fused 
with the lacZ-reporter gene coding for the enzyme ß-galactosidase. Synthesis of ß-galactosidase is 
quantified through colorimetric detection of the substrate o-nitrophenyl-β-D-galactopyranoside 
(ONPG), which is cleaved through ß-galactosidase to the yellow product o-nitrophenol. 
To date, no bioassay for the detection of genotoxic effects with metabolic activation can be performed 
directly on the HPTLC plate. One assay is available, which uses genetically modified yeasts for the 
detection of genotoxicity on the HPTLC plate [52]. However, only direct genotoxic effects can be 
captured, because the exogenous metabolic activation system does not work on the HPTLC plate so 
far. Since many substances exert an indirect genotoxic effect, in this work the umu assay in the micro-
titer plate was used as an alternative, which also enables metabolic activation (Publication 2). 
Neurotoxicity 
An important endpoint with a human-relevant mode of action is the neurotoxicity [53]. Substances 
with a proven neurotoxic effect therefore get a health-related indicator value of ≤ 0.3 µg/L in drinking 
water [48]. The detection of neurotoxic effects is difficult and very time-consuming. As very long 
observation periods are necessary for the detection of neurotoxic effects in the whole organism and the 
frequency of results is usually too low, more and more in-vitro bioassays are being used [54]. In EDA 
for example, the viability of primary cultured cerebellar granule neurons after incubation with  
fractions of environmental samples was investigated and neurotoxic brominated flame retardants could 
be identified [55]. For investigation of water samples, the in-vitro AChE inhibition assay is used most 
frequently [54]. This enzyme-based bioassay indicates the inhibition of the enzyme acetylcholinester-
ase that plays an important role in the transmission of stimuli in the synaptic cleft of the nerve cell. By 
using this assay, also unspecific binding of substances to the purified enzyme must be considered, 




such that measured potential neurotoxic effects have to be confirmed through application of further 
bioassays [20].  
After the development of the AChE inhibition assay in the microtiter plate in 1961 [56], the assay has 
also been performed on the HPTLC plate in 1964 [57] and has been widely used for investigation of 
potentially neurotoxic effects [27,58] (Publication 1). Particular emphasis in investigations was put on 
the carbamates and organophosphates [59], which specifically bind to the active center of the AChE 
[60]. These substance groups are often found in pesticides [61], but they are also used as drugs for the 
treatment of Alzheimer's disease [62,63] or Myasthenia gravis [64]. 
Estrogenic activity 
Another important endpoint is the hormonal effect of substances and in particular their estrogenic  
activity [65]. In the case of estrogens, the effect already occurs in very low substance concentrations. 
For this reason, substances with proven estrogenic effects get a health-related indicator value of 
≤ 0.01 µg/L in drinking water [48]. Three in-vitro bioassays are proposed as biotest battery for the 
detection of estrogenic effects in the health-related indicator value concept. In the first level of the 
battery, a reporter gene mediated test, such as the estrogen receptor-chemically activated luciferase 
expression® assay (ER-CALUX®) [66] or the Yeast estrogen screen (YES) [67] is to be applied. Addi-
tionally the H295R steroid genesis assay [68] is proposed for application. If estrogenic effects are  
detected with a reporter gene assay, an in-vivo reproduction assay, e.g. the Potamopyrgus antipodarum 
assay (New Zealand mud snail) [69], shall be performed in a subsequent step. 
The YES, based on genetically modified Saccharomyces cerevisiae BJ3505 yeast cells is often used 
for the detection of estrogenic effects in water samples. The yeast cells contain a plasmid with the 
human ER-α. If estrogenic substances bind to the ER-α, a signalling cascade starts at the end of which 
the enzyme ß-galactosidase is formed. By adding a substrate that is cleaved by the ß-galactosidase, the 
estrogenic effect can be detected [67]. 
In 2004, the YES was performed on the HPTLC plate for the first time and named with the abbrevia-
tion pYES for planar YES [70]. Since then, several research groups have been working on the  
advancement of the bioassay on the HPTLC plate. This enabled the duration of the assay and the 
sharpness of the effective zones to be significantly optimized [71]. Several procedures for carrying out 
the assay were developed using different HPTLC plates (normal phase, NP and reversed phase, RP) 
and substrates (4-methylumbelliferyl-ß-D-galactopyranoside, MUG and resorufin-β-D-
galactopyranoside) [72]. In some procedures the yeasts are sprayed onto the plate, while others  
immerse the plate in the yeast suspension [73,74]. 
Cytotoxicity 
Cytotoxicity refers to the ability of substances to damage cells or tissues, which can cause cell death. 
Cytotoxic substances can also damage the microorganisms used in bioassays, so that their results  
cannot be interpreted. Therefore, the detection of cytotoxic effects as performed with the neutral red 
assay [75] or the MTT assay is very useful [76]. The MTT assay detects the metabolic activity of cells 
by reducing the yellow 3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide (MTT) to  
violet MTT-formazan [77]. This reaction requires the reduction equivalents NADH and NADPH, 




which are formed in the cells during glycolysis. If cytotoxic substances are present in a sample, they 
inhibit the glycolysis rate of the cells and as a result cause a lower conversion of the substrate MTT to 
MTT-formazan [76]. The MTT assay can be performed with different bacterial cells. For Bacillus 
subtilis (BS), for example, a commercial test kit is available. 
In 1986, the Bacillus subtilis assay for the detection of cytotoxic effects was transferred to the HPTLC 
plate [78]. Since then, the assay has been continuously further developed [79,80] and was applied, for 
example, for the detection of antibacterial plant compounds [81] or antibiotics in milk [82]. 
Baseline toxicity 
Baseline toxicity is used in ecotoxicology to determine general toxic effects. The bacterium Aliivibrio 
fischeri (AF), which is capable of bioluminescence, is frequently used for this purpose. The ability of 
the bacterium to bioluminescence is directly linked to the respiration via the electron transport chain, 
so that the influence of toxic substances on the cellular metabolic state is immediately reflected in the 
bioluminescence intensity [83]. The AF inhibition assay is used in a wide variety of applications, for 
example, to investigate the toxicity of organic and inorganic substances and metals, but also for liquid 
and solid samples. There is an application for the investigation of solid sediment particles with regard 
to their baseline toxicity. Depending on the incubation period, both acute and chronic effects on 
Aliivibrio fischeri can also be investigated [84]. Since 1978, the test has also been commercially  
available under the name Microtox®. In the meantime, there are several other suppliers who distribute 
the test (LUMIStox®, ToxAlert® or BioTox™). Since 1991, the bioassay has also been standardized 
by DIN [85]. 
The AF inhibition assay was first applied on the HPTLC plate in 1996 [86]. The AF inhibition assay 
with HPTLC is quick and easy to perform and therefore has already been used in several applications. 
For example, the assay is often used as initial assay in bioassay batteries [28,87]. It has also been used 
to investigate sunscreens [88], secondary metabolites in marine sponges [89], waste and landfill water 
[90] and marine sediments [91]. 
The following Figure 5 gives an overview of the bioassays used in this work: 
 






























































































4.2.3.2 Application of bioassay batteries for investigation of aquatic samples 
Bioassay batteries have already been widely used for the analysis of aquatic environmental samples. 
One study investigated the behavior of effects during various water treatment processes such as ozona-
tion, chlorination, UV-treatment or combinations thereof [13]. Thirty-six different bioassays were 
applied, covering a total of 18 different endpoints of effects. The nine investigated water samples 
showed correlations between the reduction of effects, the applied treatment steps and the respective 
endpoint investigated. For example, ozonation could trigger a significant decrease in oxidative stress, 
whereas UV-treatment led to a reduction in glucocorticoid activity. Chlorination reduced the genotoxi-
city and herbicidal activity of the tested samples. Groundwater infiltration in turn reduced the activity 
of all investigated endpoints except genotoxicity. In some cases, bioactivity increased as a result of a 
treatment step, suggesting the emergence of effective transformation products. 
Effect behaviour during drinking water treatment was investigated in this thesis as part of the “WBA-
BeReit”-project. 10 raw and drinking water samples of 7 water suppliers in Germany were investigat-
ed with the bioassay battery described in Figure 5. In contrast to the investigation named above [13], 
which was performed without fractionation of samples, in this approach EDA with HPTLC as frac-
tionation method was applied. None of the water samples caused a potential genotoxic effect in the 
umu assay, but multiple effects were observed with the four bioassays on the HPTLC plate (Figure 6). 
 
Figure 6: EDA with four endpoints of raw water (RW) and drinking water (DW) of different water 
suppliers from Germany; determined in the context of the project “WBA-BeReit”, which was worked 
on in this thesis. Number 1 - 5: groundwater as raw water, number 6 - 10: surface water as raw water, 
modified from [19]. 

























































































































The effect pattern of each endpoint was similar in different waters studied, suggesting that similar 
substances are responsible for the detected effects (Figure 6). A comparison of the sample pairs  
revealed large differences with regard to the change of effects due to the treatment used. For example, 
for sample pair no. 2 almost no change in effects was achieved by the applied treatment, whereas the 
effect was significantly reduced in sample pair no. 9. 
In summary, the HPTLC separation of the water samples resulted in an effect pattern of each investi-
gated bioassay. On the basis of such effect patterns, a detailed examination and comparison of samples 
can be carried out. For a clear and simple description of the drinking water treatment however, the 
effects of the fractions were additionally summed up and standardised for each of the five bioassays. 
Thus, the sum of effects of a sample could be described by five numerical values (Figure 7). 
 
Figure 7: Sum of effects of 10 raw- and drinking water sample pairs and the applied treatment steps, 
modified from [19]. RW: raw water, DW: drinking water, O3: ozonation, AC: activated carbon filtra-
tion. 
When comparing the raw water samples in Figure 7, there are strong fluctuations in the sum effects 
from 56 to 345, with no clear differences between the raw water sources used. The situation is  
different for the drinking water samples, examined after water treatment processes. The drinking water 
samples obtained from groundwater showed only little effect reduction and in two of the drinking  
waters (sample pair no. 3 and 4) the effects even increased. However, in the drinking waters from  
surface waters the effects could be significantly reduced. When comparing the differences in the sum 
effects with the treatment steps, it becomes apparent that more effect reduction could be obtained, 
when several different treatment steps were applied. In the sample pairs with successful effect  
reduction (sample pair no. 7, 8 and 9), ozonation and/or activated carbon filtration were used in  
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treatment steps are particularly beneficial for effect reduction has to be investigated in subsequent 
studies. 
4.2.4 Chemical analysis 
Chemical analysis is crucial for identification of effective substances in EDA. However, it is only  
successful, if individual toxic substances or combinations of them cause the effect (toxicity drivers). If 
the measured effect is caused by the mixture itself, identification of all the compounds involved is not 
very promising. Three general approaches for identification of effective substances are applied in EDA 
[40]: 
 Mass balance approach: Quantitative chemical target analysis of candidate compounds that 
might be responsible for the effect. The mass balance approach is used most frequently in 
EDA. For this purpose, known effective candidates are selected and searched in the effective 
samples via target analysis [12,15]. This approach is especially suitable, when specific  
bioassays are applied, in which only few substances usually cause the effect (e.g. YES). These 
substances are named toxicity drivers. If a toxicity driver is present in the sample, its concen-
tration is determined and the effect of this substance concentration is checked. Thus it can be  
examined, whether the effect of a fraction can be explained by the identified substance [10]. 
 Virtual effect-directed analysis: In virtual EDA, multivariate statistical tools are used to  
obtain correlations between effects and the occurrence of substances or groups of substances. 
This approach is mainly used when the toxicity drivers of an endpoint are not known. A large 
sample number (more than 10, the more the better) is required for a meaningful application of 
virtual EDA. Additionally, investigated samples should contain a similar substance spectrum, 
which differs in the concentration of the substances and thus in the effect intensities. If these 
conditions are met, virtual EDA is very promising [92,93]. Thus, virtual EDA is suitable for 
investigation of time series of samples with the same origin and the same anthropogenic  
influences, but with seasonal variations in substance concentrations and effects. However, it 
must be considered that the linear course of the concentration level of a substance cannot 
simply be correlated with the sigmoid course of the dose-response curve of that substance. 
Thus, even a large concentration change of a substance can cause only a small change of the 
effect and vice versa, making the application of virtual EDA more difficult. 
 Higher tier effect-directed analysis: Non-target strategy for identification of effective  
compounds in one or few samples. The higher tier EDA approach is used to identify  
previously unknown toxicity drivers (Publication 3). Non-target screening (NTS) is used, 
when the detected effects cannot be explained by the known toxicity drivers in the mass  
balance approach. Higher tier EDA creates direct cause-effect relationship, but it is  
time-consuming and expensive. Therefore it is used, if identification with the other two  
approaches is not successful or they cannot be applied [40]. 
There are several analytical methods available to apply chemical analysis in EDA, but in most cases 
HPLC-MS with electrospray ionization (ESI) is used [94]. When using selected ion monitoring in 
target analysis of the mass balance approach, triple-quadrupole mass spectrometers are applied in 
EDA. For NTS, time-of-flight or orbitrap mass spectrometers are mainly used, as they provide  




sufficiently high mass accuracy (< 5 ppm at m/z 200) and resolution (> 10 000) for substance identifi-
cation [40]. NTS workflow for EDA is divided in two steps: data acquisition of the effective samples 
and fractions and data evaluation. During data acquisition, full scan MS data of protonated or deproto-
nated molecular ions (or adducts) are recorded. In addition, collision-induced fragmentation generates 
MS/MS data of the molecules, which can provide structural information. After data acquisition, the 
data evaluation is performed, which is important for reducing the quantity and complexity of the data. 
During the data evaluation the selection of the peaks (peak finding), the subtraction of blank signals as 
well as a componentization of the signals takes place, with which the individual signals (isotopo-
logues, adducts, in-source fragments) are to be assigned to one compound. By measuring a sample 
several times, additional instrumental noise signals can be reduced. When measuring several samples, 
the signals are combined in a common list by an alignment. The elaborate data evaluation results in a 
list of valid signals that can be used for the subsequent identification strategy [95].  
An important step in the identification of effective substances is the allocation of the exact masses in 
the list to molecular formulas. Therefore, mass accuracy and resolution of the mass spectrometer used 
are decisively, as are the isotope pattern and fragment information. The molecular formulas  
determined are then compared with possible structural formulas. Databases such as ChemSpider or 
Pubchem, which contain millions of substances, are helpful there. Databases on the toxicity of sub-
stances can also help to identify the effective substance. Due to the large number of different  
substances, many structural formulas can usually be assigned to one molecular formula, so that this 
must be checked by additional structural information, such as the MS/MS spectra. However, a clear 
level 1 identification of a substance can only be achieved by means of a reference standard [96].  
Despite the reduction of sample complexity via fractionation, identification of (effective) substances 
still is very challenging. Possible reasons for failing identification attempts are very complex samples, 
such that still many different substances occur in one fraction or the lack of structure and spectra data-
bases as well as the generally high manual effort for NTS [94]. 
4.2.4.1 Application of identification approaches in EDA 
There are various applications of the three identification approaches named above, including combina-
tions of them. Different surface and wastewaters in Europe were investigated for example for their 
estrogenic effects with five different in-vitro bioassays (ER-CALUX®, MELN, Hela-9903, 
GeneBLAzer, pYES). In parallel, three estrogens from the “watch-list” of the water framework  
directive (17ß-estradiol, estrone and 17α-ethinylestradiol) were investigated using the mass balance 
approach. Determined 17ß-estradiol equivalents of the five bioassays were comparable. The measured 
substance concentrations differed strongly between sampling sites and from wastewater to surface 
water. However, there was a strong correlation between the results of the bioassays and those of the 
chemical analysis [65]. 
Also in this thesis, within the scope of the “WBA-BeReit”-research project, a chemical analysis using 
the mass balance approach was carried out. Twenty raw and drinking water samples from different 
water suppliers were analysed with the pYES for their estrogenic effects and also with HPLC-MS/MS 
analysis for five estrogens (17ß-estradiol, estrone, estriol, 17α-ethinylestradiol and 17α-estradiol). 
Three estrogens (17ß-estradiol, estrone and estriol) were detected and quantified in different raw  




waters. Through performing the pYES with the quantified concentration of the detected estrogens, the 
measured estrogenic effect in the respective zones could be fully explained [19]. 
Compared to the mass balance approach, there are fewer applications in the area of virtual EDA. One 
study described the use of virtual EDA to identify antiandrogenic effects in soil samples of a chemical 
park. Therefore, an approach was developed in which first a virtual fractionation of the samples and 
then a virtual quantitative structure-retention relationship was established. Antiandrogen effects were 
detected in 8 out of 18 soil samples with the AR-antagonist assay. Multivariate statistical methods 
were used to select 76 peaks that could cause the effects. By comparison with the classical EDA  
results, 90 % of those peaks could also be confirmed in effective fractions of the soil samples. Thus 
identification of key toxicants in samples should become more efficient and faster with virtual strate-
gies [97].  
In 2018, the higher tier EDA approach was used for the identification of antiandrogenic substances in 
surface water. The samples were fractionated using four different stationary HPLC phases and the 
fractions were examined for their effect using the anti-AR CALUX® assay. One effective fraction 
occurred and an NTS by HPLC-MS/MS analysis was applied. The highly potent antiandrogenic  
substance 4-methyl-7-diethylaminocoumarin and two derivatives thereof were identified. The detected 
effect in the surface water could be explained almost completely by quantifying the identified  
substances. Moreover, the antiandrogen effect of the substances was confirmed by further in-vivo  
bioassays [22]. 
The higher tier EDA approach was also applied in this thesis for identification of effective compounds 
in the project “WBA-BeReit”. The Bacillus subtilis inhibition assay was used to detect cytotoxic  
effects in different raw and drinking waters. One effective zone occurred simultaneously in several of 
the examined raw waters and it was thus suspected that the detected effect was caused by the same 
toxicant. Therefore, the effective zones were extracted and an NTS using HPLC-HRMS/MS was per-
formed. In the extracted zones, a total of 10 substances could be clearly identified by means of refer-
ence standards, whereby these were exclusively drugs and their transformation products. Only two of 
the ten substances showed a cytotoxic effect in the BS inhibition assay, namely clindamycin-sulfoxide 
and candesartan. While candesartan is widely used as an antihypertensive, clindamycin-sulfoxide is a 
transformation product of clindamycin, which is used in many ways as an antibiotic. However, the 
cytotoxic effect of the extracted zone could not be explained by these substances, which only exert a 
cytotoxic effect in higher concentrations than those contained in the samples. Therefore, further  
unknown substances must occur in the extracted zone, which together with candesartan and  
clindamycin-sulfoxide trigger the cytotoxic effect [19]. 
4.2.4.2 Examination of water treatment processes with chemical analysis and effect detection 
Additionally to the identification of effective substances, chemical analysis with NTS is also be used 
to describe variability of substance concentrations during water treatment processes [98]. In this  
non-target process evaluation, the signals are divided into five categories according to the ratio of their 
signal intensity (fold change, fc) from drinking water (DW) to raw water (RW): 
 








 Elimination (dark green):   fc < 0,2 
 Decrease (green):       0,2 ≤ fc < 0,5 
 Consistency (grey):       0,5 ≤ fc ≤ 2,0 
 Increase (yellow):       2,0 < fc ≤ 5,0 
 Formation (red):       5,0 < fc 
NT process evaluation can be used to correlate changes in substance concentrations with changes in 
effects, even without primarily identifying effective substances. This was applied in this thesis for the 
examined raw and drinking waters of different water suppliers. The raw and drinking water samples 
showed a similar behaviour in the results of NT process evaluation and effect process evaluation. If the 
effects decreased significantly through applied treatment steps, as for example in sample pair no. 7, 
this was also reflected in the NT process evaluation with a large number of signal ratios in the  
category "Elimination” or “Decrease" (Figure 8). In the case of sample pairs with only little effect 
reduction from raw water to drinking water, a large number of signals was detected in the category  
"Consistency". 
 
Figure 8: Comparison of the effect process evaluation with the NT process evaluation of sample pair 
no. 7 (Figure 7). 
The ratio of the sum effect of drinking water to raw water is a measure to describe the effectiveness of 
the treatment with regard to the removal of the effects. In the same way, the ratio of the number of 
detectable signals in drinking water and raw water in the NT process evaluation can describe the  
effectiveness of the treatment with regard to the removal of substances. A comparison of these two 
measures shows that treatment with ozonation and/or activated carbon filtration in raw water tends to 
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5.1 Organic trace substances in the aquatic environment 
In the present work, EDA with HPTLC was applied for the analysis of effective trace compounds in 
the aquatic environment. Organic trace substances generally occur in the environment in low  
concentrations (up to µg/L), such that the working range of EDA has to be considered (Figure 9). 
While chemical analysis via LC-MS/(MS) can still cover the ng/L-range without enrichment, the 
working range of the bioassays used in this thesis spans from µg/L to mg/L (exception YES: ng/L - 
µg/L). Therefore, without sample enrichment, the usual environmental concentrations would not be 
detectable with the bioassays, so in this thesis, environmental samples were enriched by SPE with an 
enrichment factor of 1000. 
 
Figure 9: Concentration range of environmental organic trace substances in comparison with the  
working range of LC-MS/(MS) and the applied bioassays on the HPTLC plate (exception umu assay). 
There are large differences in the sensitivity of the bioassays used in this work. While the YES can 
detect substances down to the ng/L-range without enrichment, with the umu assay the genotoxic  
effects can only be gathered in much higher substance concentrations. Thus, the umu assay is not able 
to detect low environmental concentrations of trace compounds even with a 1000-fold enrichment and 
therefore is only suitable to limited extent for the use in water quality assessment. Rather, the umu 
assay is suitable for regulatory investigations, where higher substance concentrations are available 
instead of the often low environmental concentrations. In that way, the umu assay is also used in the 
health-related indicator value concept for drinking water of the FEA in Germany. But for water quality 
assessment and drinking water monitoring, there is a need for more sensitive bioassays for  
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[99] may likely lead to an increase of sensitivity, so that the endpoint genotoxicity can successfully 
gather the effects of substances contained in water in low concentrations. 
5.2 Effect-directed analysis 
Sample preparation 
SPE is the most widely used enrichment method for application in EDA, because it is suitable for  
enrichment of substances in a wide polarity range. But small and polar substances in particular, can 
only be enriched to a limited extent by SPE [18]. In the research project “WBA-BeReit”, good  
recoveries for polar and ionic substances were achieved with vacuum concentration and freeze drying, 
but they also cause enrichment of salt content, which interfered with the HPTLC separation.  
Moreover, only enrichment factors of 50 - 100 could be achieved with these methods, so that  
substance concentrations did not fell within the working range of EDA [19]. In order to be able to 
record polar substances with EDA, further investigations for the enrichment of these substances are 
required in the future. For example, multi-layer SPE materials may be used, which at the same time 
enable an enrichment of more polar substances and also achieve higher enrichment factors required for 
EDA [18]. 
Fractionation 
EDA with HPTLC as fractionation method provides the advantage that effects can be detected quickly 
and due to the possibility of applying up to 15 samples simultaneously on the HPTLC plate, a high 
sample throughput is achieved. However, the disadvantage of HPTLC is the limited peak capacity in 
comparison to HPLC and GC. For this reason, a selective 2D EDA method was developed in this work 
(Publication 1). By using a heart-cut approach, only effective zones were transferred from 1D to the 
2D and separated with another mobile phase, before the bioassay was applied again. 
The developed selective 2D EDA introduced a new method for the more selective detection of  
potential neurotoxic effects. There are already applications of comprehensive 2D HPTLC on a HPTLC 
plate with following biotesting [37], but such approaches carry out first the two separations before the 
bioassay can be performed. Thus, it cannot be checked whether effects occur in the bioassay at all and 
whether a separation in the second dimension would be necessary. There are also applications where 
the effective zones are extracted from the plate after separation in the 1D and separated in the 2D by 
HPLC [38]. However, the bioassay can only be used after the 1D, so that no further prioritization of 
the effective ingredients is possible after the second separation. 
To increase the peak capacity by 2D chromatography, orthogonal separation techniques are necessary. 
In order to obtain orthogonal separation mechanisms, it would be useful to change the selectivity of 
the stationary phase. However, in EDA with HPTLC, it is crucial that stationary phase parameters 
(pH value, wettability of the HPTLC plate, etc.) are compatible with the applied bioassay. Therefore, 
the same stationary phase, but different mobile phases for 2D chromatography were used in this thesis.  
2D HPTLC enabled peak capacities of up to 208 in this work (Publication 1). Compared to 1D 
HPTLC gradient development, an increase of peak capacity by a factor of about 7 was reached. In 
comparison, 1D HPLC provides peak capacities of approximately 100 - 1500, while 2D HPLC can 




achieve peak capacities of several thousand [100,101]. So, with 2D HPTLC only peak capacities in the 
lower 1D HPLC range can be achieved. In this work, however, the application of 2D EDA for surface 
water and sewage water showed that a peak capacity of around 200 is sufficient for the prioritization 
so that only a few signals remained as possible effective candidates. 
Biotesting 
One advantage of EDA with HPTLC is that the bioassay can be performed directly on the HPTLC 
plate, allowing a pattern comparison of the effects of different bioassays. However, the transfer of 
bioassays to the HPTLC plate considers complex method adjustments and validation steps [72,80] and 
not each bioassay can be successfully transferred. For example, the umu assay with metabolic  
activation cannot be performed on the HPTLC plate yet, because the enzymes of xenobiotic  
metabolism are not stable on the plate [102]. To bypass direct application of the xenobiotic enzymes to 
the plate, the metabolic activation can be performed in solution and the metabolized sample is applied 
to the HPTLC plate for separation. Another option, which was applied in this thesis, is to investigate 
via HPTLC separated fractions with the umu assay in the microtiter plate (Publication 2). 
The developed procedure for linking the umu assay with EDA and HPTLC enabled the assignment of 
a transformation product of the substance metformin to a genotoxic effect. By repeated extraction of 
zones over the entire retardation area and investigation of these fractions with the umu assay, it was 
possible to prioritize to one fraction with a genotoxic effect. Through chemical analysis via HPLC-
MS/MS, the effective transformation product could be clearly identified. So, in this work a possibility 
was developed to successfully carry out the EDA with HPTLC even without a direct application of the 
bioassay to the plate. This method may be expanded to further bioassays with sensitive or adherent 
cells that cannot be applied directly on the plate. As an alternative, the fractionation method may be 
changed from HPTLC to HPLC. In this case, it would be possible to collect the fractions of the  
samples directly in the microtiter plate for the following bioassay [23]. However, the fractions have to 
be solved in a solvent that is compatible with the bioassay so that the eluent of the HPLC has to be 
evaporated. Additionally, to reach the working range of the bioassay, a large sample volume must be 
injected onto the HPLC column. But such high substance concentrations may cause capacity problems 
on the column. Alternatively, the HPLC separation may be repeated several times to increase the  
substance concentration in the fractions. 
In spite of the effort for the transfer, it would be desirable to be able to apply as many different  
endpoints as possible on the HPTLC plate. Hence, the effect patterns of different samples may be  
easily compared within an endpoint and also between different endpoints of effects. There are already  
approaches to detect for example androgenic and dioxin-like effects directly on the HPTLC plate.  
Approaches for the assessment of further hormone-like effects such as glucocorticoids or  
progesterones have also already been published [103]. 
In this thesis, five bioassays were already applied as bioassay battery, so that a wide range of effects 
could be recorded. However, the applied bioassays differ in their relevance depending on the research 
question to be investigated. The AF assay and also the BS assay for the detection of baseline toxicity 
and cytotoxic effects, respectively, are very well suited for the detection of eco-toxicological effects in 
water samples. They can detect a broad substance spectrum and thus give a good overview of the  




exposure of different samples. For monitoring of drinking water, on the other hand, human-toxic  
effects are of more relevance. These two assays (AF and BS assay) are of secondary importance,  
because the bioassay results cannot be transferred to higher organisms. This is different with the three 
other bioassays applied in this thesis. Due to the mechanisms of action, which can also take place in 
higher organisms, the transferability is rather given, albeit with limitations. For example, the AChE 
assay is susceptible to the denaturation of the free enzyme by matrix compounds in the samples, which 
would not occur if the enzyme was present in an intact cell. False-positive results caused by  
non-specific effects must be expected with this assay. For this reason, the AChE assay is to be  
understood as an initial assay, whose potential neurotoxic results must be confirmed by further and 
often more complex in-vivo bioassays. 
In order to cover questions that assess effects with regard to more human-toxicological relevance, the 
bioassay battery used in this thesis should be supplemented by further bioassays. For this purpose, 
human cell lines may be used that contain the human metabolic cell equipment and so may achieve a 
greater acceptance of the EDA results. 
Chemical analysis 
In this thesis, a 2D EDA workflow for easier identification of effective substances was developed 
(Publication 3). A proof of concept with six spiked neurotoxic substances in different water samples 
showed that the workflow can be successfully applied and that the substances can be recovered after 
the prioritization steps. The efficiency of the workflow for identification of unknown substances could 
be demonstrated by identifying potentially neurotoxic substances. 
However, the necessary repeated extraction of samples results in a loss of substance concentration 
during the workflow. One opportunity to limit this loss may be a flexible elution head that could be 
adapted to the size of the zone to be extracted. Moreover, the extraction step with the TLC-MS  
Interface still requires a great deal of manual effort and skills on the part of the user, as the zones have 
to be determined by using a coordinate system on the extractor. A great simplification would be the 
automation of the extraction steps via the TLC-MS Interface, so that effective zones could be  
automatically transferred from the 1D to the 2D and to the mass spectrometric measurement. Overall, 
the workflow is particularly well suited when unknown effects occur at high intensity, as is the case 
with sewage or surface water rather than drinking water. 
If the identification of the effective substance is still not successful, different reasons may be responsi-
ble. These may be the lack of structural and spectral databases and of databases with toxicity infor-
mation and the generally high manual effort for NTS may also lead to failed identification attempts. 
5.3 Research project „WBA-BeReit” 
In this thesis, the research project “WBA-BeReit” was performed, where EDA with HPTLC was used 
in a real world application for the investigation of raw and drinking water from different water  
suppliers in Germany. It should be investigated whether EDA with HPTLC is suitable for assessing 
the behavior of effects of organic trace substances in drinking water treatment. The results showed 
clear differences in the effects depending on the raw water and the treatment methods used, so that an 
initial evaluation of the various treatment steps could take place.  




The description of the treatment process with EDA was carried out by summing up the effects over the 
entire retardation area. This allowed a simple and clear comparison of the examined samples, but the 
information obtained by the fractionation was lost through the summation. In further work, it would be 
advisable to introduce a retardation factor-dependent comparison of the effects over the treatment  
process. Then the investigated samples may be compared better, such that even small differences in 
the effects could be detected. Since so far, there is the risk, that small differences in the effects are 
masked by the summation of all effects.  
The investigation of treatment processes during drinking water production carried out to date have 
shown that the effects tend to be most effectively removed by the use of the treatment processes  
ozonation and/or activated carbon filtration. However, so far only random samples of different water 
suppliers could be examined in the project, so that the results would have to be consolidated by further 
investigations. It would also be important for the evaluation to consider single treatment steps instead 
of the entire treatment process. 
Finally, a comparison showed a strong correlation between EDA and NTS results with regard to the 
assessment of treatment processes. This relationship contradicts the assumption that only a few  
toxicity drivers are responsible for the detected effects. However, non-specific bioassays, such as the 
AF assay and BS assay, were also applied in this work, which enable the detection of the multitude of 
substances in a sample. Also the AChE assay reacts to a large number of substances and thus reflects 
the complexity of the samples. With the help of these bioassays, as with NTS, the large number of 
substances contained in the samples is recorded and thus explains the very good correlation between 
the results of EDA and NTS. 
However, in comparison to NTS data, the EDA also provides a statement on the relevance of the  
substances. For example, a process with a lot of substance reduction could result in only one substance 
with a relevant effect that is decisive for the evaluation of the process. Thus, EDA not only provides a 
statement on the quantity of signal changes, but also assigns a relevance to the occurring substances 
and is, therefore, very suitable as a supplement to the NTS. 
 





The detection of effects is of vital importance for water quality assessment, because only by detecting 
the effects, a possible arising risk of a sample can be estimated. However, if relevant effects occur in a 
sample, the identification of the bioactive substances is essential. Therefore, in this thesis a strategy for 
the prioritization of bioactive trace compounds with 2D EDA was developed. The aim of the strategy 
was to reduce the complexity of effective fractions so that they could be prioritized to only a few  
candidate signals and the effective substance(s) could be identified more easily. Since the substances  
responsible for the effect are known, targeted measures can be taken to reduce or even prevent their 
entry in the aquatic environment. Thus, EDA makes an important contribution to the water quality 
assessment and subsequently also for drinking water production. 
The developed 2D EDA with HPTLC and HPLC-HRMS approach used the AChE assay for the  
detection of neurotoxic compounds in this thesis, but it could also be transferred to further endpoints 
in the future. A broad application of the strategy with different water samples could show additional 
aspects to optimize the identification of effective compounds.  
The successful application of the EDA with HPTLC for the evaluation of processes during drinking 
water treatment could be demonstrated in the research project “WBA-BeReit”. By investigating raw 
and drinking water from various water suppliers, it was possible to describe the treatment process in 
terms of effect reduction, whereby ozonation and activated carbon filtration tended to be most  
effective in reducing the effect. This information gain through the process description with the EDA 
opens up new possibilities in the quality assurance of drinking water. However, in order to be able to 
make even more precise statements about the individual treatment processes, further investigations are 
necessary, which also look at individual treatment steps. 
By connecting bioassays in the microtiter plate to EDA with HPTLC, the application range of the 
method could be considerably extended. This allows application of additional endpoints, such that 
monitoring of aquatic samples gets broader and the detectable effect spectrum can be expanded. In 
order to record more effects in the future that could also be relevant for humans, additional bioassays 
must be used to ensure better transferability of the results to higher organisms. In addition, there is a 
need for more sensitive bioassays for the water quality assessment that are able to detect also very low 
environmental concentrations of trace compounds. 
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a  b  s  t  r  a  c  t
There  are  thousands  of organic  trace  substances  in the environment  that  are  not  fully  characterized,  and
evaluation  of their  relevance  to the  ecosystem  is  difficult.  Effect-directed  analysis  (EDA)  is a suitable  tool
to assess  the  effects  of a substance  via  in-vitro  bioassays,  which  can  provide  information  about  the  rel-
evance  of the  substance.  High-performance  thin-layer  chromatography  (HPTLC)  has  been  shown  to be
a good  method  for  fractionation.  Environmental  samples,  however,  often  have  high  complexity,  which
is  why  the peak  capacity  of HPTLC  is  not  sufficient.  Therefore,  this  study  focused  on the  development  of
selective  two-dimensional  (2D)  HPTLC-EDA  to increase  the  peak  capacity  and  facilitate  the  identification
of  effective  compounds.  Thus,  only  effective  zones  were  selected  in  the first dimension  in  terms  of  heart-
cutting and  were  transferred  to  the  second  dimension  through  elution  head-based  extraction.  Three  2D
approaches  were  developed  and validated.  The  best  results  in  terms  of peak  capacity  and  orthogonality
were  achieved  when  the  retardation  factors  of the  first dimension  were  used  to  adjust  the  mobile  phase
(MP) for  the  second  dimension.  Applying  the  acetylcholinesterase  (AChE)  inhibition  assay  as  an  example
EDA,  analysis  of spiked  surface  water  by  2D  HPTLC-EDA  allowed  zones  with  neurotoxic  effects  to respon-
sible  substances  to be assigned.  The  2D  separation  reduced  the  complexity  of  effective  zones  and  thus
facilitated  the  subsequent  identification  of effective  compounds.  Knowledge  about  a  substanceı́s  effects
enabled  assessment  of its  relevance  to the environment.
© 2017  Elsevier  B.V.  All  rights  reserved.
1. Introduction
Because of human influences, the environment gets increasingly
polluted with anthropogenic trace substances in addition to natu-
rally occurring ones [1]. Many of these substances have not been
characterized, and their impact on humans and the ecosystem has
not been sufficiently studied [2]. The challenge is to evaluate the
relevance of these various contaminants and to select the impor-
tant ones. Therefore, effect-directed analysis (EDA) – a combination
of physicochemical fractionation, bio-testing and chemical analy-
sis – is a suitable technique [3]. Through fractionation of pollutants
∗ Corresponding author at: Laboratory for Operation Control and Research, Zweck-
verband Landeswasserversorgung, Am spitzigen Berg 1, 89129 Langenau, Germany.
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in complex samples it is possible to assign bioactive substances to
the detected effects in a certain end point [4].
For volatile compounds, gas chromatography coupled with mass
spectrometry (GC–MS) is used for EDA because of the good peak
capacity and the wide availability of mass spectral databases [5].
However, the limitation of GC with thermo-labile and non-volatile
compounds and the challenge to trap the compounds from gaseous
phase after separation enables the use of high-performance liquid
chromatography (HPLC), which gathers broader substance diver-
sity. Today, HPLC is a frequently used separation technique for
EDA [6]. High-performance thin-layer chromatography (HPTLC)
has proven to be a particularly suitable separation technique for
EDA [7,8]. In contrast to column chromatography, HPTLC is an open
separation system, and since the layer is solvent-free after sepa-
ration, an in-vitro bioassay can be applied directly [9]. It is also
possible to vary the applied sample volume over a wide range to
increase the sensitivity of the method. Identification of effective
compounds is realizable through coupling to a mass spectrometer
(MS) or a nuclear magnetic resonance spectrometer (NMR) [10,11].
https://doi.org/10.1016/j.chroma.2017.10.009
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However, despite all these advantages, the main disadvantage of
HPTLC is the lower peak capacity compared to HPLC [6].
For improvement of HPTLC peak capacity, one-dimensional (1D)
gradient development was already shown to be a good strategy
[12,13]. In that method, the plate is developed in a stepwise manner
with increasing migration distances and different solvent com-
position within each step. For environmental samples, the peak
capacity of such gradient development is often insufficient, which is
why a two-dimensional (2D) separation strategy was developed in
this study. Many studies have described comprehensive 2D HPTLC
where the complete sample was separated on the same plate but
in two directions [14–16], but a selective 2D HPTLC-EDA is pre-
sented here for the first time. Also a study about 2D HPLC-AChE
was identified, where a 2D on-line HPLC separation was  applied
to sewage water. But the main difference of the study to our one
is, that the bioassay was not applied in two dimensions but only
after the second separation [17]. We  used the elution head-based
extraction technique to transfer effective zones from the first to
the second dimension [18]. Thereby the elution head is pressed to
the layer to seal the zone which should be extracted. The elution
solvent flows over the sealed zone and washes out the compounds,
where a frit in the elution head restrains solid components from
the layer and matrix [19]. After the separation in each dimension,
the acetylcholinesterase (AChE) inhibition assay, an enzyme test
for the detection of neurotoxic effects, was used [20]. The coupling
of HPTLC and AChE assay is applied frequently for investigation of
acetylcholinesterase inhibiting compounds in plant extracts [21].
But the assay procedure is quite different depending on the user.
A significant variation is the application of AChE onto the HPTLC
plate. This is done either by spraying [22,23] or by immersing the
plate in the enzyme solution [24]. Various substrates are also used,
e.g. 1-naphtyl acetate or 5,5′-dithiobis-(2-nitrobenzoic acid) [21].
For the present study, the plate was immersed in the AChE solution
and 3-indoxyl-3-acetate was used as substrate. With our devel-
oped workflow, only effective zones were transferred to the second
dimension so that substances without any effect were already
excluded after the first dimension. Through the second separation,
a further fragmentation of the effective zones could be achieved
with the aim of prioritizing effective compounds of interest. The
next important step was the coupling of this method to further ana-
lytical techniques such as MS  or NMR  with the aim of identifying
the prioritized effective compounds.
2. Materials and methods
2.1. Chemicals and reagents
Ultrapure water was received with an ultrapure apparatus
(Purelab Ultra, Elga LabWater, Lane End, UK). Acetonitrile (Roti-
solv ≥ 99.95 %, LC–MS-Grade), 2-propanol (Rotisolv ≥ 99.95 %,
LC–MS-Grade) and acetone (Rotisolv ≥ 99.9 %, HPLC) were pur-
chased from Carl Roth (Karlsruhe, Germany). Dichloromethane
and n-hexane were purchased from J.T. Baker (Center Valley,
USA). Methanol (AMD Chromasolv ≥ 99.9%) was supplied by Sigma-
Aldrich (Steinheim am Albuch, Germany). Chloroform (HiPerSolv
Chromanorm) and ammonia (25%, AnalaR Normapur) were pur-
chased from VWR  International (Bruchsal, Germany), and formic
acid (98–100%), ethyl acetate (Uvasol) and toluene (Uvasol) were
supplied by Merck (Darmstadt, Germany).
For the AChE inhibition assay, acetylcholinesterase Type VI-S
(2000 U/vial) from electric eel and ascorbic acid and 3-indoxyl-
3-acetate from Sigma-Aldrich were used. Dimethyl sulfoxide,
bovine serum albumin, hydrochloric acid (32%) and 2-amino-
2-(hydroxymethyl)-1,3-propanediol were supplied by Merck
(Darmstadt, Germany).
2.2. Standards
Pure standard substances were acquired from various suppliers
(Carl Roth, Karlsruhe, Germany; LGC Standards, Teddington, UK;
Merck, Darmstadt, Germany; Sigma-Aldrich, Steinheim am Albuch,
Germany; Thermo Fischer, Karlsruhe, Germany; VWR  Interna-
tional, Bruchsal, Germany). Standard stock solutions were prepared
by dissolving 10 mg  of each pure substance in 100 mL  methanol
and storing at −18 ◦C. To prepare respective standard solutions, the
stock standards were diluted in methanol to the required concen-
tration. Standard solutions were used for four weeks.
For mobile phase (MP) development, five standard solutions
(A–E) with 5–8 compounds (10 ng/L) were used. Their exact com-
position is given in Fig. 2. To gather a possibly broad retention area
the substances were chosen according to their polarity. The logKow
values were determined using the KOWWIN software (v1.68) from
US EPA. For the 35 model compounds the middle value of logKow
was 3.0 with a range from 0.1 (cefixime) up to 6.1 (bromophos-
ethyl). The stability of chromatography was  examined with a
mix  consisting of nine substances (1,3,6-naphthalenesulfonic acid,
1,5-naphthalenesulfonic acid, 1-naphthalenesulfonic acid, theo-
bromine, caffeine, thiourea, N-phenylacetamide, benzamide, and
N,N-dimethyl-4-[(E)-phenyldiazenyl]aniline) with 10 ng/L [8]. A
multi-component standard (83 g/L) with 448 environmentally
relevant anthropogenic trace substances, such as pharmaceuticals,
herbicides, X-ray contrast agents, and others, was  used for the
determination of a frequency distribution across the retardation
factors (hRF). The spiking of surface water was performed with a
mix  consisting of 50 neurotoxic substances (Table S1).
2.3. Sampling and sample preparation
A grab sample of surface water was taken from the river Danube
(Leipheim, Germany). The sample (1 L) was  spiked with the neu-
rotoxic mix  to a final concentration of 4 g/L. Enrichment was
performed by solid phase extraction (SPE) with an enrichment fac-
tor of 1000.
Enrichment was  performed by solid phase extraction (SPE) with
Bond Elut Plexa cartridges (Agilent Technologies, Santa Clara, USA)
containing a non-polar divinylbenzene-based neutral polymeric
sorbent. The cartridges were conditioned with each 5 mL  n-hexane,
dichloromethane, acetone, methanol, and ultrapure water. The
sample was filled in a storage vessel and ran over the cartridge,
powered by a peristaltic pump with a flow of 2.5 mL/min. After
loading, the cartridges were dried for 45 min  in an airstream. Three
solvents were used for elution. At first, 3 mL  methanol (0.4% v/v
ammonia) was used. The second eluent consisted of a 50:50 v/v
mixture of methanol (0.4% v/v ammonia)-ethyl acetate (4 mL), and
the third eluent was dichloromethane (3 mL). Evaporation was per-
formed in a gentle stream of nitrogen, and 50 L of ultrapure water
was added as keeper before evaporation of dichloromethane. The
residue was diluted with methanol to a volume of 1 mL s condi-
tioned and eluted the same way the sample cartridge was treated
but without any contact with a sample.
Recovery rates of SPE were determined for the 35 model com-
pounds used for method development. The substances were spiked
to deionized water before and after solid phase extraction to get
the same matrix in both samples. Concentrations were chosen that
100% recovery would lead to 10 g/L after the enrichment. Mea-
surement was  done via HPLC-HRMS (see Chapter 2.4). The median
of recovery achieved 87.5% with a 10% quantile of 46.1%. One sub-
stance could not be detected in the positive ESI mode, why it was
not considered (cefixime). With that a medium enrichment factor
of 875 could be calculated.
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2.4. Apparatus and software
For application, separation and detection, the Automatic TLC
Sampler 4 (ATS 4), Automatic Developing Chamber 2 (ADC 2), Auto-
mated Multiple Development 2 (AMD 2), TLC Scanner 3 and TLC
Visualizer were used. The associated software was  winCATS (1.4.9).
Elution of zones from the plate was performed with the TLC–MS
Interface 2 with an oval elution head (4 × 2 mm)  (all from CAMAG,
Muttenz, Switzerland).
For application of the AChE inhibition test, the Chromatogramm
Immersion Device 3 (CAMAG), the spraying apparatus, ChromaJet
DS 20 (Desaga, Wiesloch, Germany), and an incubator at 37 ◦C (VWR
International) were required.
The determination of the frequency distribution of the
multi-component standard across the hRF values and also the
determination of SPE and extraction recoveries were performed
via HPLC-HRMS analysis with the LC20 series (Shimadzu, Kyoto,
Japan) coupled to the Quadrupol-Time-of-flight/mass spectrome-
ter (Q-TOF/MS), TripleTOF 5600, from Sciex (Framingham, USA). For
ionization, electrospray ionization (DuoSpray) in the positive mode
was used. Gradients and parameters were adjusted according to
the study of Bader et al. [25]. Data acquisition was  performed with
Analyst TF software (1.7). For peak integration, the MultiQuant soft-
ware package (3.0.2) was used. For each of the 448 substances (also
includes the 35 model compounds used for method development)
a MS/MS  spectrum was recorded and retention time was  deter-
mined. So the substance identification (min. 2 fragments) could be
achieved through a library search via the software tool LibraryView
(Sciex, Framingham, USA).
2.5. Selective 2D HPTLC-EDA
HPTLC LiChrospher silica gel 60 F254S plates (Merck) were
immersed twice in 2-propanol for 20 min. After drying at 120 ◦C
on the plate heater, the plates were predeveloped to the top edge
with acetonitrile. Finally, the plates were heated again to 120 ◦C for
20 min. Cleaned plates were stored in a desiccator at room temper-
ature. This procedure was necessary because otherwise the dirt of
the plates gathers in streaks over the whole plate after separation
and disturbs the bioassay detection.
Application of standards and samples was performed with the
ATS 4 as 6 mm  bands 10 mm from the lower edge. For development,
two apparatuses were used. The ADC 2 was used for isocratic, one
step separations, and the AMD  2 was used for separations with
more than one development step. In the ADC 2, 1 min was chosen
as the duration for the humidity setting. The chamber saturation
amounted to 15 min, preconditioning time was  set to 30 s, the
migration distance came to 70 mm,  and the drying time amounted
to 20 min. The migration distance of the gradient development with
16 steps was 80 mm.  The AMD  2 was rinsed once before use. The
minimum end pressure was set to 10 mbar, and the maximum pres-
sure increase allowed was 10 mbar/min.
The selective extraction was performed by choosing only effec-
tive zones of the first dimension to be eluted with the TLC–MS
interface. Therefore, an additional separation of the sample on a
new plate was necessary, and the target zones were located by
the coordinates after the first in-vitro assay. With methanol as the
extraction eluent, the substances in the target zone were eluted for
1 min  with a flow of 200 L/min [26]. To avoid a carryover between
extractions, the elution head was purged after each extraction with
methanol for at least three minutes. To obtain enough extract for
separation in the second dimension, the sample was applied three
times, and the eluates of the effective zones were collected in a vial
and again applied to a plate with the same stationary phase at a
volume of 200 L. After separation in the second dimension with
Fig. 1. General workflow of 2D HPTLC-EDA.
another solvent, the effects were detected by the in-vitro bioassay
again (Fig. 1).
Recovery rates of elution head-based extraction were deter-
mined for the 35 model compounds used for method development.
A mix  of these substances (83.3 g/L) was applied to the plate
with 6 × 4 mm and extraction was done without separation in the
middle of this area. This procedure was repeated three times. The
extracted zones were measured via HPLC-Q-TOF/MS with respec-
tively three injections (10 L) and by consideration of the elution
headı́s area (7.142 mm2) substance concentrations could be calcu-
lated. The extraction recovery was determined through comparison
of signals with an external standard-mix, so matrix effects cannot
be excluded.
Three different approaches were developed for the 2D chro-
matography. The composition of all developed MPs  can be found in
Table S2. Due to the long development times of the gradients, only
isocratic separations were considered for the second dimension:
- Isocratic approach: Both dimensions were developed with iso-
cratic MPs.
-  Gradient approach: A gradient development was used in the
first dimension, whereas the same isocratic MP  as the isocratic
approach was used for separation in the second dimension.
- Dynamic approach: The gradient development of the gradient
approach was used for the first dimension, and several MPs  for
separation in the second dimension were developed. These MPs
were adjusted on the hRF in the first dimension. Five arbitrary
retardation areas were appointed in equal intervals: A: [0–20],
B:]20–40], C:]40–60], D:]60–80] and E:]80–100], and for each of
these areas a different MP  was  developed. Therefore, the elution
strength could be exactly adjusted to the substances that were
investigated.
The results were documented with the TLC-Visualizer (254 nm,
366 nm and white light) and with the TLC-Scanner as a multiple
wavelength scan (7 wavelengths from 190–300 nm).
2.6. Acetylcholinesterase inhibition assay with HPTLC
Before application of the biological assay the plate has to be
adjusted to a neutral pH. Therefore the plates, which were devel-
oped with acidic mobile phases (MP  1, MP  2 and MP A) were placed
for 10 s in NH3 vapor. Afterwards the plates were put under vac-
uum (10 min) to remove the remaining NH3 (pH after neutralization
approx. 7.5).
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Fig. 2. Separation of 35 compounds with MP  2 in the first dimension of the dynamic approach.
The AChE inhibition assay described in Weins and Jork was  used
[27] with several modifications. AChE was dissolved in 0.05 M Tris-
HCl buffer (pH 7.8). For stabilization of the enzyme on the Plate 0.1%
v/v bovine serum albumin was added. In contrast to Weins and Jork,
we used 3-idoxyl-3-acetate as a substrate to evaluate the activity
of the enzyme. Therefore, 0.5 g/L 3-indoxyl-3-acetate was  dissolved
in an aqueous solution of 4% v/v DMSO. If the enzyme was  active,
the substrate was cleaved to indoxyl, which reacted with oxygen
to indigo white. Both products could be measured because of their
blue fluorescence at 366 nm.
The AChE inhibition test began with the immersion of the plate
in the enzyme solution (Chromatogramm Immersion Device 3,
dipping time 2 s, dipping speed 2 cm/s). The supernatant enzyme
solution was carefully pulled off with a squeegee. The plate was
incubated for 5 min  in an incubator at 37 ◦C with humidity higher
than 90 %. After 6.5 min, the substrate solution was  sprayed to the
plate with the spraying apparatus from Desaga (amount of reagent:
580 L, distribution: 0.03 L/mm2). The plate was  placed in the
TLC Visualizer, and 9 min  after the immersion, the detection of
enzyme inhibition started. A wavelength of 366 nm was  chosen,
and a sequence capturing 10 pictures in 10 min  was  started. The
exposure time was set to 800 ms.  For the evaluation, the second pic-
ture was used. Paraoxon-ethyl and methiocarb-sulfoxide were used
as positive controls and therefore applied to each plate in a total
amount of 20 ng/band and 10 ng/band. After the bioassay the effects
of the substances were evaluated [28] and used as quality control.
Paraoxon-ethyl achieved an effect of 47% (SD = 3.9%, N = 40), where
methiocarb-sulfoxide inhibited AChE to 40% (SD = 2.1%, N = 40).
2.7. Calculation of analytical parameters
2.7.1. Orthogonality O⊥
To evaluate the effectiveness of the 2D HPTLC separations, dif-
ferent analytical parameters were calculated, and the first one was
the orthogonality. A 2D separation was considered orthogonal if
the current hRF of the compounds were completely independent.
For calculation of orthogonality, a procedure called bin counting
published by Gilar et al. [29] was used. The following formula








/0.63 · Pmax (1)
Briefly, Pmax gives the number of all bins that were equal to the
number of measured compounds. The sum of the bins describes
the total number of occupied bins after 2D development. Here, the
area between hRF = 0–100 was  divided into bins in both directions
of the development according to the number of substances that
were separated.
2.7.2. Practical peak capacity Np
The second analytical parameter investigated was the practical
peak capacity (Np). The peak capacity (P) represents the maximum
number of compounds that could theoretically be separated within
a specific migration range. The peak capacity of a 1D separation was
calculated as the quotient of the effective analytical distance (dis-
tance between the first and the last peak) and the peak base width
(4). If the separation methods of a 2D approach were completely
orthogonal, the peak capacities could be multiplied. In reality, this
case does not occur, and the area of coverage has to be considered.
The practical peak capacity (Np) could be calculated as [29]:
Np = P1D · P2D · (0.63 · O⊥ + 1/
√
Pmax (2)
P1D and P2D are the peak capacities of the first and the second
dimension whereas the area coverage is obtained from the quotient
of the summed bins and Pmax.
2.7.3. Eluent strength AB
The procedure for estimation of eluent strength (AB) was pre-
viously described [30] and used here with a few restrictions. First of
all, there was no value for solvent strength (0) for formic acid. For
acetic acid, 0 was  given as »1, whereas the 0 of formic acid was
estimated to be 1.2. Through this estimation, changes to the true
eluent strength of MP  A could be calculated. However, formic acid
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was only used in low volume concentrations in the MP  A, which
was why this change was deemed to be negligible. Because of the
changing solvent system constitutions after each step, no eluent
strength could be calculated for gradient development.
3. Results and discussion
3.1. Development of selective 2D separations with HPTLC
First of all, an isocratic 2D approach with constant com-
position of the MP  was developed. Formic acid-acetonitrile-
dichloromethane (1:50:49, v/v/v, MP  1) was used as the solvent for
the first dimension, and the second dimension was  separated with
methanol-chloroform (20:80, v/v, MP  B). This MP  B was applied
because of its medium eluent strength of 0.56 to gather both the
polar and the nonpolar compounds in a sample. The total time for
the two isocratic separations amounted to 80 min.
For improvement of the peak capacity of the first dimension,
gradient development (automated multiple development, AMD)
with 16 steps was applied (gradient approach). The plate was
developed in a stepwise manner with increasing migration dis-
tances. Each step consisted of another solvent composition with
decreasing solvent strength (Table S2). The first three separation
steps were necessary to focus the substances on the application
zone to a thin band. As solvents, methanol (0.05% v/v formic acid),
dichloromethane and n-hexane were used. For better comparison
of the peak capacities of the two approaches, the same solvent as the
isocratic approach was used for separation in the second dimension
(MP  B). This gradient approach required a total time of 215 min.
To further increase the peak capacity, the gradient approach
was extended to a dynamic one. Therefore, the retardation area
of the first dimension (MP  2, AMD) was divided in five areas (A–E).
For each area, another MP  was developed (MP A–E) so that the
substances were separated in the second dimension in a man-
ner dependent on their hRF in the first dimension. Thus, after the
gradient development in the first dimension, a second gradient
development was applied in the second dimension with eluent
strengths adjusted to the substanceı́s hRF in the first dimension. For
the method development of these MPs, 35 substances with known
hRF in the first dimension (MP  2) were used (Fig. 2).
Method development for the dynamic approach was performed
on the basis of these 35 compounds with the aim of distributing
the selected substances over a preferably broad retardation area. In
the end, several substances that had similar hRF in the first dimen-
sion could be separated at baseline after the second dimension (e.g.,
diflubenzuron D4, methiocarb D5, alachlor D6, profenphos D7). The
advantages of the dynamic approach over the gradient approach
were shown by comparing the 2D separation of the 35 substances
(Fig. 3). Whereas the gradient approach only achieved an improved
separation of standards in area B, the dynamic approach led to an
obviously broader distribution of the compounds over the whole
separation area compared to separation in the first dimension. MP
B, which was used as the solvent for the separation in the sec-
ond dimension, proved to be best qualified for separation of the
retardation area from]20–40].
For separation in the second dimension with the dynamic
approach, different MPs  were developed. The separation with MP
C–E showed better results with more than one development step as
the whole migration distance of 60 mm was developed. As an exam-
ple, the first separation step with MP  D led to only four fractions
distributed over a retardation range of 23. After the third devel-
opment step, all substances could be almost completely separated
over a retardation range of 43.
Different variables influenced the separation of the compounds.
One influential variable was the selectivity of the used MP,  which
became apparent in the alternating order of the compounds after
the second separation (e.g., Fig. 3, B, MP  C). A further variable was
the eluent strength (AB), which could be observed by separation
with MP  E. Though the order of the substances remained the same
as during chromatography in the first dimension, they could be
separated to a hRF range from 8 up to 97. The AB was calculated
for all of the five developed MPs  of the dynamic approach (Fig. 3).
MP A, developed for retardation area from [0 −20], achieved the
highest AB (0.65). With increasing hRF, the AB of the developed
MPs  decreased, which is equivalent to a gradient development in
the second dimension. MP  B and C achieved ABs of 0.56 and 0.53,
respectively, and the eluent strengths of MP D and E were 0.40 and
0.23, respectively.
3.2. Investigation of orthogonality and peak capacity
For assessment of the developed 2D separations, the orthogonal-
ity was determined using the bin counting method. For each pair of
MPs, the hRF of 25 substances were determined. According to [29],
hRF were normalized with the minimal and maximal retardation
factors of each separation to remove void spaces in the 2D separa-
tion plot (feature scaling). Then, the number of occupied bins was
determined (TablesS3–S5 and Figs S1–S3). Orthogonality of 32%
and 25% was reached with the isocratic and the gradient approach,
respectively. The something better orthogonality of the isocratic
approach could be explained by the fact, that acetonitril (class VI),
which is used in the 1D of the isocratic approach, is in another selec-
tivity class [31] than methanol (class II), which is used in the 1D of
the gradient approach. The MP  B for the second dimension of both
approaches consists of methanol-chloroform (20:80, v/v). As was
expected, the dynamic approach led to a higher orthogonality com-
pared to the former 2D approaches. For each retardation area, A–E,
25 substances with appropriate retardation factors (1D, MP 2) were
selected. Thus, 125 substances in total were measured in the five
areas leading to an orthogonality of 65% for the dynamic approach
(Table 1).
To compare the effectiveness of the developed approaches, their
peak capacities were calculated considering the effective separa-
tion distance and the mean peak width (at base) across all 25
substances. First of all, the peak capacities of the two  MPs  for the
separation in the first dimension were considered (MP  1 and 2).
The isocratic MP  1 achieved a peak capacity of 19.1, whereas the
gradient development reached a peak capacity of 29.9. In compar-
ison, the gradient development lasted four times longer than the
isocratic development but resulted in smaller peaks (MP  1: mean
peak width 2.9 mm,  MP  2: mean peak width 1.6 mm). The width
of the elution head was  2 mm,  and zones smaller than 2 mm are
more suitable for extraction. The width of the elution head limited
the maximal achievable peak capacity. A lower peak width than
2 mm  did not lead to an improvement in peak capacity because a
width of 2 mm was  determined through the extraction of zones.
This effect only occurred during 2D separation with the gradient
development (MP  2) where the zones were smaller than 2 mm.
Thus, for 2D separation with the MP  2, a peak capacity of 24.1 (peak
width set as 2 mm)  was used for the calculations in Table 1. In an
ideal orthogonal system, the peak capacities of both dimensions
can be multiplied, whereas in reality, the orthogonality of the sep-
aration dimensions has to be considered. Because orthogonalities
of <100% were always reached, the ideal peak capacities (P) were
reduced to practical peak capacities (Np), which were calculated for
each 2D approach (Table 1).
The isocratic and gradient approaches achieved peak capaci-
ties of 112.2 and 127.8, respectively. Compared to the dynamic
approach with a practical peak capacity of 204.2, they were lower
by a factor of 1.6. In summary, the peak capacity could be increased
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Fig. 3. Comparison of 2D separation of the 35 substances with the gradient approach (A) and the dynamic approach (B). The numerals give the substances in the respective
area  listed in Fig. 2. The peak width of compounds in both dimensions is given in the error bars. AB gives the eluent strength of MP  A–E.
Table 1




(P1D or P1D * P2D)
Orthogonality Practical peak
capacity
1D MP 1 19.1 – –
MP  2 29.9 – –
Isocratic approach MP  1 - MP  B 280.6 0.32 112.2
Gradient approach MP  2 - MP  B 355.0 0.25 127.8
Dynamic approach MP  2 - MP  A - E 411.6 0.65 204.2
by a factor of 6.8 using the dynamic 2D approach compared with
the 1D gradient approach (MP  2).
In the literature, peak capacities of 1D HPLC gradient develop-
ments are distributed over a wide range from 100 to 1500, whereas
with 2D HPLC separations with different stationary phases, peak
capacities of several thousand could be achieved [32–35]. When
comparing these values with the peak capacities obtained in the
present study, 2D HPTLC is still in the lower range of 1D HPLC
separation.
These calculated peak capacities for separation can differ
slightly from peak capacities by application of the described
approaches in EDA. Through application of in-vitro bioassays on
the HPTLC plate, diffusion effects may  cause zone broadening
compared to mere separation. Thus, peak capacity is somewhat
decreased depending on the amount of the applied substance and
also on the effective power of the substance. The higher the amount
per zone and the effective power of the substance, the higher the
diffusion effects through detection of the effect. There are sub-
stances with only low effects on the applied bioassay. Then, the
zone width might be smaller by consideration of the effects com-
pared to the mere separation because only the maximum of the
peak exceeded the detection limit and caused an effect in the bio-
logical test. To estimate the influence of these effects, the zone
widths of five substances were determined before and after the
application of the AChE inhibition assay (Table 2). Both the iso-
cratic separation (MP  1) and the gradient development (MP  2) for
separation in the first dimension were considered. Three of five
substances did not differ in the zone width before and after the
AChE inhibition assay. This result can be explained by the fact that
the AChE inhibition assay is a very fast assay with a short incuba-
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Table  2













Aminocarb 1 4.8 4.8 0.0
2 3.5 3.5 0.0
Azamethiophos 1 5.4 8.4 3.0
2 2.8 4.9 2.1
Isoprocarb 1 4.2 4.2 0.0
2 2.8 3.5 0.7
Chlorpyriphos 1 4.2 1.8 −2.4
2 2.8 1.4 −1.4
Paraoxon 1 4.2 4.2 0.0
2 2.8 2.8 0.0
tion time (9 min). By application of bioassays with long incubation
times of a few hours (e.g., Yeast estrogen screen, 3 h), higher peak
broadening is expected.
In this study, a qualitative 2D method for improvement of peak
capacity was developed. For review, that the substances generally
achieve the second dimension, a recovery test was performed for
the 35 model compounds used for method development. This test
revealed that the recoveries of substances fluctuate dependent on
their solubility in the extraction solvent. For methanol as extrac-
tion solvent a medium recovery of 56.0% could be achieved, with a
10% quantile of 39.8%. This determination of recovery was  gained
without separation of substances. But additionally, the zone width
of substances is crucial for recovery because of the given width of
the elution head. Peaks wider than 2 mm are only extracted in the
middle part, and the peak flank gets lost and recovery decreases.
3.3. Frequency distribution of the dynamic approach
In the dynamic approach, the retardation area of the first dimen-
sion was divided into five areas. To confirm the arbitrary division
of these areas, a multi-component standard comprising 448 sub-
stances was separated, and a qualitative frequency distribution
across the five areas was  determined. The multi-component stan-
dard was separated on the first dimension with MP  2, and then 29
zones from 10 to 80 mm at an interval of 2.5 mm were extracted.
The elution head had a width of 2 mm so that 0.5 mm was  not
extracted, but because of a middle zone width of 2 mm,  almost all
substances could be gathered. The measurement was performed in
triplicate by HPLC-Q-TOF/MS in the positive mode.
Of the 448 substances, 90 compounds were located in the first
retardation area A from]0 –20], corresponding to 20 % of substances.
One hundred eleven (25%) compounds had hRF between]20–40],
and 21% (94 compounds) of the substances were located in the
third retardation area C between]40–60]. In the fourth retardation
area D, 26% (118) of all compounds were located. The area that
was the least occupied was the fifth area with 33 compounds (7%).
Two (iopromide and irgarol-descyclopropyl) of the 448 substances
could not be gathered with this investigation.
With these results, it could be shown that the 446 compounds
are distributed relatively consistently over the whole retardation
area in the first dimension. All areas were occupied by 20–26% of the
substances with the exception of the fifth area, E. Through the con-
sistent distribution of compounds in the areas, equal classification
was confirmed.
3.4. Investigation of stability of hRF
Because the extraction of the effective zone was performed
on another plate than the bioassay, the stability of hRF was very
important to ensure that the right coordinates were used for the
Table 3
Stability of retardation factors (SD = average standard deviation about all measure-
ments and substances, time period: 6 month).
Dimension Mobile phase No. of plates SD of control substances
(N = No. of control
substances)
1D 1 17 1.28 (N = 7)
2 41 1.93 (N = 9)
2D  A 12 1.92 (N = 9)
B 28 1.81 (N = 8)
C 12 1.24 (N = 7)
D 8 1.76 (N = 7)
E 10 1.00 (N = 7)
extraction. This issue is also substantial for the comparison of
results over a longer period. Therefore, the chromatography control
and also the respective mixes A–E were applied to each developed
plate. According to the substances that could be separated with the
applied MP,  7–9 substances were used as controls, and their hRF
were documented. Then, the standard deviation of each substance
for all measurements was determined and averaged for all sub-
stances investigated (Table 3). With a mean standard deviation of
1.56, the variation in hRF between the plates was so small that the
coordinates from another development could be used for extraction
of effective zones.
3.5. Selective 2D HPTLC-AChE inhibition assay with spiked
surface water
A sample from the river Danube was investigated with the devel-
oped 2D approaches in combination with the AChE inhibition test as
the in-vitro bioassay. The sample was  spiked with a mix  consisting
of 50 neurotoxic compounds to show that the developed method
was also applicable to other compounds besides the 35 standards
used for method development.
Initially, the MPs  for the separation in the first dimension (MP  1
and MP  2) were compared (Fig. 4). With the use of gradient develop-
ment, thinner and sharper zones could be achieved, and the effects
in the AChE inhibition assay were separated much better compared
to isocratic development with MP  1.
In all approaches, seven effective zones were selected for
extraction. Through overlap of zones by separation with MP  1, iden-
tification of clearly separated effective zones was  difficult. Each
zone was  extracted three times (200 L, respectively), and the
extract was  collected in a vial and mixed. By application of 200 L
to the second dimension, dilution effects could be prevented. For
the gradient and dynamic approaches, the same MP  was used in
the first dimension, for which reason the same zones for extraction
were selected.
For the isocratic and gradient approaches, all seven extracted
zones were separated in the second dimension with MP  B. By appli-
cation of the dynamic approach, the MPs  were chosen dependent on
the hRF of the extracted zones in the first dimension. The hRF of zone
1 amounted to 24, which is why  the development was performed
with MP  B. MP  C was used for separation of zone 2 (hRF = 54). Zones
3–6 (hRF = 64, 68, 71 and 78) were separated with MP D,  and the
seventh zone with an hRF of 81 was separated with MP  E. Finally,
the AChE inhibition assay was  used (see Fig. 5).
Through comparison of the three approaches, it became obvi-
ous that there were very few differences between the isocratic
and gradient approaches. The better peak capacity reached by MP
2 compared to MP  1 seems not to be crucial for the final out-
come of the 2D HPTLC-EDA in this case. The thinner and sharper
zones achieved by use of gradient development were an advan-
tage during extraction of effective zones because they had higher
recovery rates. A decisive improvement, however, was achieved
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Fig. 4. Investigation of a spiked surface water extract in the first dimension with (A) the isocratic development (MP  1) and (B) the gradient development (MP  2). Neurotoxic
effects were detected with the AChE inhibition assay. The hRF of the extracted zones (1–7) are listed in the tables.
Table 4












MP 1 7 0 6 1
MP  2 7 1 6 0
Isocratic approach 10 3 3 4
Gradient approach 9 2 6 1
Dynamic approach 17 8 5 4
with the dynamic approach. With the gradient approach, nine zones
could be separated in the second dimension, and with the dynamic
approach, 17 zones could be distinguished. Some zones, which
could not be separated in the gradient approach, were divided into
five zones through the application of the adjusted MPs  (Fig. 5, zone
6).
For further description of the separations, the number of spiked
substances needs to be reviewed to clearly assign the substances
to the detected neurotoxic effects. Therefore, the assignment was
exclusively accomplished based on the known hRF of the 50 spiked
substances, which were determined for all MPs  (Table S1). Then,
for each zone, appropriate substances were searched using the hRF
of the first and second dimension. Thereby, a variation of ±2 was
tolerated because this value was determined as the hRF’s average
standard deviation during separations (Table 3).
If only the hRF of the first dimension was considered, just one
substance could be unambiguously assigned to an effective zone
(donepezil was assigned to the zone 1 by development with MP
2). To all other zones in the isocratic approach with no match-
ing substance, more than one possible candidate could be found.
By consideration of the hRF of both dimensions, 13 candidates
could be unambiguously matched to one effective zone. Whereas
with the isocratic and the gradient approaches, 3 and 2 candidates
were merged to effective zones, respectively, and with the dynamic
approach, 8 substances could be clearly assigned to the detected
effects (Tables 4 and 5).
In Table 5, all zones with exactly one matching candidate are
shown. Additionally, there were some effective zones (N = 10) with-
out any possible assignment of the spiked substances. Either the
neurotoxic effects were caused through unknown substances in
the surface water itself or the hRF of the spiked substances var-
ied too much for an assignment. Such false-negative results were
confirmed through the allowance of ±4 as tolerable variation of
retardation factors, and then only 5 zones could not be matched to
a possible candidate. However, the higher tolerance also reduced
Table 5
Zones with one matching candidate to hRF of the first and second dimension.
Approach Zone hRF1D (±2) hRF 2D (±2) Candidate
isocratic 3.1 50 69 metoxuron
5.1 71 78 trichlorfon
5.2 71 85 paraoxon
gradient 1.1 24 54 donepezil
7.1 81 78 carbosulfan
dynamic 1.1 24 54 donepezil
2.1 54 75 3-hydroxycarbofuran
3.2 64 46 methabenzthiazuron
4.1 68 20 pirimicarb
4.3 68 47 methabenzthiazuron
4.4 68 57 acridine
6.3 78 50 trichlorfon
6.4 78 74 linuron
the clearly assigned substances to 6 so a variation of ±2 was main-
tained.
For several zones (N = 26), more than one possible candidate
could be found. The main reason was co-migrating substances
with the same retardation factors in both dimensions. However,
the allowed standard deviation of hRF (±2) could be a cause for
false-positive results. This possibility is also reflected through the
substance methabenzthiazuron with a hRF of 66 by use of MP  2. By
allowing ±2 variation, the substance fit to zone 3.2 and also to zone
4.3 in the dynamic approach. Thus, one of these assignments is pos-
sibly a false-positive. However, with a hRF of 64 and 68, zones 3 and
4 are close together, and the peak width of methabenzthiazuron by
separation with MP  2 amounted to 2.8 mm (hRF = 64–68). Through
an extraction width of 2 mm,  it is quite possible that the substance
actually occurs in both zones 3.2 and 4.3.
With the investigation of the spiked surface water, the advan-
tages of 2D separations and especially of the dynamic approach
were shown. Through adjusted MPs  in the second dimension, much
better separation was  achieved, and more candidates could be
matched to an effective zone. One example is zone 6, which could
not be divided by MP  B, but was  separated to five effective zones
with MP  D. For two of the five effective zones, a matching candidate
could also be assigned.
This developed concept now could be applied to complex envi-
ronmental samples. When the effective compounds in the samples
are completely unknown coupling to HRMS gets rudimentary for
identification. Through the used elution head-based extraction a
coupling to HRMS would be easily realizable, but first of all the
recovery of twice done extraction of effective zones (from 1D to
2D, from 2D to HRMS) has to be determined. But through variable
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Fig. 5. Selective 2D HPTLC-AChE inhibition assay with spiked surface water. A:
isocratic approach, B: gradient approach, C: dynamic approach.
application volume of HPTLC a possible loss during extraction could
be equated.
4. Conclusions
In the current work, a strategy for selective 2D EDA with HPTLC
as fractionation method was developed. Through application of elu-
tion head-based extraction, only effective zones were transferred
from the first to the second dimension.
Three 2D approaches were developed and validated. The
dynamic approach adjusting the MPs  for the second dimension to
the substanceı́s hRF in the first dimension achieved the best results
for peak capacity and orthogonality. Thus, peak capacity could be
increased by the factor 6.8 compared to the 1D gradient develop-
ment, and the potential of the method to compensate the lower
peak capacity of HPTLC compared to 1D HPLC was confirmed. Peak
capacities of several thousands, which were achieved with 2D HPLC
cannot be reached with 2D HPTLC. But nevertheless HPTLC is a suit-
able fractionation method for EDA. The plate is solvent free after the
separation, what tolerates the use of many different solvents and
therefore leads to still passable orthogonality despite the same sta-
tionary phase. In 2D HPLC one challenge are incompatible solvents
in the first and second dimension, but fractionation is more auto-
mated and therefore more suitable for high-throughput analysis.
A further increase in peak capacity may be achieved by the
change in the stationary phase from instance normal to reversed
phase. However, a challenge is the transfer of the bioassay from
one to another stationary phase, because the pH and also the wet-
tability of the plate have to be considered and so comparability of
effects is not warranted [36].
By application of this method to spiked surface water, some
neurotoxic effects could be clearly assigned to a spiked substance
merely through determination of hRF. Better peak capacity reduced
the complexity of effective zones and thus facilitated the assign-
ment of effective compounds. For the identification of unknown
compounds, the coupling of this method to further analytical tech-
niques such as MS  or NMR  would be the next important step. Hence,
knowledge of the substanceı́s effects can be extended resulting in
the assessment of their relevance and supporting the determina-
tion of limit values.
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Table S1: Ingredients of the neurotoxic mix used for spiking of surface water and their retardation 
factors (hRF) (substances which hRF in the first dimension were less than ± 2 away from edge to 
another retardation area were measured twice with both possible mobile phases (MP) in the dynamic 
approach. The name of the used mobile phase for determining of the hRF is given in subscript). 
No. Substance name hRF MP 1 hRF MP 2 hRF MP B hRF MP B - E 
1 3-Hydroxycarbofuran 55 52 70 76C 
2 Acephate 24 29 54 54B 
3 Acridine 56 69 82 55D 
4 Aminocarb 58 66 78 30D 
5 Asulam 62 49 50 45C 
6 Azamethiphos 61 65 81 19D 
7 Azinphos-methyl 90 79 88 80D / 1E 
8 Benfuracarb 82 71 80 46D 
9 Bromophos-ethyl 97 88 90 93E 
10 Caffeine 22 39 69 69B / 10C 
11 Carbetamide 46 53 71 71C 
12 Carbosulfan 82 80 79 46D / 3E 
13 Chlorbromuron 81 78 81 79D 
14 Chlorfenvinphos 82 72 86 63D 
15 Chloroxuron 62 62 75 57C / 27D 
16 Chlorpyriphos 96 88 90 82E 
17 Diazinon 87 78 88 73D 
18 Dichlorophos 71 72 81 59D 
19 Dicrotophos 14 40 70 70B / 4C 
20 Difenoxuron 55 56 75 49C 
21 Dimefuron 59 45 72 43C 
22 Dimethoate 53 52 72 32C 
23 Diuron 67 62 70 64C / 33D 
24 Donepezil 2 22 56 56B 
25 Fenthion 95 86 90 42E 
26 Fluometuron 67 61 68 72C / 32D 
27 Isoprocarb 82 74 77 60D 
28 Isoproturon 53 58 73 64C 
29 Linuron 84 77 81 76D 
30 Malathion 91 79 88 90D / 0E 
31 Mephosfolan 49 50 77 25C 
32 Methabenzthiazuron 59 66 49 46D 
33 Methacriphos 59 81 87 28D / 7E 
34 Methamidophos 22 34 47 2B 
35 Methidathion 89 80 88 87D / 1E 
36 Methiocarb 84 75 80 70D 
37 Metobromuron 78 75 81 68D 
38 Metoxuron 51 56 70 48C 
39 Monolinuron 77 77 80 67D 
40 Paraoxon 73 73 85 46D 
41 Phosalone 93 84 89 6E 
4 
 
No. Substance name hRF MP 1 hRF MP 2 hRF MP B hRF MP B - E 
42 Phosphamidon 45 54 78 32C 
43 Pirimicarb 64 66 83 22D 
44 Promecarb 87 77 80 70D 
45 Propetamphos 91 81 87 90D / 2E 
46 Propham 85 81 82 89D / 7E 
47 Rivastigmin 1 14 19 - 
48 Triallate 93 86 89 46E 
49 Triazophos 88 78 86 65D 





Table S2: Overview of the used mobile phases  
Dimension Mobile 
phase  
Composition Steps Migration 
distance [mm] 
1D MP 1 Formic acid-acetonitrile-dichloromethane  
(1:50:49, v/v/v) 
1 70.0 
MP 2 Methanol (0.05 % v/v formic acid)-
dichloromethane-n-hexane 
  
 (100:0:0, v/v/v) 1 11.0 
 (100:0:0, v/v/v)  2 11.0 
 (100:0:0, v/v/v)  3 11.0 
 (70:30:0, v/v/v) 4 16.3 
 (30:70:0, v/v/v)  5 21.6 
 (20:80:0, v/v/v) 6 26.9 
 (15:85:0, v/v/v)  7 32.2 
 (11:89:0, v/v/v)  8 37.5 
 (8.5:91.5:0, v/v/v)  9 42.8 
 (6.5:93.5:0, v/v/v)  10 48.2 
 (5:95:0, v/v/v)  11 53.5  
 (4:96:0, v/v/v)  12 58.8  
 (3.5:96.5:0, v/v/v)  13 64.1  
 (0:100:0, v/v/v)  14 69.4  
 (0:50:50, v/v/v)   15 74.7  
 (0:0:100, v/v/v) 16 80.0 
     
2D MP A Formic acid-methanol-chloroform  
(3.3:36.6:60, v/v/v) 
1 70.0 
MP B Methanol-chloroform  
(20:80, v/v) 
1 70.0 
MP C Ethyl acetate-dichloromethane-n-hexane  
(65:10:25, v/v/v) 
2 70.0 
MP D Acetonitrile-chloroform-n-hexane  
(7:70:23, v/v/v) 
3 70.0 







Table S3: hRF and normalized hRF (feature scaling) of 25 substances in 1D (MP 1) and 2D (MP B) for 
investigation of orthogonality of the isocratic approach. 
No. Substance hRF 1D hRF 1D 
normalized 
hRF 2D hRF 2D 
normalized 
1 4-Hydroxydiclofenac 53 56 43 46 
2 Acephate 24 23 54 59 
3 Aldicarb sulfoxide 14 11 55 60 
4 Alprenolol 4 0 6 1 
5 Benazolin 49 52 11 7 
6 Bitertanol 49 52 71 80 
7 Bupirimate 81 89 85 96 
8 Carbendazim 32 32 69 77 
9 Chloramphenicol 47 49 48 52 
10 Ethidimuron 63 68 59 65 
11 Ethirimol 8 5 60 66 
12 Fenitrothion 91 100 88 100 
13 Fenoxaprop 49 52 19 17 
14 Foramsulfuron 24 23 58 64 
15 Ketoprofen 48 51 18 16 
16 Methacriphos 89 98 87 99 
17 Monocrotophos 22 21 63 70 
18 N-Acetyl sulfamethoxazole 54 57 54 59 
19 Omethoate 19 17 60 66 
20 Pentoxyfylline 27 26 66 73 
21 Propazin 81 89 81 92 
22 Pyroquilon 50 53 80 90 
23 Rimsulfuron 61 66 66 73 
24 Triclopyr 47 49 12 8 
25 Valsartan acid 47 49 5 0 
 Min 4  5  
 Max 91  88  
 
ℎ𝑅𝐹,𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 = (ℎ𝑅𝐹  −  ℎ𝑅𝐹,𝑚𝑖𝑛) / (ℎ𝑅𝐹,𝑚𝑎𝑥 − ℎ𝑅𝐹,𝑚𝑖𝑛) * 100 
 
𝑂⊥ = (∑ 𝑏𝑖𝑛𝑠 − √𝑃𝑚𝑎𝑥) / (0.63 ∙ 𝑃𝑚𝑎𝑥) 
𝑂⊥  =  (10 − √25 ) / (0.63 ∙  25)  =  0.32  
 
Figure S1: Illustration of occupied bins through 
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Table S4: hRF and normalized hRF of 25 substances in 1D (MP 2) and 2D (MP B) for investigation of 
orthogonality of the gradient approach. 
No. Substance hRF 1D hRF 1D 
normalized 
hRF 2D hRF 2D 
normalized 
1 4-Hydroxydiclofenac 32 21 43 46 
2 Acephate 29 17 54 59 
3 Aldicarb sulfoxide 28 15 55 60 
4 Alprenolol 18 0 6 1 
5 Benazolin 25 11 11 7 
6 Bitertanol 37 29 71 80 
7 Bupirimate 67 74 85 96 
8 Carbendazim 38 30 69 77 
9 Chloramphenicol 34 24 48 52 
10 Ethidimuron 45 41 59 65 
11 Ethirimol 26 12 60 66 
12 Fenitrothion 84 100 88 100 
13 Fenoxaprop 28 15 19 17 
14 Foramsulfuron 25 11 58 64 
15 Ketoprofen 28 15 18 16 
16 Methacriphos 80 94 87 99 
17 Monocrotophos 30 18 63 70 
18 N-Acetyl sulfamethoxazole 30 18 54 59 
19 Omethoate 31 20 60 66 
20 Pentoxyfylline 36 27 66 73 
21 Propazin 66 73 81 92 
22 Pyroquilon 55 56 80 90 
23 Rimsulfuron 28 15 66 73 
24 Triclopyr 29 17 12 8 
25 Valsartan acid 24 9 5 0 
 Min 18  5  
 Max 84  88  
 
ℎ𝑅𝐹,𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 = (ℎ𝑅𝐹  −  ℎ𝑅𝐹,𝑚𝑖𝑛) / (ℎ𝑅𝐹,𝑚𝑎𝑥 − ℎ𝑅𝐹,𝑚𝑖𝑛) * 100 
 
𝑂⊥ = (∑ 𝑏𝑖𝑛𝑠 − √𝑃𝑚𝑎𝑥) / (0.63 ∙ 𝑃𝑚𝑎𝑥) 
𝑂⊥  =  (9 −  √25 ) / (0.63 ∙  25)  =  0.25  
 
 
   
Figure S2: Illustration of occupied bins through 






















hRF 1D norm., MP 2 
8 
 
Table S5: hRF and normalized hRF of 125 substances in 1D (MP 2) and 2D (MP A - E) for 
investigation of orthogonality of the dynamic approach. 
No. Substance hRF 1D hRF 1D 
normalized 
hRF 2D hRF 2D 
normalized 
1 1-(2-Chlorophenyl)-3-phenylurea 71 78 65 66 
2 2,6-Dichlorbenzamide 55 60 85 87 
3 2-Aminobenzothiazole 41 44 53 54 
4 2-Hydroxybenzothiazole 59 65 93 96 
5 3,4-Dichloranilin 78 86 61 62 
6 4-Hydroxydiclofenac 32 34 43 43 
7 Acephate 29 31 54 55 
8 Acetamiprid 44 48 11 9 
9 Aclonifen 85 94 42 42 
10 Alachlor 75 83 76 78 
11 Aldicarb sulfoxid  28 30 55 56 
12 Ametryn 61 67 34 34 
13 Amisulpride N-oxide 5 3 24 23 
14 Atenolol 10 9 29 28 
15 Azoxystrobin 63 69 15 14 
16 Benazolin 25 26 11 9 
17 Bezafibrate 26 27 31 31 
18 Bisoprolol 17 17 68 69 
19 Bitertanol 38 41 71 73 
20 Boscalid 69 76 45 45 
21 Bromacil 52 57 87 89 
22 Bromophos ethyl 90 100 93 96 
23 Bupirimate 67 74 42 42 
24 Caffeine 39 42 69 71 
25 Candesartan 24 25 12 11 
26 Carbendazim 38 41 69 71 
27 Carbosulfan 81 90 3 1 
28 Cefixime 9 8 64 65 
29 Chloramphenicol 34 36 48 48 
30 Chlorotoluron 55 60 56 57 
31 Ciprofloxacin 2 0 9 7 
32 Clodinafop-propargyl 80 89 2 0 
33 Clomazone 72 80 67 68 
34 Clopyralid 18 18 67 68 
35 Cyprodinil 70 77 57 58 
36 Dapsone 50 55 46 46 
37 Diazepam 52 57 70 72 
38 Diazinon 72 80 73 75 
39 Dichlofenthion 89 99 86 88 
40 Diflubenzuron 74 82 59 60 
41 Diflufenican 78 86 84 86 
42 Dihydrocodeine 9 8 26 25 
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No. Substance hRF 1D hRF 1D 
normalized 
hRF 2D hRF 2D 
normalized 
43 Dimefuron 45 49 43 43 
44 Dimethoat 52 57 32 32 
45 Dimethomorph 45 49 15 14 
46 Diphenylamine 87 97 72 74 
47 Ditalimphos 75 83 50 51 
48 Epoxiconazole 54 59 47 47 
49 Estrone 65 72 41 41 
50 Ethidimuron 44 48 21 20 
51 Ethion 86 95 42 42 
52 Ethirimol 26 27 60 61 
53 Fenarimol 49 53 62 63 
54 Fenitrothion 84 93 29 28 
55 Fenobucarb 73 81 61 62 
56 Fenoxaprop 28 30 19 18 
57 Fenpropathrin 84 93 31 31 
58 Fenpyroximate 67 74 54 55 
59 Fenthion 86 95 42 42 
60 Flecainide 15 15 61 62 
61 Fluazinam 87 97 92 95 
62 Fluazinofop 26 27 18 17 
63 Flufenacet 72 80 54 55 
64 Fluopicolide 75 83 72 74 
65 Flurtamone 56 61 89 92 
66 Foramsulfuron 25 26 58 59 
67 Imazapyr 25 26 22 21 
68 Iodipamid 13 13 53 54 
69 Iodofenphos 89 99 86 88 
70 Iotalamic acid 15 15 44 44 
71 Iprovalicarb 58 64 96 99 
72 Isoprocarb 73 81 60 61 
73 Ketoprofen 28 30 18 17 
74 Ketotifen 15 15 35 35 
75 Kresoxim methyl 81 90 2 0 
76 Melamin 12 11 20 19 
77 Metamitron 41 44 24 23 
78 Metformin 5 3 6 4 
79 Methacriphos 80 89 7 5 
80 Methidathion 80 89 87 89 
81 Methiocarb 74 82 68 69 
82 Metoprolol acid 11 10 50 51 
83 Metsulfuron methyl 34 36 72 74 
84 Monocrotophos 30 32 63 64 
85 Myclobutanil 45 49 25 24 
86 N-Acteyl sulfamethoxazol 34 36 54 55 
10 
 
No. Substance hRF 1D hRF 1D 
normalized 
hRF 2D hRF 2D 
normalized 
87 Nadolol 13 13 43 43 
88 Naphazolin 10 9 42 42 
89 Norflurazon 56 61 58 59 
90 Olmesartan 18 18 68 69 
91 Omethoate 31 33 60 61 
92 Oxadixyl 52 57 51 52 
93 Pencycuron 75 83 71 73 
94 Pendimethalin 88 98 82 84 
95 Pentoxifylline 36 39 66 67 
96 Phenacetin 45 49 46 46 
97 Phentoate 83 92 12 11 
98 Phosalone 82 91 8 6 
99 Phoxime 86 95 44 44 
100 Picloram 17 17 61 62 
101 Pirimiphos ethyl 81 90 6 4 
102 Pirimiphos methyl 81 90 6 4 
103 Procymidone 81 90 8 6 
104 Profenophos 75 83 80 82 
105 Profluralin 90 100 97 100 
106 Propazine 66 73 42 42 
107 Prosulfocarb 80 89 8 6 
108 Pyroquilon 54 59 42 42 
109 Rimsulfuron 28 30 66 67 
110 Ritalinic acid 7 6 30 29 
111 Roxithromycin 10 9 46 46 
112 Sebuthylazine 63 69 35 35 
113 Sitagliptin 10 9 26 25 
114 Sulbactam 18 18 55 56 
115 Sulfadimidin 41 44 51 52 
116 Sulfamethoxazol 44 48 74 76 
117 Sulpiride N-oxid 5 3 16 15 
118 TCMTB 80 89 9 7 
119 Thiourea 29 31 34 34 
120 Tramadol 13 13 40 40 
121 Triallate 84 93 46 46 
122 Triclopyr 29 31 12 11 
123 Triethylphosphate 41 44 19 18 
124 Trimethoprim 15 15 49 49 
125 Valsartan acid 24 25 5 3 
 Min 2  2  






ℎ𝑅𝐹,𝑛𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 = (ℎ𝑅𝐹  −  ℎ𝑅𝐹,𝑚𝑖𝑛) / (ℎ𝑅𝐹,𝑚𝑎𝑥 − ℎ𝑅𝐹,𝑚𝑖𝑛) *100 
 
𝑂⊥ = (∑ 𝑏𝑖𝑛𝑠 − √𝑃𝑚𝑎𝑥) / (0.63 ∙ 𝑃𝑚𝑎𝑥) 
𝑂⊥  =  (64 − √125 ) / (0.63 ∙  11)  =  0.65  
 
 


































L. Stütz, P. Leitner, W. Schulz, R. Winzenbacher, Identification of genotoxic transformation  
products by effect-directed analysis with high-performance thin-layer chromatography and non-target 
screening, Journal of Planar Chromatography - Modern TLC 32 (2019) 3, 173-182, 
https://doi.org/10.1556/1006.2019.32.3.1. 
Published 2019 by Akadémiai Kiadó, reprinted from Journal of Planar Chromatography - Modern 
TLC with kind permission of the publisher. 
 
Journal of Planar Chromatography 29 (2016) 3 173
Summary
The widespread use of the pharmaceutical metformin for diabetes 
therapy has led to fi nding its way into many surface waters up to 
the μg L−1 range and subsequently into diff erent water treatment 
processes. In this study, metformin was treated with hypochlorite 
on the laboratory scale, and the resulting transformation prod-
ucts were investigated with the umu assay in a microtiter plate, 
where a genotoxic eff ect was detected. For the characterization 
of this genotoxic eff ect, the sample was separated using high-per-
formance thin-layer chromatography (HPTLC), and 29 zones 
over the whole retardation area were extracted from the HPTLC 
plate with the thin-layer chromatography–mass spectrometry 
(TLC–MS) Interface. Then, the umu assay was performed again 
with each extracted zone, such that the genotoxic eff ect in the 
sample could be assigned to a certain zone. By the measurement 
of this eff ective zone with high-performance liquid chromatogra-
phy with high-resolution mass spectrometry and by performing 
a non-target screening, the eff ective substance could be identifi ed 
as a cyclic dehydro-1,2,4-triazole derivate with an intense yellow 
color. This substance formerly was found by Armbruster et al. 
(Water Research, 2015), which is a major transformation product 
of chlorine-treated metformin.
1 Introduction
Through human infl uences, increasing quantities of anthropo-
genic trace substances are found in the water cycle. Sophisti-
cated methods must be used to remove these substances during 
drinking water treatment, using diff erent processes, such as 
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chlorination or ozonation in combination with fi ltration or acti-
vated carbon [1, 2]. While these oxidation processes disinfect 
water and prevent microbial contamination in drinking water 
[3], they also cause the degradation of organic substances into 
transformation products (TPs), resulting in a reduced toxicity 
in general [4–6].
Though many of these TPs are not characterized, and their 
impacts on humans and the ecosystem are not known, it is 
diffi  cult to select the relevant ones, namely, those with toxico-
logical eff ects. One opportunity for selection is eff ect-directed 
analysis (EDA), which is a combination of physicochemical 
fractionation, biotesting, and chemical analysis [7]. Fractiona-
tion makes it possible to assign individual fractions of a sample 
to the eff ects. This reduces the complexity of the substances 
contained in the whole sample to the substances present in the 
eff ective fraction [8]. 
A substantial endpoint, which is also crucial for the determi-
nation of limit values, is the genotoxicity. Substances with a 
demonstrated genotoxic eff ect are only allowed to occur in 
drinking water at levels ≤ 0.1 μg L−1 according to the health-re-
lated indicator value concept [9]. Diff erent in vitro bioassays, 
such as the Ames fl uctuation assay [10] or the micronucleus 
assay [11], can measure genotoxicity, and they complement 
each other. In our study, the in vitro umu assay according to 
DIN 38415-T3 (DIN: German Institute for Standardization) 
was used [12]. When genotoxic substances cause DNA dam-
age in genetically modifi ed Salmonella typhimurium TA1535/
pSK1002, the SOS response starts, which triggers the genetic 
expression of β-galactosidase. The activity of β-galactosidase 
is determined through the addition of o-nitrophenyl-β-D-ga-
lactopyranoside (ONPG) substrate, which is cleaved by β-ga-
lactosidase to the yellow o-nitrophenol (λ = 420 nm) [13]. Many 
substances achieve their genotoxic eff ects only after their 
activation in the xenobiotic metabolism of the liver, which 
is why the bioassay was performed with (+S9) and without 
(−S9) metabolic activation. For the execution of the metabolic 
activation in a microtiter plate, an enzyme mix obtained from 
rat livers was used. With the assays in the microtiter plate, 
the eff ects are detected as sum eff ects, since no fractionation 
of the samples is performed. This approach is advantageous, 
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since it refl ects the real conditions in the environment, where 
individuals come into contact with the whole sample, but it 
hampers the identifi cation of eff ective compounds.
For identifi cation of eff ective compounds in complex samples, 
EDA is a suitable tool. Through fractionation, the complexity 
of the samples can be reduced, and the occurring eff ects can 
be matched to the related fraction. Diff erent EDA approaches 
with high-performance liquid chromatography (HPLC) as the 
separation method are already known [14, 15]. High-perfor-
mance thin-layer chromatography (HPTLC) has also been 
demonstrated to be a suitable separation technique for EDA 
[16, 17]. Rather insensitive bioassays can also be employed 
by applying high sample volumes to the HPTLC plate [18]. 
The separation with HPTLC is notably tolerant against matrix 
infl uences, and in contrast to LC, the ingredients of the sam-
ple, which cannot be separated and therefore remain on the 
application zone, can also be detected. Compared to LC sep a-
rations, HPTLC has lower separation effi  ciency. The HPTLC 
gradient development was already shown to be a good strat-
egy for improvement of peak capacity [19, 20]. Moreover, 
there are already multidimensional approaches that have been 
able to signifi cantly increase the peak capacity of HPTLC 
[21]. In many cases, bioassays were applied directly on the 
HPTLC plate after separation [22]. However, the metabolic 
activation of the indirect genotoxic substances is currently 
not feasible using the HPTLC plate [23], which is why in this 
study, the assay was performed using a microtiter plate. With 
the so-called thin-layer chromatography–mass spectrome-
try (TLC–MS) Interface 2, zones can be extracted from the 
HPTLC plate and transferred to the bioassay in a microtiter 
plate and/or to the LC with high-resolution mass spectrometry 
(HRMS) [24]. A challenge of this technique is the lack of auto-
mation of the extraction with the TLC–MS Interface 2, so that 
manual eff ort is required. For the extraction from the HPTLC 
plate, the selection of zones is important. One opportunity is 
to extract zones over the whole retardation area in order to 
achieve a preferable comprehensive mapping of the eff ects in 
the bioassay or the signals (from now on called features) using 
HRMS. Another possibility is the selection of the extraction 
zones according to certain properties, such as fl uorescence 
or absorption under 254 nm. Often, previous knowledge of 
the samples is available, which facilitates decision-making 
regarding where to extract the zones.
In this study, pharmaceutical metformin (MF), which has wide-
spread uses in diabetes therapy, was investigated with the umu 
assay after treatment with hypochlorite. MF is commonly found 
in sewage and surface waters and is among the most produced 
pharmaceuticals worldwide. In the investigations of 5 German 
rivers, MF was detected from 1.3 up to 17 μg L−1, while in the 
infl uent of a sewage treatment plant, concentrations of up to 
129 μg L−1 were measured [25]. Since a genotoxic eff ect of the 
chlorinated MF sample in the umu assay could be detected, the 
aim of this study was to assign the eff ect to a transformation 
product of metformin. Therefore, the bioassay in the microti-
ter plate was coupled to HPTLC separation, and through the 
extraction of the eff ective zone with the TLC–MS Interface 2 
and by performing a non-target screening, the eff ective com-
pound could be identifi ed. The structure of the identifi ed yel-
low transformation product was elucidated in Ref. [26], but this 
study was able to assign a genotoxic eff ect to it and thus signif-
icantly increased its relevance.
2 Experimental
2.1 Chemicals and Reagents
Ultrapure water was acquired by using ultrapure apparatus 
(PURELAB Ultra, Elga LabWater, Lane End, United King-
dom). Acetonitrile (ROTISOLV ≥ 99.95%, LC–MS-grade) and 
2-propanol (ROTISOLV ≥ 99.95%, LC–MS-grade) were pur-
chased from Carl Roth (Karlsruhe, Germany). Dichlorometh-
ane and n-hexane were purchased from J.T. Baker (Center 
Valley, PA, USA). Methanol (AMD Chromasolv ≥ 99.9%) was 
supplied by Sigma-Aldrich (Steinheim  am Albuch, Germany) 
and formic acid (98–100%) was supplied by Merck (Darmstadt, 
Germany).
Sodium hypochlorite (13% Cl2) was purchased from Bernd 
Kraft (Duisburg, Germany), and sodium thiosulfate solution 
(1 mol L−1) was supplied by Merck.
Salmonella typhimurium TA 1535/pSK1002 was obtained 
by the DSMZ (Leipzig, Germany). S9 Sprague Dawley (SD) 
rat liver extract was supplied by Trinova (Giessen, Ger-
many). Cofactor β-nicotinamide-adenine-dinucleotide-phos-
phate (NADP) came from Carbolution (St. Ingbert, Germany) 
and glucose-6-phosphate (G6P) was supplied by AppliChem 
(Darmstadt, Germany). O-nitrophenyl-β-D-galactopyranoside 
(ONPG) was supplied by Merck. Bacto tryptone, potassium 
chloride, magnesium chloride hexahydrate, disodium hydrogen 
phosphate, sodium dihydrogen phosphate dihydrate, 2-mercap-
toethanol, and disodium carbonate were obtained from Merck. 
Sodium chloride, ampicillin sodium salt, and sodium dodecyl 
sulfate were supplied by Sigma-Aldrich. HEPES and α-D-glu-
cose were purchased from AppliChem.
2.2 Standards
Standard stock solutions were prepared by dissolving 10 mg of 
each pure substance in 100 mL of methanol and storing it at 
−18°C. To prepare the respective standard solutions, the stock 
standards were diluted in methanol to the required concentra-
tion. The standard solutions were used for 4 weeks.
The stability of HPTLC was examined with a mix consist-
ing of 9 substances: 1,3,6-naphthalenes ulfonic acid triso-
dium salt hydrate (Sigma-Aldrich, purity ≥ 90%), 1,5-naph-
thalenedisulfonic acid tetrahydrate (Sigma-Aldrich, purity 
≥ 97%), 1-naphthalenesulfonic acid (Alfa Aesar, Haverhill, 
MA, USA, purity ≥ 99%), theobromine (Sigma-Aldrich, 
purity ≥ 98%), caff eine (Sigma-Aldrich, purity ≥ 99%), 
thiourea (Sigma-Aldrich, purity ≥ 99%), N-phenylaceta-
mide (LGC-Standards, Teddington, United Kingdom, purity 
100%), N-phenylbenzamide (Sigma-Aldrich, purity ≥ 98%), 
and N,N-dimethyl-4-[(E)-phenyldiazenyl]-aniline (Merck, 
purity 100%), with 300 ng on the HPTLC plate for each sub-
stance. The stability of the umu assay was reviewed with 
the two positive controls, namely, 4-nitroquinoline-N-oxide 
(4-NQO, −S9 activation to measure the direct genotoxicity) 
from Sigma-Aldrich (purity ≥ 98%) and 2-aminoanthracene 
(2-AA, +S9 activation to measure the indirect genotoxicity) 
from Alfa Aesar (purity ≥ 94%).
The metformin hydrochloride standard substance was supplied 
by Sigma-Aldrich (purity ≥ 99.2%). The yellow and colorless 
TPs were supplied by Technologiezentrum Wasser (Karlsruhe, 
Germany).
Identifi cation of Genotoxic Transformation Products by EDA with HPTLC and Non-Target Screening
Journal of Planar Chromatography 32 (2019) 3 175
2.3 Treatment of Metformin with Chlorine
In a laboratory trial, 100 mg L−1 of metformin (MF, 0.77 mmol 
L−1) in ultrapure water was treated with 2 (1.5 mmol L−1), 4 
(3.1 mmol L−1), and 6 (4.6 mmol L−1) molar equivalents (eq) 
of sodium hypochlorite, respectively. The active chlorine was 
determined iodometrically before each trial [27]. Because of 
the chlorate formation, the sodium hypochlorite solution was 
used for 6 weeks after procurement, only. After 60 min of stir-
ring, the reaction was stopped by adding sodium thiosulfate. 
The dosage of thiosulfate was calculated, depending on the 
sodium hypochlorite concentration with a security factor of 1.4. 
In each trial, a blank without MF and a control with MF but 
without hypochlorite were established in parallel.
2.4 Salmonella typhimurium TA1535/pSK1002 Assay 
(Umu Assay)
The umu assay was performed according to the DIN 38415-T3. 
Briefl y, Salmonella typhimurium TA1535/pSK1002 was culti-
vated and stored at −80°C in a ULUF 125 freezer from Arctiko 
(Esbjerg, Denmark). On the day of the execution of the assay, 
the overnight culture of bacteria was diluted at a ratio of 1:10 
with fresh tryptone, glucose, and ampicillin (TGA) media and 
then was incubated again for 90 min at 37°C until an optical 
density (OD) of 350 formazine attenuation units (FAU, pho-
tometer Nanocolor 400D, Macherey Nagel, Düren, Germany) 
was reached. The microtiter plate was fi lled with 180 μL of the 
sample (diff erent dilution levels), 20 μL of the fresh 10-fold con-
centrated TGA media, and 70 μL of inoculum. With metabolic 
activation also, 180 μL of the sample at diff erent dilution levels, 
but 20 μL of the 10-fold concentrated TGA media with cofac-
tors and 70 μL of the inoculum with the S9 liver extract were 
applied to the microtiter plate. The samples were investigated in 
triplicate and at six dilution levels (1:1.5, 1:3, 1:6, 1:12, 1:24, and 
1:48) in ultrapure water. The incubation of the 96-well plate 
was done using a PHMP-4 Thermo Shaker (Grant Instru-
ments, Shepreth, United Kingdom) for 2 h at 37°C. Then, the 
plate was diluted 10 times in fresh TGA media and incubated 
for another 2 h. The bacterial growth rates (GRs) were meas-
ured using a FLUOstar® Omega microtiter plate reader from 
BMG LABTECH (Ortenberg, Germany) at a wavelength of 
600 nm. O-nitrophenyl-β-D-galactopyranoside (ONPG) was 
used as the substrate for the detection of the β-galactosidase 
activity. If genotoxic substances occurred in the sample, β-ga-
lactosidase was expressed and ONPG was cleaved to o-nitro-
phenol, which could be measured at 420 nm due to its yellow 
staining.
In the umu assay, the bacterial growth rate (GR) was calculated 
using the following formula (OD: optical density):
600 600
600 600
 –  
  –  
sample OD blank ODGR
negative control OD blank OD
   (1)
GRs smaller than 0.5 indicate cytotoxicity; thus, those wells of 
the microtiter plate could not be evaluated. The induction rate 




1  –  
  –  
sample OD blank ODIR
GR negative control OD blank OD  (2)
In accordance with DIN 38415-T3, samples with an IR ≥ 1.5 
were considered to be genotoxic. In the case of diff erent IRs 
with and without metabolic activation, the larger IR was used. 
For the positive control substances, IR ≥ 2 was required. 
4-Nitroquinoline-N-oxide was used as a positive control with-
out metabolic activation. It achieved a mean IR of 3.69 (N = 
16, standard deviation (SD) = 0.55). 2-Aminoanthracene was 
applied as a positive control with metabolic activation, and a 
mean IR of 3.47 (N = 15, SD = 0.63) was determined.
The results of the assays were indicated as the lowest ineff ective 
dilution (LID). The LID is the lowest dilution level within the 
assay that does not show any genotoxic eff ect (IR < 1.5). Thus, 
higher LID values mean higher genotoxicity.
2.5 High-Performance Thin-Layer Chromatography 
(HPTLC)
2.5.1 HPTLC Apparatus and Software
For the application, separation and detection of HPTLC plates, 
an automatic TLC sampler 4 (ATS 4), an automated multiple 
development 2 (AMD 2), a TLC Scanner 3, and a TLC visual-
izer 2 were used. The associated software was winCATS (1.4.9). 
The elution of the zones from the plate was performed using the 
TLC–MS Interface 2 with an oval elution head (4 mm × 2 mm). 
All devices were from CAMAG (Muttenz, Switzerland). 
2.5.2 High-Performance Thin-Layer Chromatography
Before they were used, the HPTLC LiChrospher silica gel 
60 F254S plates (Merck) were immersed twice in 2-propanol for 
Table 1












1 100.0 0.0 0.0 11.0 
2 100.0 0.0 0.0 11.0 
3 100.0 0.0 0.0 11.0 
4 70.0 30.0 0.0 16.3 
5 30.0 70.0 0.0 21.6 
6 20.0 80.0 0.0 26.9 
7 15.0 85.0 0.0 32.2
8 11.0 89.0 0.0 37.5
9 8.5 91.5 0.0 42.8
10 6.5 93.5 0.0 48.2
11 5.0 95.0 0.0 53.5
12 4.0 96.0 0.0 58.8
13 3.5 96.5 0.0 64.1
14 0.0 100.0 0.0 69.4
15 0.0 50.0 50.0 74.7
16 0.0 0.0 100.0 80.0
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20 min. After drying at 120°C using a TLC plate heater (approx-
imately 20 min, CAMAG), the plates were pre-developed to the 
top edge with acetonitrile. Finally, the plates were heated again 
to 120°C for 20 min. The cleaned plates were stored in a desic-
cator at room temperature.
The samples were applied to the HPTLC plate in a 6 mm × 3 mm 
area with 500 μL each. For separation, the AMD 2 was used. 
The plate was developed in a stepwise manner with increasing 
migration distances. Each step consisted of another solvent com-
position with decreasing eluent strength. The fi rst three separa-
tion steps were necessary to focus the substances on the applica-
tion area (y = 6.5 − 9.5 mm) to a thin band (Table 1).
The stability of chromatography was examined using a mix 
consisting of nine substances, which were distributed over the 
whole retardation area after separation: 1,3,6-naphthalenesul-
fonic acid (100-fold retardation factor [hRF] = 12, % relative 
standard d eviation [%RSD] = 6%), 1,5-naphthalenesulfonic 
acid (hRF = 14, %RSD = 6%), 1-naphthalenesulfonic acid 
(hRF = 20, %RSD = 5%), thiourea (hRF = 28, %RSD = 6%), the-
obromine (hRF = 31, %RSD = 8%), caff eine (hRF = 41, %RSD = 
8%), N-pheny lacetamide (hRF = 56, %RSD = 4%), N-phenylben-
zamide (hRF = 77, %RSD = 2%), and N,N-dimethyl-4-[(E)-phe-
nyldiazenyl]-aniline (hRF = 83, %RSD = 1%). There were N = 42 
HPTLC plates over a period of 6 months.
2.5.3 HPTLC Extraction with the TLC–MS Interface 2
For the extraction of the zones from the plate, the TLC–MS 
Interface 2 was used, where the elution head was pressed to 
the HPTLC plate for 1 min with a fl ow of 200 μL min−1. For 
the extraction of the zones, ultrapure water was used as eluent, 
because the bacteria do not tolerate organic solvents, and for the 
normal phase HPTLC plates, water has high eluent strength. In 
order to obtain suffi  cient extracted volume for the umu assay 
(diff erent dilution levels, measurements in triplicate, parallel 
approach with and without metabolic activation, altogether 
2160 μL extract volume required), the separation of the sample 
and the extraction of the eff ective zones have to be repeated 12 
times. This is why one sample was applied several times to one 
plate. Subsequently, the extracts were combined in one vial. 
To avoid a carryover, after each extraction, the elution head was 
pressed to an empty site of the HPTLC plate and was purged 
with ultrapure water for at least 3 min. For the LC–HRMS 
measurement, additional to the eff ective zone, a blank from the 
HPTLC plate was always required. First investigations showed 
that the blanks within one plate are quite diff erent. Therefore, 
the blank extraction was done on an empty track directly beside 
the eff ective zone with the same hRF. In the non-target evalua-
tion, a feature was considered valid if its signal was at least fi ve 
times higher than the corresponding signal in the blank. This 
allowed false positive results to be ruled out, which were caused 
by blank values from the plate material or the binder.
2.6 Non-Target Screening with LC–HRMS
LC–HRMS analysis was performed with the Shimadzu Nexera 
Prominence LC (Kyoto, Japan) coupled to a quadrupole-time-
of-fl ight‒mass spectrometer (QTOF–MS X500R, Sciex, Fram-
ingham, MA, USA). Each sample (injection volume: 10 μL) 
was analyzed in triplicate using reversed-phase separation 
(Zorbax Eclipse Plus C18, 2.1 mm × 150 mm, 3.5 μm, Agilent, 
Santa Clara, CA, USA) with a fl ow of 0.3 mL min−1. An LC gra-
dient, consisting of (A) water (0.1%, V/V formic acid) and (B) 
acetonitrile (0.1%, V/V formic acid) with the following param-
eters, was used: 2% B (0 min), 2% B (1 min), 20% B (2 min), 
100% B (16.5 min), 100% B (22 min), 2% B (22.1 min), and 2% 
B (33 min). For ionization, electrospray ionization (ESI) was 
used in the positive mode, and ions were monitored within the 
mass range of m/z 100 up to 1200. The acquisition of the MS2 
spectra was performed using data dependent acquisition (DDA) 
experiments for a maximum of 12 precursors with the highest 
intensity (after dynamic background subtraction) within one 
cycle. After fragmentation by collision-induced dissociation 
(CID) with collision energy ramped from 20 to 55 V, fragment 
ions were acquired between m/z 30 and 1200.
The data acquisition was done via the Sciex OS (1.2) software. 
For non-target screening, the MarkerView (1.2.1) software 
was used for fi nding and aligning the peaks across diff erent 
samples and replicates, and the Sciex OS (1.2) software (Ana-
lytics tool) was required for the peak integration. All further 
processing steps were performed with in-house MATLAB 
scripts (R2017a, The MathWorks, Inc., Natick, MA, USA). 
The detailed procedure of the used non-target evaluation is 
described in Ref. [28].
3 Results and Discussion
3.1 Investigations on the Genotoxicity of Chlorinated 
Metformin Samples
After a 5-min reaction time with hypochlorite, the chlorinated 
MF samples (treated with 2, 4, and 6 eq NaOCl) turned to an 
intense yellow color, where the sample MF with 4 eq NaOCl 
(MF 4, analogue abbreviations: MF 2 and MF 6) displayed the 
yellow staining with the highest intensity. The three samples, 
T able 2
Maximal IR and LID of the umu assay from the investigation of chlo-
rinated MF samples. The respective dilution level of the maximal IR 
is listed in the brackets.
Samplea)





MF 2c) 2.94 (3) 6 1.84 (1.5) 3
MF 4d) 2.96 (6) 24 4.92 (1.5) 12
MF 6e) 2.46 (3) 6 3.08 (1.5) 6
Blankf) 0.95 (12) 1.5 1.28 (24) 1.5
Controlg) 1.21 (6) 1.5 1.15 (6) 1.5
a) Direct analysis of the samples after chlorination without HPTLC 
separation
b)Criterion for genotoxicity: IR ≥ 1.5
c)MF with 2 eq hypochlorite
d)MF with 4 eq hypochlorite 
e)MF with 6 eq hypochlorite 
f)Ultrapure water with hypochlorite
g)MF in ultrapure water without hypochlorite
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the blank (ultrapure water with hypochlorite), and the control 
(MF in ultrapure water without hypochlorite) were investigated 
using the umu assay with and without metabolic activation 
(Table 2).
All three samples showed a genotoxic eff ect in the umu assay. 
The highest IR of 4.92 was measured for sample MF 4 with 
metabolic activation. Therefore, the assay was repeated once 
more with this sample, and the eff ect could be confi rmed. More-
over, it was observed that the lowest dilution level (1.5) of all 
three samples and the dilution level 3 of sample MF 4 without 
metabolic activation were cytotoxic to the bacteria. The GRs of 
these attempts were below 0.5, which is why the IR must not be 
calculated. The blank and the control did not show any geno-
toxic eff ect, which is why the highest LID of 1.5 was assigned.
For the confi rmation of the potential genotoxic eff ect of the sam-
ple, diff erent bioassays with the endpoint genotoxicity should 
be performed. Therefore, the AMES fl uctuation assay (DIN 
38415-4) and the micronucleus assay (DIN EN ISO 21427-2) 
were chosen. The sample MF 4, the blank, and the control were 
investigated with the assays, and the genotoxic eff ect of the sam-
ple MF 4 could be confi rmed with the AMES assay. Salmonella 
typhimurium strain TA100, which refl ects point mutations, 
showed a dose-dependent genotoxic eff ect with and without 
metabolic activation. The highest IR of 4.9 was detected with 
metabolic activation at the smallest dilution level of 3. With the 
bacteria strain TA98, in the detection of frameshift mutations, 
no genotoxic eff ect was measured. In the micronucleus assay 
that was performed with the Hep G2-cell line, the sample MF 4 
only showed cytotoxic and secondary eff ects.
3.2 Workfl ow of EDA with HPTLC and Non-Target Screening
For the characterization of the measured genotoxic eff ects, an 
eff ect-directed analysis with the fractionation of the sample, 
the subsequent umu bioassay, and chemical detection was per-
formed (Figure 1). Therefore, the sample MF 4 was applied 
to a HPTLC plate, separated via gradient development, and 
the zones were extracted with the TLC–MS Interface 2. The 
extracted zones were investigated with the umu assay to detect 
fractions with a genotoxic eff ect. The eff ective zone was further 
investigated with LC–HRMS, and a non-target screening was 
performed. The aim of this procedure was the identifi cation of 
the genotoxic substance in the sample.
Instead of HPTLC, LC could also be used as a fractionation 
method, as has already been shown in some studies [14, 15]. 
This would have the advantage of a higher peak capacity of 
LC compared to HPTLC [7] as well as a better automation 
capability by direct spotting after separation into the microti-
ter plate. However, the solvent of the LC separation must be 
carefully evaporated before carrying out the bioassay. When 
using HPTLC, this step can be bypassed by aqueous extraction 
from the plate. Further advantages in favor of HPTLC as a frac-
tionation technique are the already mentioned, namely, higher 
matrix tolerance compared to LC and the high variability of the 
application volume.
3.2.1 Coupling of HPTLC with the Umu Assay
The sample MF 4 was applied twice to the HPTLC plate, and 
gradient separation (composition, Table 1) was performed. 
Then, 29 zones were extracted with the TLC–MS Interface 
2 over the whole retardation area, where extraction started at 
10 mm up to 80 mm at an interval of 2.5 mm (Figure 2B). 
Since the elution head width is 2 mm, the extraction of 29 zones 
in one track would be too tight causing leakage of the elution 
head. Therefore, the extraction was performed by alternating 
between two tracks.
All 29 zones were extracted two times through the repeated 
application of the sample MF 4 on one HPTLC plate such that 
400 μL of the extract volume per zone was available for the 
umu assay. Because of this limited available extract volume, the 
umu assay was performed without repetition and dilution but 
with and without metabolic activation, such that only 360 μL of 
extract per zone was required. With the extraction of 29 zones 
and an elution head width of only 2 mm, a distance of 0.5 mm 
(hRF-range = 0.7) between the two zones was not extracted. 
Nevertheless, because of the substance’s middle zone width of 
2 mm [21] from the separation with the used gradient develop-
ment, all of the zones were defi nitely covered but with recovery 
losses.
Figure 1
General workfl o w of EDA with HPTLC and non-target screening.
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By the separation of a metformin standard (100 mg L−1) with the 
gradient development, metformin achieved a hRF of 5 (Figure 
2A). After chlorination of metformin with hypochlorite, many 
bands over a broad separation distance could be detected. Two 
yellow zones occurred, which caused the yellow staining of the 
sample MF 4 (Figure 2B, arrows on zone 7 and zone 22). All 29 
extracted zones were investigated with the umu assay (without 
dilution steps), but fi rst, no genotoxic eff ect could be detected 
(Figure 3A). Only the yellow zone 22 (62.5 mm) caused a cyto-
toxic eff ect to Salmonella typhimurium TA1535/pSK1002. The 
GR of zone 22 without metabolic activation was only −0.1 and 
that with metabolic activation reached 0.2, while the GRs of all 
the other extracted zones were between 0.7 and 1.1. This fi nding 
indicates the intense inhibition of the bacteria in zone 22, as 
already mentioned from the investigation of the whole sample.
To check the eff ect of the yellow zone 22, the extraction of this 
zone was performed again. For the implementation of the umu 
assay in triplicate and with 6 dilution levels now, the extraction 
of zone 22 was repeated 12 times on one HPTLC plate to obtain 
a suffi  cient extract volume (2400 μL). Next, 2160 μL of extract 
was required for the umu assay with and without metabolic 
activation, and the remaining extract was used for LC–HRMS 
measurement. The extracted zone was already stained yellow; 
therefore, it could be ensured that the yellow substance in the 
zone could be (at least partly) extracted from the HPTLC plate 
with the used eluent (ultrapure water). This time, the umu assay 
showed a genotoxic eff ect for zone 22, both with and without 
metabolic activations. The maximal IR without metabolic acti-
vation reached 2.23 (LID = 6), and with metabolic activation, it 
was 1.92 (LID = 12). The dilution level of 1.5 without metabolic 
activation again was cytotoxic to the bacteria and therefore 
could not be evaluated (Figure 3B).
In comparison to the fi rst investigation of zone 22, where in 
both approaches (−S9 and +S9 activation) no IR could be cal-
culated because of cytotoxicity (not shown), with the second 
investigation, the GR of the umu assay at the dilution level 
of 1.5 with metabolic activation was suffi  cient for calculating 
the IR (Figure 3A* and B). However, the GR of 0.8 was still 
under the mean GR of 0.93 ± 0.08 (N = 10) for the remain-
ing dilution levels, and thus the little cytotoxic eff ect was 
determined. Altogether, it became apparent that cytotoxic-
ity occurs to a lesser extent with metabolic activation com-
pared to trials without metabolic activation. It is likely that 
cytotoxic compounds were transformed through enzymes in 
the S9 mix. Since the S9 enzyme mix from rat liver is a very 
Figure 3
(A) IR of the u mu assay with 29 extracted zones from the HPTLC plate at a dilution level of 1.5. (B) IR of the umu assay with zone 22 at different 
dilution levels. In the case of different IRs with and without metabolic activation, the larger IR is shown.
Figure 2
(A) Separation  of MF and (B) separation and extraction of 29 zones 
from 10 to 80 mm of sample MF 4. 
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complex system, the transformational effi  ciency of cytotoxic 
compounds may fl uctuate, which would explain the diff erent 
GRs between diff erent trials.
3.2.2 Combining EDA with HPTLC to Non-Target Screening
Since the genotoxic eff ect was matched to zone 22 through the 
extractions of 29 zones from the HPTLC plate, the identifi ca-
tion of the eff ective compound was sought. Therefore, the sam-
ple MF 4 and the extracted zone 22 were measured via LC–
HRMS. The blank, the control, and a blank extract from the 
HPTLC plate at the same hRF as zone  2 (hRF = 76) were used 
as blanks for the validation of the features in the non-target 
screening. The signals in the sample have to be 5 times higher 
than the mean of the blank signals to pass the feature validation. 
The assigned isotopes and adducts were not involved in further 
data evaluation.
After feature validation, 624 features remained for the sample 
MF 4. Zone 22 contained 194 valid features with an intersection 
with the sample MF 4 of 61 features (Figure 4).
Figure 4
Scatter diagram  with valid features of sample MF 4, zone 22, and 
the intersection of MF 4 with zone 22. The enlargement shows the 
5 features with highest intensity in the intersection of sample MF 4 
and zone 22.
Through the separation of the sample with HPTLC and the 
extraction from the plate, the number of features, which could 
be responsible for the genotoxic eff ect, was reduced by a factor 
of 10 from 624 to 61. Within the remaining 61 possible features, 
the eff ective substance was sought. Therefore, the features were 
sorted based on their intensity, and the most intense features 
were investigated fi rst because they provide the most expressive 
isotopic patterns and MS/MS spectra. In Table 3, the fi ve fea-
tures with the highest intensities in zone 22 are shown.
The proposed formulas for the features with the highest 
intensity were matched based on the isotopic pattern and the 
respective MS/MS spectrum. The formulas with the highest 
accordance in both criteria were selected. In the literature, 
two of these formula proposals (C4H6ClN3 and C4H6ClN5) were 
already described as the TPs of the chlorine-treated metformin 
[26] (Figure 5).
Ta ble 3
The fi ve most intense features of the intersection of sample MF 4 
and zone 22 (cps: counts per second).





132.0319 5.98 524660 353463  C4H6ClN3
132.0319 6.77 868898 90062 C4H6ClN3
128.0929 6.78 253985 27476 C4H9N5
160.0384 6.76 109494 10486  C4H6ClN5
223.1409 6.35 599282 9107 C8H14N8
Armbruster et al. [26] found that during the chlorination, met-
formin is degraded to a cyclic dehydro-1,2,4-triazole derivate 
with an intense yellow color. This TP accords to the found 
feature 160.0384/6.76, and the proposed formula of C4H6ClN5. 
However, this reaction product is not that stable and is degraded 
to a colorless chloroorganic nitrile, which is suited to the fea-
tures 132.0319/5.98 and 132.0319/6.77 with the proposed for-
mula of C4H6ClN3. Therefore, the occurrence of the two fea-
tures with the same mass (132.0319) but with diff erent retention 
times can be explained. One part of the yellow TP is already 
degraded to the colorless TP before LC separation and therefore 
occurs at another retention time (5.98 min). The other feature of 
the colorless TP with the same retention time as the yellow TP 
(6.77 min) is probably an in-source fragment, which is caused 
by the N2-elimination in the ESI source.
For further confi rmation, if one of these two products caused 
the genotoxic eff ect on the umu assay, recrystallized yellow 
Figure 5
Degradation of m etformin to a yellow and a colorless TP through sodium hypochlorite [26].
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and colorless TPs were obtained from DVGW Technologiezen-
trum Wasser. The detailed procedure for the recrystallization 
is described in Ref. [26]. Both TPs were dissolved in ultrapure 
water (1 mg mL−1), and their purities were reviewed with 
HPTLC separation (application volume 10 μL) (Figure 6).
The HPTLC gradient separation of the yellow TP occurred 
in two zones, whereby one zone showed a yellow staining 
and reached the same hRF as zone 22 (hRF = 76), and the sec-
ond one was found just below the yellow zone. It reached the 
same hRF as the colorless TP (hRF = 72), which indicated that 
parts of the yellow TP were already degraded to the colorless 
TP.
Then, the umu assay was performed with both of the TPs (500 
mg L−1, without HPTLC separation), and it could be shown that 
the yellow one causes a genotoxic eff ect with and without met-
abolic activation, while the colorless TP only has a cytotoxic 
eff ect on the bacteria. The maximal IRs for the yellow TP were 
5.82 (−S9, LID = 48, cLID = 10 mg L
−1) and 3.37 (+S9, LID = 
48, cLID = 10 mg L
−1). Until reaching the dilution level of 6, the 
yellow TP is cytotoxic to the bacteria; therefore, the IR must not 
be calculated (Figure 7).
To review, if both the TPs can be eluted from the HPTLC plate 
with ultrapure water, the recoveries of the substances were 
determined. Therefore, both TPs (100 mg L−1) were applied to 
the HPTLC plate in a 6 mm × 6 mm area with 50 μL each, and 
extraction with the TLC–MS Interface 2 was performed in the 
middle of this area. The required concentrations of 100% recov-
ery were calculated over the elution head’s area. These concen-
trations of the two TPs were doped to blank extracts from the 
HPTLC plate as references, and were set as 100% recovery. 
Based on their accurate masses in the LC–HRMS measure-
ment, the recoveries of the TPs in the plate extracts could be 
determined. The recovery of the yellow TP was 106%, and for 
the colorless, TP it was 101%.
The fi nal identifi cation of the yellow TP in zone 22 was done 
via the comparison of the retention times, isotopic patterns, and 
the MS/MS spectra of the recrystallized yellow TP, the sample 
MF 4, and zone 22. The retention time of m/z 160.0384 was 
6.8 min in all the 3 measured samples. The isotopic pattern of 
the m/z 160.0384 showed the typical chlorine isotopic pattern, 
and the MS/MS spectra were identical (Figure 8).
3.3 Quantifi cation of the Yellow TP
The quantifi cation of the yellow TP in the sample MF 4 was per-
formed via HPTLC and the measurement of yellow absorption 
(400 nm) at hRF = 76. Thereby, it must be considered that the 
yellow TP is not stable, such that only its concentration could 
be estimated. The polynomial calibration curve (y = −1.188x2 
+ 255.4x − 1025, r = 0.99986, %RSD = 3.0%) was determined 
with 4 standard concentrations (0.039 mmol L−1, 0.077 mmol 
L−1, 0.39 mmol L−1, and 0.77 mmol L−1). The concentration of 
the yellow TP in the sample MF 4 was estimated as 0.43 mmol 
L−1 by applying 0.77 mmol L−1 MF at the beginning. Therefore, 
it could be said that through chlorination with 4 eq NaOCl, 
about a half of the applied MF is converted to the yellow TP.
Figure 6
Purity review of the recrystallized yellow and colorless TP.
Figure 7
IR of the umu as say with the yellow and colorless TPs.
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4 Conclusion
In this study, EDA was perf ormed by the coupling of HPTLC 
with biological detection in the microtiter plate using the umu 
assay. Since the umu assay currently cannot be directly applied 
on the HPTLC plate, the assay was performed according to 
DIN 38415-T3 on the microtiter plate. The diffi  culty of the cou-
pling of HPTLC with a bioassay in the microtiter plate is the 
selection of the suitable zones for extraction with the TLC–MS 
Interface 2, because after HPTLC, the position of the eff ective 
zone on the plate is unknown. If no metainformation regarding 
the eff ective zone is available, the solution is the extraction of 
the whole retardation area.
This procedure was applied for a chlorinated metformin sam-
ple whereby a genotoxic eff ect was measured in the form the 
HPTLC plate extracted zones. By combining EDA with a 
non-target screening with LC–HRMS, fi nally a genotoxic 
compound could be identifi ed. Thereby, the advantage of the 
separation before the biological detection became apparent, 
because the number of possible features for the identifi cation 
of the compound could be narrowed down from 624 to only 61. 
The identifi cation of the remaining 60 unknown features in the 
intersection of sample MF 4 and zone 22 would require further 
research, which is still a major challenge.
In further work, the developed workfl ow could be transferred to 
other bioassays in order to broaden the fi eld of application. The 
advantage of the method is that standardized test systems in the 
microtiter plate can also be used directly without the need to 
transfer the bioassay to the HPTLC plate. Finally the developed 
method is intended to help the often complex identifi cation of 
substances eff ective in bioassays and to simplify this process as 
much as possible.
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a b s t r a c t 
Effect-directed analysis (EDA) is increasingly used in environmental monitoring to detect and identify key 
toxicants. High-performance thin-layer chromatography (HPTLC) has proven to be a very suitable fraction- 
ation technique for this purpose. However, HPTLC is limited in its separation efficiency. Thus, separated 
fractions could still contain many different components and identification of the effective substances re- 
mains difficult. Therefore, in this study a workflow for selective EDA with two-dimensional HPTLC in com- 
bination with high-performance liquid chromatography-high-resolution mass spectrometry (HPLC-HRMS) 
was developed. The aim of the workflow was the stepwise reduction of the sample complexity in order 
to reduce the number of signals that could be responsible for the measured effects. As a consequence, the 
identification of effective substances should be facilitated. The acetylcholinesterase inhibition assay (AChE 
assay) for the detection of potential neurotoxic compounds was applied for biotesting. The transfer of ef- 
fective zones from the first to the second dimension and also to the mass spectrometric measurement 
was enabled by extraction. 
A proof of concept was performed by spiking six acetylcholinesterase inhibiting substances into three 
different water matrices that were investigated with the developed workflow. The successful prioritiza- 
tion of all spiked compounds confirmed the efficiency of the workflow, regardless of the sample matrix. 
Biotesting of different water samples resulted in numerous potentially neurotoxic effects, which over- 
lapped strongly in the first separation dimension. The higher peak capacity reached by two-dimensional 
HPTLC, on the other hand, resulted in discrete effective zones and enabled the identification of several 
compounds. For the substances lumichrome, a derivate of riboflavin and paraxanthine as well as for lin- 
ear alkylbenzene sulfonates that were applied as anionic surfactants in detergents, the inhibiting effect 
to the AChE could be confirmed. 
© 2020 Elsevier B.V. All rights reserved. 
1. Introduction 
Protecting the aquatic environment and providing people 
around the world with safe drinking water are main challenges 
of our time [1] . Therefore, monitoring of the aquatic environment, 
also serving as a source of raw water for drinking water produc- 
tion, is of particular importance. Since aquatic environmental sam- 
ples are complex substance mixtures their characterization and as- 
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sessment remains challenging [ 2 , 3 ]. Often, target analysis is used 
to detect and to quantify known substances in water samples sen- 
sitively and accurately [ 4 , 5 ]. However, target analysis is not suffi- 
cient to capture the multitude of substances in environmental mix- 
tures, especially because it is not able to capture the unknown 
compounds [6] . But there are substances, which have not been 
characterized yet and many transformation products currently are 
not known. To be able to detect also the unknowns, non-target 
screening has to be applied [ 7 , 8 ], such that a more comprehensive 
description of environmental samples becomes possible. In addi- 
tion to the identity of substances and their transformation prod- 
ucts, to date only little is known about their effects on humans 
and the ecosystem they come in contact with [9] . Therefore, effect- 
directed analysis (EDA) can be applied, which combines biotesting 
https://doi.org/10.1016/j.chroma.2020.461239 
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with a fractionation and chemical analysis [10] . The aim of the EDA 
is the detection of effects and the identification of effective com- 
pounds. 
If an environmental sample causes an effect in a bioassay, the 
challenge is to evaluate the relevance of the contained compounds 
and select the important ones, namely the key toxicants [ 11 , 12 ]. 
With EDA, the goal of prioritizing and identifying relevant key tox- 
icants by using fractionation steps can be pursued, so that envi- 
ronmental samples are divided into less complex fractions [ 13 , 14 ]. 
Only the effective fractions have to be further investigated to iden- 
tify the respective bioactive compounds [15] . 
High-performance thin-layer chromatography (HPTLC) has 
proven to be a particularly suitable fractionation technique for EDA 
[ 16 , 17 ]. In contrast to column chromatography, HPTLC is an open 
separation system and since the layer is solvent-free after the sep- 
aration, the in-vitro bioassay can be applied directly on the HPTLC 
plate [18] . But compared to high-performance liquid chromatogra- 
phy (HPLC), the achievable peak capacity of HPTLC is limited [10] . 
In a previous work, a selective two-dimensional (2D) HPTLC ap- 
proach with use of the acetylcholinesterase inhibition assay (AChE 
assay) for the detection of potential neurotoxic effects in water 
samples was thus developed [19] . The aim of the work was to in- 
crease the peak capacity via a 2D HPTLC separation that results 
in a reduction of the number of substances in an effective zone. 
The characteristic of the developed approach was the transfer of 
only effective zones from the first to the second dimension by 
extraction (heart-cut approach) and was therefore called selective 
EDA with 2D HPTLC. Fractions without effects could already be ex- 
cluded after the first dimension (1D). The AChE assay was applied 
twice, after the first and after the second separation dimension. 
Five mobile phases (MP) were developed for separation in the 2D, 
which were adapted to the retardation factor of the effective zone 
in the 1D. Thus, the eluent strength of the MP in the 2D was op- 
timally adjusted and a peak capacity of 208 compared to the pre- 
vious 29 in one-dimensional gradient development was achieved 
[19] . 
When environmental samples are investigated with EDA and 
unknown effective substances should be identified, additional 
structure elucidation has to be performed. Therefore, in the cur- 
rent study the selective EDA using the described 2D HPTLC ap- 
proach was connected to high-performance liquid chromatography 
(HPLC) with high-resolution mass spectrometry (HRMS) and a non- 
target screening (NTS). Approaches that combine 2D separations 
with bioassays and mass spectrometry are already known from the 
literature [ 14 , 20 ]. However, either 2D HPLC separations or a com- 
bination of 2D HPTLC + HPLC separation were used, whereby in 
both approaches the bioassay is applied only once. In one study, 
EDA was performed with a 2D HPTLC separation [21] . However, no 
additional analysis for structure elucidation was performed, so that 
only known effective substances could be determined on the basis 
of their retardation factors. 
In this study, a workflow for selective EDA with 2D HPTLC in 
combination with HPLC-HRMS was developed with the aim to pri- 
oritize and identify effective compounds. With HPTLC separation 
and the AChE assay in two dimensions, many components of the 
sample were separated from the effective zone and therefore could 
already be excluded as cause for the effect. The sam ples were in- 
vestigated via NTS and a prioritization was performed by forming 
the intersection of the signals detected in the sample and the cor- 
responding plate extracts. Thus, a detailed and elaborate examina- 
tion of the individual remaining signals, with the aim of identi- 
fying the effective substance(s), was enabled. In the first part of 
the work, the developed workflow was evaluated and a proof of 
concept with spiked water samples was carried out. Subsequently, 
different water samples were examined via EDA with 2D HPTLC in 
combination with HPLC-HRMS regarding their potential neurotoxic 
effects and several substances could be identified in the effective 
zones. 
2. Materials and methods 
2.1. Chemicals and reagents 
Ultrapure water was produced with an ultrapure water sys- 
tem (Purelab R © Ultra, Elga LabWater, Lane End, UK). Acetonitrile 
(Rotisolv R © ≥ 99.95%, LC-MS-Grade), acetone (Rotisolv R © ≥ 99.9%, 
HPLC), water for LC-MS analysis (Rotisolv R © Ultra LC-MS) and 
2-propanol (Rotisolv R © ≥ 99.95%, LC-MS-Grade) were purchased 
from Carl Roth (Karlsruhe, Germany). Dichloromethane (Ultra Resi- 
analyzed R ©, ≥ 99.8%) and n-hexane (Ultra Resi-analyzed, ≥ 99.5%) 
were purchased from J.T. Baker (Center Valley, US). Methanol (AMD 
Chromasolv TM ≥ 99.9% and Rotisolv R © ≥ 99.95%, LC-MS-Grade) was 
supplied by Sigma-Aldrich (Steinheim am Albuch, Germany) and 
Carl Roth. Chloroform (HiPerSolv Chromanorm R ©) and ammonia 
(25%, AnalaR Normapur R ©) were purchased from VWR International 
(Bruchsal, Germany), while formic acid (98 - 100%), ethyl acetate 
(Uvasol R ©) and toluene (Uvasol R ©) were supplied by Merck (Darm- 
stadt, Germany). 
For the AChE assay, acetylcholinesterase Type VI-S (20 0 0 U/vial) 
from electric eel, ascorbic acid and 3-indoxyl-3-acetate from 
Sigma-Aldrich were used. Bovine serum albumin, hydrochloric acid 
(32%) and 2-amino-2-(hydroxymethyl)-1,3-propanediol were sup- 
plied by Merck. 
2.2. Standards 
The stability of HPTLC was examined with a chromatog- 
raphy control mix consisting of nine substances (1,3,6- 
naphthalenesulfonic acid, 1,5-naphthalenesulfonic acid, 1- 
naphthalenesulfonic acid, theobromine, caffeine, thiourea, 
N-phenylacetamide, benzamide, and N,N-dimethyl-4-[(E)- 
phenyldiazenyl]-aniline) with 10 mg/L each. 
89 substances were investigated regarding their recovery after 
solid phase extraction (SPE) and after extraction with the TLC-MS 
Interface (Table S 1). The proof of concept of the developed work- 
flow was performed by spiking six substances with potential neu- 
rotoxic effects to three water samples ( Table 1 ). For final confirma- 
tion of identified substances, reference standards were purchased: 
clopidogrel carboxylic acid (TRC, North York, Canada, 97.0%), meto- 
lachlor ethanesulfonic acid (Neochema, Bodenheim, Germany), 
sodiumdodecylbenzenesulfonate (Sigma-Aldrich, 49.7%, mixture of 
homologues C10-C13 and isomers), triamterene (TRC, 98.0%), lu- 
michrome (Cayman Chemical, Ann Arbor, US, 98.1%), methocar- 
bamol (Sigma-Aldrich, 99.8%), oxazepam (Neochema), phenazone 
(Dr. Ehrenstorfer, Augsburg, Germany, 99.0%) and paraxanthine 
(Cayman Chemical, 98.0%). 
2.3. Sampling and sample preparation 
Grab samples of drinking water and surface waters were taken 
with 1 L each. Sewage waters were sampled as grab samples af- 
ter the first treatment stage consisting of a grit chamber and a 
grease trap. In the following, the sample is referred to as untreated 
sewage water. The second sampling was done after the final treat- 
ment of the purified sewage water with powdered activated carbon 
(purified sewage water). 
Enrichment was performed by solid phase extraction (SPE) 
[ 22 , 23 ]. The enrichment factor for drinking, surface and purified 
sewage water was 10 0 0. In order to prevent clogging of the SPE 
cartridge, the untreated sewage water was enriched by a factor of 
100 due to the higher matrix load of the sample. Two pH-values 
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Table 1 
Overview of the spiked substances. 
Substance hR F (1D) h R F area (2D) h R F (2D) Formula 
log K OW 
(EPIWEB 4.1) Class ß, spiked (μg/L) 
Azamethiphos 61 D 17 C 9 H 10 ClN 2 O 5 PS 1.00 Pesticide (Thiophosphoric acid ester) 500 
Caffeine 43 C 8 C 8 H 10 N 4 O 2 0.16 Drug (Alkaloide) 41.5 
Donepezil 25 B 56 C 24 H 29 NO 3 4.86 Pharmaceutical (Piperidinderivate) 40.7 
Galanthamine 14 A 27 C 17 H 21 NO 3 2.29 Pharmaceutical (Plant alkaloid) 46.9 
Methiocarb-sulfoxide 39 B 64 C 11 H 15 NO 3 S 0.70 Metabolite pesticide (Carbamate) 3.0 
Paraoxon-ethyl 69 D 47 C 10 H 14 NO 6 P 1.97 Metabolite pesticide (Phosphoric acid ester) 1.7 
(pH 2 and pH 7) were applied for investigation of the SPE recov- 
ery. Therefore the samples were adjusted to these pH values with 
HCl or NaOH, respectively. Due to higher substance recoveries at 
pH 7, only this pH value was used for the enrichment of the water 
samples. 
Bond Elut Plexa cartridges (500 mg, Agilent Technologies, Santa 
Clara, US) containing a non-polar divinylbenzene-based neutral 
polymeric sorbent were used for the enrichment. The cartridges 
were conditioned with each 5 mL n-hexane, dichloromethane, ace- 
tone, methanol and ultrapure water. The sample was filled in a 
storage vessel and ran over the cartridge, powered by a peristaltic 
pump with a flow of 2.5 mL/min. After loading, the cartridges were 
dried for 45 min in an airstream. Three solvents were used for 
elution. At first, 3 mL methanol (0.4% v/v ammonia) was used. 
The second eluent consisted of 4 mL of a 50:50 v/v mixture of 
methanol (0.4% v/v ammonia) - ethyl acetate, and the third elu- 
ent was dichloromethane (3 mL). Evaporation was performed in a 
gentle stream of nitrogen after respectively 1 mL of solvent was 
eluted. 50 μL of ultrapure water was added as a keeper before 
evaporation of dichloromethane. The residue (about 50 μL of ul- 
trapure water) was diluted with 1 mL methanol. Additionally, a 
blank of the SPE cartridge was prepared. Therefore, the cartridge 
was conditioned and eluted the same way as the sample cartridge 
but without any contact with a sample. 
2.4. High-performance thin-layer chromatography 
2.4.1. HPTLC apparatus and software 
For application, separation and detection, the Automatic TLC 
Sampler 4 (ATS 4), Automatic Developing Chamber 2 (ADC 2), Au- 
tomated Multiple Development 2 (AMD 2), TLC Scanner 4 and TLC 
Visualizer were used. The associated software was winCATS (1.4.9). 
Elution of zones from the HPTLC plate was performed with the 
TLC-MS Interface 2 with an oval elution head (4 mm × 2 mm). 
Immersion of the plates in the AChE solution was done with the 
Chromatogram Immersion Device 3 (all from CAMAG, Muttenz, 
Switzerland). For the AChE assay additionally the spraying appa- 
ratus, Derivatizer from CAMAG and an incubator at 37 °C (VWR 
International) were used. 
2.4.2. HPTLC chromatography 
Before use, HPTLC LiChrospher silica gel 60 F 254S plates (Merck) 
were immersed twice in 2-propanol for 20 min. After drying at 
120 °C on the plate heater, the plates were predeveloped to the 
top edge with acetonitrile. Finally, the plates were heated again to 
120 °C for 20 min. Cleaned plates were stored in a desiccator at 
room temperature. This procedure was necessary to remove plate 
contaminations interfering with the bioassay detection. 
The sample application to the HPTLC plate was performed 
with the ATS 4. 30 μL of the control mix for chromatogra- 
phy was applied. 50 μL of each sample and SPE blank extract 
was applied in the 1D as area application to reduce matrix ef- 
fects (6 mm × 3 mm). In order to minimize the substance loss, 
the extracted zones were applied with the entire extracted vol- 
ume (200 μL, sufficient extract volume by extracting the zones 
three times from the plate) for 2D separation as band application 
(6 mm × 1 mm). 
For separation in the 1D the automated multiple development 
system (AMD 2) was used. The plate was developed in a stepwise 
manner with increasing migration distances and decreasing eluent 
strength. The first three separation steps were necessary to focus 
the substances on the application zone to thin bands. As solvents, 
methanol (0.05% v/v formic acid), dichloromethane and n-hexane 
were used (Table S 2). A dynamic approach was used for separation 
in the 2D, where only the selected effective zones of the 1D were 
applied and separated again on the same stationary phase material 
but with a different mobile phase (MP). The detailed procedure is 
described in [19] . For this approach five arbitrary retardation areas 
were appointed in equal intervals and for each of these areas a 
different MP was applied (Table S 3). The MP used in the 2D was 
selected dependent on the apex h R F of the effective zone in the 
1D. 
After the separation, images were taken from the HPTLC plate 
with the TLC Visualizer (254 nm, 366 nm, white light) and a multi 
wavelength scan at seven wavelengths (190 nm up to 300 nm) was 
recorded. The quality control of the HPTLC separations in both di- 
mensions was performed using the h R F of the substances in the 
chromatography control mix (Table S 4). Before the application 
of the bioassay, the HPTLC plates were adjusted to a neutral pH. 
Therefore, the plates were placed for 10 s in NH 3 -vapor and then 
put under vacuum (10 min) to remove the remaining NH 3 (pH af- 
ter neutralization approx. 7.5). 
2.5. Acetylcholinesterase inhibition assay with HPTLC (AChE assay) 
The AChE assay was performed as described in [19] with few 
modifications. 20 g/L of 3-idoxyl-3-acetate dissolved in methanol 
was used as a substrate to evaluate the activity of the enzyme. 
When the enzyme was active, the substrate was cleaved to indoxyl 
and reacted with oxygen to indigo white. Both reaction products 
could be measured at 366 nm because of their blue fluorescence. 
The AChE assay starts with the immersion of the plate in the 
enzyme solution (Chromatogram Immersion Device 3, dipping time 
1 s, dipping speed 5 cm/s). The supernatant enzyme solution was 
carefully pulled off with a squeegee. The plate was incubated in 
an incubator for 5 min at 37 °C with humidity higher than 90%. 
After 6.5 min, the substrate solution was sprayed to the plate with 
the spraying apparatus (amount of reagent: 600 μL, nozzle: green, 
level: 5). 8.5 min after the immersion, the fluorescence detection 
of the enzyme inhibition started (wavelength: 366 nm, exposure 
time: 200 ms). A sequence capturing 10 pictures in 10 min was 
gathered, where always the third picture was used for evaluation 
to obtain comparable results. 
The evaluation of the results of the AChE assay was performed 
by means of an image evaluation with in-house MATLAB scripts 
(R2017a, The MathWorks, Inc., Natick, US). For this purpose, the 
blue channel of the color image was read out (B) and the blue lev- 
els of the sample tracks, B(sample) and the corresponding back- 
ground tracks, B(BG), were determined. The effect was calculated 
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for each point of the h R F range using the following formula: 
effec t hR F = 
(
B ( BG ) hR F − B ( samp le ) hR F 
)
/ B ( BG ) hR F 
After the evaluation, a chromatogram could be generated in 
which the effect was plotted against the h R F . 
2.6. Extraction of effective zones 
During the workflow, the TLC-MS Interface was required twice 
for extraction of effective zones. In the first step, the zones have 
to be transferred from the 1D to the 2D for further separation and 
biotesting. After the 2D the zones were extracted again and a non- 
target screening was performed. 
A challenge is to determine the coordinates of the effective 
zone on the HPTLC plate correctly. One reason for this is that 
the extraction cannot be performed after the bioassay has been 
applied, because the biological system would interfere with the 
second HPTLC separation and with the HPLC-HRMS detection. But 
separations on different HPTLC plates for the biotesting and the 
extraction cause variability of the retardation factors ( h R F ± 1.7) 
and it becomes more difficult to hit the effective zones correctly. 
Fluctuations of the retardation factors within an HPTLC plate, how- 
ever, are significantly lower. Therefore, all samples were applied 
four times to one HPTLC plate. After the separation in the 1D, the 
plate was cut in two parts, one part for the biotesting (one sample 
track) and the other part for the extraction of the effective zones 
(three sample tracks). Thus, the coordinates of the effective zone 
could be determined within one separation and variations between 
the separations were reduced. Each effective zone in the 1D was 
extracted three times, twice for the application in the 2D (again 
biotesting and extraction) and once for the HPLC-HRMS measure- 
ment. In order to ensure a uniform composition, the three extracts 
were mixed before their further use. 
Since methanol has the highest eluent strength following wa- 
ter, it was used as the extraction eluent. Water, on the other hand, 
dissolves the silica layer and therefore more often leads to a leak- 
age of the elution head. The substances in the target zone were 
eluted for 1 min with a flow of 200 μL/min [24] . To avoid a carry- 
over between extractions, the elution head was purged after each 
extraction with methanol for at least three minutes. Additional to 
the effective zone, always a blank from the HPTLC plate was re- 
quired. The blank extraction was performed on an empty track on 
each HPTLC plate with the h R F = 50. 
2.6.1. Investigations of the recovery with the TLC-MS Interface 
Recovery of the extraction with the TLC-MS Interface was in- 
vestigated in two approaches. The first approach was to check the 
extent to which the substances can be dissolved from the HPTLC 
plate without considering how accurate the zones were hit with 
the extractor. Therefore a mix standard containing 89 substances 
was applied to the HPTLC plate in a 6 mm × 6 mm area and the 
extraction with the TLC-MS Interface was performed in the mid- 
dle of this area. 10 ng of each substance in the mix was applied 
to the area of 36 mm 2 , such that with the elution head (halved 
circle in the middle of which a rectangle is inserted, 7.14 mm 2 ) 
a maximal substance quantity of 1.98 ng could be extracted. This 
amount was set as 100% recovery and was spiked to a blank ex- 
tract from the HPTLC plate. Based on their signal intensities in 
the HPLC-HRMS measurement, the recoveries of the 89 substances 
were determined. This examination was repeated four more times 
and the mean value of the data is shown in Table S 1. 
In the second approach, the geometry of the elution head and 
the band geometry were considered. Therefore, the mix standard 
was applied in a 6 mm x 1.9 mm area, since 1.9 mm is the aver- 
age peak width after the used gradient development in the AMD 2 
[19] and 6 mm is used as the standard band length in our labora- 
tory. The extraction was performed in the same way, as in the first 
approach and was repeated four more times. The mean value of 
the data is shown in Table S 1. Due to the geometry of the elution 
head, a maximum recovery of 62% can be expected under these 
conditions (peak width 1.9 mm and band length 6 mm). 
It should be taken into account that the extraction of non- 
separated zones from the HPTLC results in an evenly distributed 
substance concentration within the zones. However, if a chromato- 
graphic separation is carried out beforehand, a Gaussian distribu- 
tion of the substance concentrations is to be expected. Further- 
more, the depth profile of the substances resulting from the HPTLC 
separation could also have an influence on the recovery of the ex- 
traction and is not considered in this investigation. 
2.7. HPLC-QTOF-MS 
Prior to injection (injection volume 95 μL), the sample extracts 
and the extracts from the HPTLC plate were diluted by a fac- 
tor of 1:9 in ultrapure water each. HPLC-HRMS analysis was per- 
formed with the Shimadzu Nexera Prominence LC (Kyoto, Japan) 
coupled to a Quadrupole-Time-of-flight-mass spectrometer (QTOF- 
MS X500R, Sciex, Framingham, US). Each sample was analyzed in 
triplicate using reversed phase separation (Zorbax Eclipse Plus C18, 
2.1 mm x 150 mm, 3.5 μm, Agilent, Santa Clara, US) with a flow 
of 0.3 mL/min. An HPLC gradient, consisting of A: water (0.1% v/v 
formic acid) and B: acetonitrile (0.1% v/v formic acid) with the fol- 
lowing parameters was used: 2% B (0 min), 2% B (1 min), 20% B 
(2 min), 100% B (16.5 min), 100% B (22 min), 2% B (22.1 min), 2% B 
(33 min). For ionization, electrospray ionization (ESI) was used in 
the positive and negative mode and ions were monitored within 
the mass range of m/z 100 up to 1200. The acquisition of the MS 2 
spectra was performed using data dependent acquisition (DDA) ex- 
periments for a maximum of 12 precursors with the highest inten- 
sity (after dynamic background subtraction) within one cycle. Af- 
ter fragmentation by collision-induced dissociation (CID) with the 
collision energy ramped from 20 V to 55 V, fragment ions were 
acquired between m/z 30–1200. The MS1 and MS2 experiments 
result in a total cycle time of roughly 1.1 s. Considering an aver- 
age chromatographic peak width of about 10 s, the number of data 
points across the peak is still satisfying. 
The data acquisition was done via the Sciex OS (1.2) software. 
For non-target screening, the MarkerView (1.2.1) software was used 
for finding and aligning the peaks across different sam ples and 
replicates and the Sciex OS (1.2) software (analytics tool) was re- 
quired for the peak integration. All further processing steps were 
performed with in-house MATLAB scripts (R2017a, The MathWorks, 
Inc., Natick, US). The detailed procedure of the used non-target 
evaluation is described in [25] . 
After evaluation of non-target signals, validated features were 
prioritized by mathematical intersection formation. It was assumed 
that a substance causing an effect in the 1D and 2D occurs in the 
extracted zones of both dimensions and also in the sample extract. 
Thus, the intersection of the signals in the sample extract, the 1D 
zone and the 2D zone was formed and only signals detected in all 
three samples were considered for further identification attempts. 
The first step in the identification of effective substances is 
the allocation of the exact masses to possible molecular formu- 
las based on the isotope pattern and fragment information. By 
database searches, possible structural formulas were selected and 
reviewed based on their isotope patterns and MS/MS spectra. For 
clear identification of the substances, a comparison with the ref- 
erence standard was performed. Concentrations of identified sub- 
stances were determined by HPLC-QTOF-MS via an external eight- 
point calibration (0.01 μg/L up to 100 μg/L). In case of higher sub- 
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Fig. 1. Workflow of selective EDA with 2D HPTLC in combination with HPLC-HRMS. 
stance concentrations, the sample extracts were diluted accord- 
ingly. 
3. Results and discussion 
3.1. Workflow of selective two-dimensional EDA with HPTLC and 
coupling to HPLC-HRMS 
In this work, the identification of effective com pounds detected 
via EDA should be facilitated through 2D separation and stepwise 
reduction of possible candidate signals. Therefore, a workflow com- 
bining selective EDA with 2D HPTLC in combination to HPLC-HRMS 
was developed. Effective zones of the 1D were extracted and ap- 
plied to a HPTLC plate for second separation and biotesting. Ef- 
fective zones in the second biotesting were extracted again ( Fig. 1 , 
Part A). This procedure provided three samples of each detected ef- 
fect for the HPLC-HRMS measurement: the sample extract (1), the 
extracted zone of the 1D (2) and the extracted zone of the 2D (3). 
Non-target screening and evaluation was performed as de- 
scribed in [ 25 , 26 ]. Mathematical intersections were formed to pri- 
oritize the signals that occurred in the sample extract, in the ex- 
tracted zone of the 1D and also in the extracted zone of the 2D 
but not in the SPE and the HPTLC plate blank ( Fig. 1 , Part B). In 
a first step, the mathematical intersection of the sample extract 
and the extracted zone after 1D separation was formed (sample 
extract ∩ zone 1D). In the next step, the second separation dimen- 
sion was included by forming the intersection of sample extract, 
extracted zone of the 1D and extracted zone of the 2D (sample ex- 
tract ∩ zone 1D ∩ zone 2D). The procedure for identification of ef- 
fective substances was adopted from previously published studies 
[ 8 , 12 , 27 ]. In short, it was tried to allocate the features in the in- 
tersection to the molecular formulas and then possible candidate 
structures were obtained by database searches. For identification, 
a comparison with a reference standard was performed. 
If a substance could be identified via a reference standard, the 
h R F and also the effect of the substance in the 1D and 2D were 
checked. Quantification of the identified substances was performed 
in the sample extract. Finally, the explainable portion of the effect 
in the sample extract was determined on the basis of the substance 
concentrations ( Fig. 1 , Part C). 
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3.1.1. Recovery of 89 substances in the developed workflow 
A total of three extractions are carried out in the developed 
workflow. It has to be ensured that the extractions can be per- 
formed repeatedly and deliver good recoveries for substances in a 
broad polarity range. Therefore, 89 water relevant substances were 
selected and examined for their recoveries during the extractions. 
The substances covered a broad log K ow range (EPIWEB, 4.1, US 
EPA) from -2.34 (metoprolol acid) up to 8.42 (telmisartan). 
SPE recoveries of the 89 substances were determined at two pH 
values (pH 2 and pH 7) while the substances were spiked to deion- 
ized water before (10 ng/L) and after the SPE (10 μg/L). The mean 
recovery of SPE at pH 2 reached 62.1% ± 33.9% ( ± SD). Higher re- 
coveries were achieved for the enrichment with pH 7, with 81.9% ±
27.9%. At the enrichment with pH 2, 21 substances revealed recov- 
eries below 25%, where at pH 7, only 5 substances had recoveries 
below 25% (clopyralid, gabapentin, metoprolol acid, pregabalin, ri- 
talinic acid), Table S 1. Four of the five substances with low recov- 
eries at pH 7 also show a negative log K ow value. This indicates po- 
lar functional groups of the substances, which can be less enriched 
by solid phase extraction than more non-polar substances. In or- 
der to check the repeatability of the SPE, the experiments were 
repeated once at both pH values, whereby a mean SD = 7.3% for 
pH 2 and a mean SD = 5.9% for pH 7 was achieved (Figure S 1). 
Due to the higher recovery, the SPE was carried out exclusively at 
pH 7 for the investigation of water samples. 
The recovery of the extraction with the TLC-MS Interface was 
investigated in two approaches. In the first approach, the band 
length and peak width of the substances after the chromatog- 
raphy was not taken into account, considering only the dis- 
solving capacity of the substances from the HPTLC plate. The 
mean recovery of the 89 substances reached 88.2% ± 7.2%, where 
three substances obtained recoveries below 25%: pindolol (2.4%), 
ciprofloxacin (16.3%) and oxytetracycline (12.4%). In the second ap- 
proach, the recovery of the substances under the consideration of 
the mean peak width by separation with the gradient develop- 
ment in the AMD 2 (mean peak width: 1.9 mm) and with a band 
length of 6 mm was determined. Now the accurate positioning of 
the elution head was decisive for substance recovery. The mean 
recovery of the first approach amounted to 60.8% ± 9.5%, where 
additionally to the three substances in the second approach now 
ketoprofen (1.7%) and chlorobromuron (17.1%) also obtained recov- 
ery rates below 25%. The repeatability of the extraction (n = 5) in 
both approaches is shown in Figure S 2. These investigations re- 
vealed that the recovery strongly depends on the substances to be 
extracted. Furthermore, the accuracy of hitting the effective zone, 
equally leads to recovery losses as well as the solubility of the sub- 
stances from the HPTLC plate. 
The extraction recovery with the TLC-MS Interface is crucial for 
the developed workflow, because if the zone cannot be extracted 
from the plate or it is not properly hit by the elution head, the 
non-target evaluation and intersection formation cannot succeed 
and the prioritization fails. While losing the effective substance in 
the 1D is still noticeable because no effect can be detected in the 
2D, losing it in the 2D remains unnoticed. In addition, low recov- 
ery of substances is further enhanced by double extraction of the 
substances from the HPTLC plate. To prevent the user from miss- 
ing the zone to be extracted, an automated extraction would be 
helpful. Moreover, a flexible elution head that could be adapted to 
the peak width of the zone to be extracted could further reduce 
extraction losses. 
Furthermore, it can be assumed that the recovery of the sub- 
stances both during SPE and extraction from the HPTLC plate could 
be increased by specific method optimization, such as adjustments 
of the pH value or optimization of the extraction solvent. For ex- 
ample, substances with a carboxyl group could possibly be better 
recovered by lowering the pH value into the acidic range. In re- 
ality, however, the substances to be enriched are not known and 
several enrichments and extractions would have to be carried out 
in order to cover the different substance groups. This would lead 
to additional time and effort during the workflow and is therefore 
only recommended if information on the effective substances con- 
tained in the sample is already available.Finally, the total recov- 
ery of the workflow was calculated. Therefore, the extraction re- 
coveries taking into account the geometry of the elution head and 
the band geometry were employed and recoveries above 100% (due 
to measurement fluctuations) were corrected to 100%. Considering 
the SPE enrichment at pH 2, the total recovery of the three extrac- 
tions for the 89 substances was 24.6% ± 16.5%. Higher recoveries 
were achieved when applying data of the SPE enrichment at pH 7 
with 31.7% ± 16.1%. The recoveries of the substances were deter- 
mined using a mixed standard in methanol. When considering the 
recoveries in real water samples, even lower yields must be ex- 
pected. 
Due to these extraction losses, the concentration of the effec- 
tive substances could decrease considerably up to the HRMS mea- 
surement. However, the detection limit of the AChE assay with ap- 
prox. 1 μg/L lies significantly higher than the detection limit of the 
HPLC-HRMS detection (approx. 10 ng/L). Thus, also effective sub- 
stances that are only partially transferred to the mass spectromet- 
ric detection may give a sufficient signal. Alternatively, the appli- 
cation volume to the HPTLC plate can be increased to compensate 
the extraction loss at the expense of sample extract. 
The application of the heart-cut approach used in this study re- 
quired an additional extraction step for the transfer of the effective 
zones from the 1D to the 2D. In comparison, with comprehensive 
2D HPTLC separation and biotesting [21] , the entire sample is sep- 
arated in the 2D on the same plate and no extraction is required 
for the transfer from 1D to 2D. However, with this comprehensive 
2D separation, only one sample can be separated per HPTLC plate 
and the bioassay can only be applied after the second separation 
step. Thus, the separation has to be repeated for the extraction of 
the effective zone after the 2D, because it is not possible to extract 
zones after the application of the bioassay. Since h R F fluctuations 
are to be expected in both dimensions, the uncertainty of hitting 
the effective zone correctly becomes greater. 
3.1.2. Proof of concept with spiked water samples 
In order to check the developed workflow for its function- 
ality, six acetylcholinesterase inhibiting substances were selected 
for spiking in water samples ( Table 1 ). The spiked concentrations 
were determined on the basis of the strength of the substance ́s 
effects. The selected substances covered diverse substance classes 
that cause inhibition through different bonds to the enzyme AChE. 
A further criterion for the substances was their h R F in the 1D. The 
substances should be distributed over a broad retardation range, 
such that different MPs have to be applied in the 2D. To take into 
account different matrix influences, the workflow was carried out 
with drinking, surface and purified sewage water. 
After the separation with the gradient development in the 
AMD 2 and effect detection with the AChE assay in the 1D ( Fig. 
2 ), the effective zones of the six spiked substances were extracted 
in all three samples. Dependent on their h R F in the 1D ( Table 1 ), 
the extracted zones were separated in the 2D with the MP A - D 
and the AChE assay was performed again (Figure S 3). 
When comparing the h R F of the spiked substances in the 1D 
and 2D ( Fig. 3 , A), it is noticeable that all the substances achieved 
different h R F due to other selectivity and eluent strength of the 
used MPs. Also the h R F order of the substances changed in the 2D. 
Substances with low h R F in the 1D (galanthamine, donepezil and 
methiocarb-sulfoxide) migrated to higher h R F in the 2D because of 
higher eluent strength ( εAB ) of the MP A and MP B ( εAB = 0.65 
resp. 0.56). The substances with higher h R F in the 1D (caffeine, 
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Fig. 2. AChE assay of the three spiked samples in the first dimension. + : spiked sample, - sample, A - E: h R F area for the selection of the mobile phase A-E, which is used 
for the separation in the 2D. 
Fig. 3. h R F (A) and effects (B) of the spiked substances in the 1D and 2D. The points indicate the range over the three spiked water samples. 
azamethiphos and paraoxon-ethyl) migrated to lower h R F in the 2D 
due to the lower eluent strength of the MP C and MP D ( εAB = 0.53 
resp. 0.40). A significant improvement of the separation was ob- 
served for the substances methiocarb-sulfoxide and caffeine. While 
these substances had almost identical h R F in the 1D ( h R F (1D) = 39 
and 43; α = 1.1), they could be clearly separated in the 2D using 
the MP B and MP C ( h R F (2D) = 64 and 8; α = 8). 
In the 1D, the largest h R F variation between the spiked samples 
occurred for the substance galanthamine ( h R F, range = 12 - 15). The 
higher variation of the h R F of galanthamine may be caused by ma- 
trix effects in the surface water. Diffuse effects to the AChE also 
occurred in the non-spiked surface water in the same h R F range 
than galanthamine retardate ( Fig. 2 ). This indicates an increased 
matrix load in this area, which may be responsible for the changed 
peak shape and the shift of galanthamine to lower h R F in the sur- 
face water sample. The largest fluctuations of the h R F occurred 
in the 2D by use of the eluent MP A and MP B (galanthamine 
h R F, range = 26 - 30; donepezil h R F, range = 53 - 58; methiocarb- 
sulfoxide h R F, range = 62 - 65). 
When comparing the effects of the spiked substances in the 1D 
and 2D, all effects in the 2D are lower than in the 1D ( Fig. 3 , B). 
This can be explained by the recovery of the spiked substances 
during the extraction with the TLC-MS Interface, which reached 
53.5% ± 5.2%. Nevertheless, a higher percentage of the substance ́s 
effects were recovered, that was 64.1% ± 4.9%. Differing effect re- 
coveries compared to substance recoveries can be explained by the 
dose-response relationship, which is not linear like the analyti- 
cal signal of the substance concentration, but shows a sigmoidal 
course. Higher matrix content in the purified sewage and surface 
water compared to the drinking water showed no influence on the 
effect recovery. 
Methiocarb-sulfoxide and caffeine each caused two effective 
zones in the 2D (Figure S 3). This can be traced back to the fact 
that these two substances migrate very close together in the 1D 
and for this reason cannot be extracted completely separate. 
All the extracted zones of the 1D showed effects on the AChE 
assay in the 2D (Figure S 3) and were extracted again. The spiked 
sample extracts, the extracted zones of the 1D and the zones of 
the 2D were measured via HPLC-HRMS and the non-target evalua- 
tion and intersection formation was performed. For verification of 
the prioritization success, the number of signals in the sample ex- 
tracts (without HPTLC separation) was compared with the number 
of signals in the 1D intersection (1D HPTLC separation) and in the 
2D intersection (2D HPTLC separation), Table 2 . 
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Table 2 
Number of signals in the intersections of the spiked sample extracts, the extracted zones of the 1D and the extracted zones of the 2D, detected with HRMS (ESI + ) 
for the proof of concept (spiked sample extract (1), extracted zone of the 1D (2), extracted zone of the 2D (3)). 
Zone Spiked substance Drinking water Surface water Purified sewage water 
1 1 ∩ 2 1 ∩ 2 ∩ 3 1 1 ∩ 2 1 ∩ 2 ∩ 3 1 1 ∩ 2 1 ∩ 2 ∩ 3 
1 Galanthamine 339 21 18 4445 202 97 7816 82 26 
2 Donepezil 30 17 174 28 305 44 
3 Methiocarb-sulfoxide 10 10 59 32 109 37 
4 Caffeine 10 2 53 14 89 25 
5 Azamethiphos 62 28 71 52 104 49 
6 Paraoxon-ethyl 43 8 46 22 80 27 
As expected, the drinking water showed the lowest number of 
features in the sample extract (n = 339), compared to the sur- 
face water (n = 4 4 45) and the purified sewage water (n = 7816). 
The number of features of all samples could be reduced through 
extraction of the effective zones from the HPTLC plate in the 1D 
and 2D. In any cases, the number of features in the intersection 
of sample extract, 1D and 2D plate extracts was lower than in the 
intersection of the sample extract and the 1D plate extract. That 
confirmed the usefulness of the second separation dimension. An 
exception was methiocarb-sulfoxide in drinking water, where the 
number of features in the 2D remained constant. Lowest signal 
numbers were always achieved in the drinking water and the puri- 
fied sewage water contained the most signals in the intersections, 
with exception of the substances galanthamine and azamethiphos 
( Table 2 ). 
In all three samples, the reduction in the number of signals in 
the 2D was more than 90%. It was shown that the filtering of rele- 
vant signals through 2D separation was most successful and most 
necessary for more complex samples. In the drinking water, the 
features were already adequately reduced after the 1D so that the 
2D is of only little avail (mean signal quantity 1D: 31, 2D: 14). 
However, on average 137 signals were still present in the inter- 
section of the purified sewage water after the 1D and the effort 
to look through every single signal for effective substances is very 
high. But only 35 ± 10 signals remained after the 2D separation, 
such that significant further reduction could be achieved. From this 
it can be concluded that for less polluted water with low expected 
overall effects, EDA with 1D HPTLC may be sufficient to filter rel- 
evant signals. However, if more complex samples, such as surface 
or sewage water should be examined, the EDA with 2D HPTLC ap- 
proach is necessary. 
The prerequisite for a successful prioritization is that the sub- 
stances responsible for the effect are contained in the intersection 
at the end of the workflow and are not lost (false negative ones). 
With the exception of methiocarb-sulfoxide in the drinking wa- 
ter, all the spiked substances were found in the 1D and 2D inter- 
sections of the three water samples. In the spiked drinking wa- 
ter, methiocarb-sulfoxide was transformed to methiocarb-sulfoxide 
phenol, which instead occurred in the extracted zone of the 1D. 
The loss of the substance in the intersection is therefore not a fail- 
ure of the workflow, but rather a problem of stability of the ef- 
fective substance. However, unstable substances must also be ex- 
pected when examining real water samples. These can transform 
during the workflow and new signals are detected with the MS 
that are difficult to assign to the original bioactive substances. 
In addition to the spiked substances, further signals remained 
in the intersections of the sample extracts. Some of them could 
be assigned to isotopologues and adducts of the spiked substances. 
So in all cases the sodium adducts of the spiked substances were 
detected and in several intersections also the dimers [2M + H] + and 
[2M + Na] + . The automatic componentization for the evaluation of 
non-target data is not yet solved. Additional reaction products of 
some spiked substances, such as paraoxon-methyl and paraoxon- 
nitrophenylphosphate were detected, both resulting from reaction 
processes of paraoxon-ethyl. 
When comparing the signal lists of the intersections, it was 
noticed that in most cases the spiked substances occurred with 
the highest signal intensity. Only the transformation product 
methiocarb-sulfoxide phenol was more intensive in the intersec- 
tion of zone 3 in drinking water and surface water, than the pre- 
cursor substance methiocarb-sulfoxide. In the intersection of zone 
3 of the drinking water, the precursor methiocarb-sulfoxide was 
not detected at all, but only the transformation product. In the 
intersection of zone 5 of the drinking water, azamethiphos was 
only the fourth most intensive signal. The sodium adduct of aza- 
methiphos was on the second place in the intersection, whereby 
the signals at the positions one and three could not be assigned 
to any molecular formula. Whereas the retention time of azame- 
thiphos was 8.6 min, the retention times of the two unknown 
masses amounted to 6.1 min. 
Finally, the recoveries of the spiked substances in the three wa- 
ter matrices were compared and the intensity losses of the sub- 
stances during the workflow were determined. In all three wa- 
ter matrices, the intensities of the spiked substances decreased 
strongly during the workflow. After 1D extraction, the substances 
were recovered with 39.3% ± 1.3%, whereas the recovery in the 
2D reached 25.3% ± 2.3%. Although the recovery of the substances 
was highest in the drinking water, the matrix of the water sample 
played a rather subordinate role for the recovery (mean recovery 
of the 1D in drinking water: 40.8%, surface water: 38.3%, purified 
sewage water: 38.8%). It was also shown that greater substance 
losses occurred in the 1D than in the 2D, which can be explained 
by the fact that the substance peaks were wider due to higher 
concentrations in 1D and could therefore only be extracted incom- 
pletely. Compared to the recoveries of the 89 substances (chapter 
3.1.1), the values are in the same range and show that the recov- 
ery also depends strongly on the substances. For example, caffeine 
could be recovered with 42.3% ± 6.6% after the 2D, whereas the 
recovery of azamethiphos after the 2D was only 7.1% ± 5.9%. De- 
spite the successful proof of concept, the intensity losses show the 
limitations of the workflow, such that substances with already low 
concentrations in the water samples may not be recovered after 
the 2D. Moreover, it is likely that samples with a high background 
of effects would have led to difficulties in localizing the effects of 
the spiked substances. 
3.2. Investigation of real water samples 
Three water samples were examined with the workflow, two 
surface waters and one untreated wastewater. After the 1D sepa- 
ration, many inhibiting effects on the AChE were detected ( Fig. 4 ). 
Especially in the surface water A, the effective substances could 
not be separated completely and the potential neurotoxic effects 
were blended. Clearest effective zones could be detected in the un- 
treated sewage water. 
L. Stütz, W. Schulz and R. Winzenbacher / Journal of Chromatography A 1624 (2020) 461239 9 
Fig. 4. AChE assay of three water samples in the 1D and selection of effective zones 1–6 for extraction, A - E: h R F area for the selection of the mobile phase A-E, which is 
used for the separation in the 2D. 
Six effective zones (zones 1 - 6) were selected for extraction 
with the zones being as intense and clear as possible. By extracting 
effective zones with the same h R F in different samples, it should be 
checked whether the detected effects are possibly caused by the 
same substances. 
The zones 1 - 5 showed clearly defined effects in the 2D, 
whereas with zone 6 no effect could be detected ( Fig. 5 ). A weak 
effective area in the lower h R F range suggests that the effect of the 
zone 6 in the 1D was caused by several rather weak effective sub- 
stances, which were separated in the 2D. By observing the absorp- 
tion scan at 220 nm and the fluorescence image at 366 nm, ad- 
ditionally to the effective zone also non-effective substances were 
detected, that could be separated from the effective zone through 
the second separation. For example, three fluorescent zones were 
detected in the zone 4, but none of them had any effect to the 
AChE. The h R F of the zones 1 and 4 as well as of the zones 3 and 
5, which already matched in the 1D, also matched after the second 
separation. Therewith the suspicion was confirmed that the same 
substances may be responsible for the detected effect. Additionally 
to the same h R F in the 1D and 2D, also both the effective zones 3 
and 5 showed a blue fluorescence at 366 nm. In all the cases, with 
exception of the zone 6, an absorption peak with the same h R F 
than the effective zone could be detected, that may be caused by 
the effective substance. 
With the exception of zone 6, the effects of all extracted zones 
were recovered in 2D. Only in zone 6 no clear effect could be de- 
tected. For this reason, no further extraction could be performed 
and the workflow was stopped for the zone 6. 
The effective zones 1 - 5 of the 2D were extracted again and 
transferred to the HPLC-HRMS. Three samples per effect were mea- 
sured: the sample extract, the extracted zone of the 1D and the 
extracted zone of the 2D. After the non-target evaluation, inter- 
sections of the detected signals were built ( Table 3 ). Several thou- 
sand signals were detected in the surface water extracts A and B, 
whereas in the untreated waste water even about 18,0 0 0 signals 
occurred. By extracting the zones in the 1D, the number of remain- 
ing signals could be reduced to an average of 307. In the intersec- 
tion of the 2D, only an average of 36 signals occurred. 
The intersections of signals after the 2D were investigated to 
identify effective substances. Therefore, the signals were sorted 
Table 3 
Number of signals in the intersections of the water extracts, the ex- 
tracted zones of the 1D and the extracted zones of the 2D, detected 
with HRMS ESI + (sample extract (1), extracted zone of the 1D (2), ex- 
tracted zone of the 2D (3)). 
Sample Zone 1 1 ∩ 2 1 ∩ 2 ∩ 3 
Surface water A Zone 1 8681 462 28 
Surface water A Zone 2 68 3 
Surface water B Zone 3 7187 31 10 
Untreated sewage water Zone 4 17,721 540 33 
Untreated sewage water Zone 5 433 108 
based on their intensity, starting with the most intense signals, 
which generally provide the most expressive isotope pattern and 
MS/MS spectra. In the first step, possible molecular formulas were 
determined on the basis of the MS, MS/MS and isotope pattern 
data (elements: C,H,O,N,S,P; Cl in the presence of a characteris- 
tic isotope pattern, mass tolerance: 10 ppm, intensity tolerance: 
10 ppm). Structural formulas were searched in structural databases 
(Pubchem, ChemSpider and ForIdent). For confirmation of possible 
structures, the MS/MS data were compared with reference spectra 
in spectra databases (MassBank) and with in-silico fragmentation 
tools (MetFrag). When substances could be identified on the ba- 
sis of their accurate masses, isotope pattern and MS/MS spectra, 
the structure was confirmed using a reference standard. With ex- 
ception of the zones 2 and 6, possible effective substances could 
be identified in all the other zones. In zone 2, only three signals 
remained in the intersection of the 2D and none of them could 
be assigned to a structural formula, such that also the intersection 
after the 1D was investigated for candidates. But yet, no possible 
effective substance could be identified. All the substances identi- 
fied via a reference standard (Level 1 and Level 2) are shown in 
Table 4 . 
The h R F of the substances and their effects in the 1D and 2D 
were verified via the reference standards ( Table 4 , Figure S 4). Fluc- 
tuations in the h R F may be explained by the separations on differ- 
ent HPTLC plates of samples and standards. In addition, the peak 
widths of the substances have to be considered. Even if the h R F of 
a substance and the extracted zone are varying, the peak flank of 
the standard may overlap with the extraction area. 
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Fig. 5. Fluorescence image (366 nm), AChE assay (image and effect chromatogram) and absorption scan (220 nm) of extracted zones of the three water samples in the 2D. 
Table 4 
Identified substances in three water sample extracts via EDA with 2D HPTLC and HPLC-HRMS. 
Sample Zone Substance Molecular formula h R F 1D h R F 2D m/z RT / min ß
1 / mg/L 
ident. Level 
[ 28 ] 
Surface 
water A 
1 Clopidogrel CA 2 
Metolachlor ESA 3 
LAS C10-C13 4,5 
Triamterene 
C 15 H 14 ClNO 2 S 
C 15 H 23 NO 5 S 
C n H 2n + 1 C 6 H 4 O 3 S 
n = 10–13 































C 12 H 10 N 4 O 2 
C 11 H 15 NO 5 
C 15 H 11 ClN 2 O 2 



























4 LAS C10-C13 4,5 C n H 2n + 1 C 6 H 4 O 3 S 
n = 10–13 





C 12 H 10 N 4 O 2 













1 Concentration in the enriched sample extract. Enrichment factor for surface water (zone 1 and zone 3): 10 0 0, enrichment factor for untreated sewage water (zone 4 and 
zone 5): 100. 
2 Clopidogrel carboxylic acid 
3 Metolachlor ethanesulfonic acid 
4 Linear alkylbenzene sulfonates C10 - C13 homologues 
5 identified through ESI negative measurement, data not shown in this work. 
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The concentration of the identified substances was determined 
in the enriched sample extracts ( Table 4 ), to be able to match the 
measured effect with the effect of the substances in these con- 
centrations. For this reason, the concentration of the substances 
in the original water sample can only be estimated, since the re- 
covery during the enrichment is not known. Moreover, it must be 
taken into account that there was only a reference standard for the 
substance sodium dodecylbenzene sulfonate that contained a mix- 
ture of linear alkylbenzene sulfonate (LAS) homologues (C10 - C13), 
each with different isomers. While the homologues could still be 
separated partly in the HPLC, the isomers overlapped, so that only 
a semi-quantitative estimation of the LAS concentration could be 
performed. 
All the substance concentrations ranged from 10 μg/L to a max- 
imum of 2.75 mg/L in the enriched samples. The exceptions were 
the LAS, which were found in the samples extracts (surface water 
A and untreated sewage water) with concentrations in the mean 
mg/L area (semi-quantitative estimation). By mixing the identified 
substances in a zone in the quantified concentrations, separating 
them in the 1D and performing the AChE assay, the proportion of 
the explainable effect could be determined. 
In the surface water A at h R F = 19 (zone 1), the potential neu- 
rotoxic effect could be fully explained by the mix of the four iden- 
tified substances (effect mix 1 /effect zone 1 : 1.05). By investigation of 
the four substances individually with the AChE assay, only the LAS 
homologues (C10 - C13) caused an effect on the AChE. Since the 
homologues and isomers of the LAS group on the HPTLC plate 
could not be separated from each other, it could not be conclu- 
sively determined whether the effect was caused by one or all ho- 
mologues or isomers in combination. The other three substances in 
mix 1 (clopidogrel CA, metolachlor ESA and triamterene) showed 
no effect, even at higher concentrations (100 mg/L). The effect at 
h R F = 19 in the untreated sewage water could also be explained 
almost completely by the LAS concentration (effect LAS /effect zone 4 : 
0.90). For the zones 3 and 5, however, only a small part of 
the effects in the samples could be explained with the identi- 
fied substances (effect mix 3 /effect zone 3 : 0.07; effect mix 5 /effect zone 5 : 
0.14). In the mix 3 (lumichrome, methocarbamol, oxazepam and 
phenazon), only the substance lumichrome inhibited the enzyme 
AChE, whereas the other three substances showed no effect. In the 
mix 5, however, both the substances lumichrome and paraxanthine 
inhibited the AChE and so together caused the effect in the un- 
treated sewage water at h R F = 31. The proportion of the effects 
that cannot be explained with the identified substances may be 
caused by further unknown substances also contributing to the ef- 
fects. This finding is similar to results of other studies, where also 
only parts of the detected effects could be explained [ 13 , 29 , 30 ]. It 
has to be considered that some bioactive substances are not de- 
tectable with LC-HRMS at all, such that the used workflow can- 
not succeed in these cases. Additionally, many more effects in the 
investigated samples detected in the 1D bioassay remained un- 
known, because due to time constraints only a certain number 
of strong effective zones can be selected for identification. This 
demonstrated the difficulty of the identification, which despite all 
the progress made in separation efficiency and prioritization still 
poses a great challenge. 
Especially for such heavily loaded samples, other multi- 
dimensional separations could also be suitable for time reasons. In- 
stead of selective 2D HPTLC separation, it would also be possible to 
use comprehensive 2D HPTLC separations, which have the advan- 
tage that no individual fractions have to be selected. In the case 
of highly blurred effects that were distributed over the entire h R F 
range, laborious extraction of zones over the entire range or the 
difficult selection of individual effective zones would be eliminated 
and instead the entire sample would be separated in 2D. Another 
opportunity would be multi-dimensional HPLC separation of the 
extracted effective zone. This could possibly lead to higher separa- 
tion efficiency with lower time expense. In addition, different mo- 
bile phases may be used for HPTLC separation of one sample. By 
extracting the effective zone after each separation and measuring 
them with HPLC-HRMS, the intersection of the signals occurring in 
all the extracted zones could be determined. Maybe the success of 
identification would be increased with such applications. 
However, for the suitability of multi-dimensional separations 
for routine applications, the time and effort required must be taken 
into account. More separations and more extractions increase the 
experimental time, such that they are only conditionally suitable 
for the application with many samples. Rather, the application of 
such multi-dimensional separations, as also used in our developed 
workflow lies in the examination of conspicuous samples, where 
1D separation does not lead to successful identification of effective 
compounds.The effective substances identified in this work differ 
greatly in their areas of application. Lumichrome is a derivate of 
riboflavin and is created by its photolysis. As a plant metabolite, 
it is crucial for the growth of plants [31] . Lumichrome was al- 
ready found as AChE inhibiting substance in-vitro with an IC 50 of 
12.24 μM ± 0.12 μM and was comparable to the effect of galan- 
tamine (IC 50 = 11.31 μM ± 0.11 μM) in this study [32] . Parax- 
anthin is a derivate of caffeine that is used in many ways as a 
stimulant. The AChE inhibiting effect of paraxanthin has already 
been described in earlier studies [33] . The effective substance of 
the LAS group could not be clearly identified (Level 2 identifica- 
tion), because the homologues and isomers contained in the avail- 
able reference standard could not be separated in both dimensions 
by HPTLC. For clear identification of the effective substance(s), suf- 
ficiently pure reference standards of the substances would have to 
be available. For these reasons, the concentration of LAS in the two 
water samples could so far only be estimated semi-quantitatively. 
Linear alkylbenzene sulfonates are used in large quantities in de- 
tergents and cleaning agents and are released into the environment 
by incomplete degradation in sewage water treatment plants [34] . 
The AChE inhibiting effect of LAS has already been described in 
previous studies. For example, in a work of Guilhermino, inhibitory 
effects of dodecyl benzyl sulfonate (DBS) and sodium dodecyl sul- 
fate (SDS) on the AChE of Daphnia magna were demonstrated in- 
vivo and in-vitro in the mg/L range. It must be taken into account 
that LAS do not inhibit the enzyme by a specific binding to the 
active center, but cause a non-specific inhibition [35] . 
To finally asses the detected effects, further bioassays should be 
performed in addition to the AChE assay. Since the AChE assay is 
an initial assay for the detection of potential neurotoxic effects, its 
results have to be verified by further bioassays gathering neurotox- 
icity. Thus, in-vivo assays also considering toxicokinetic processes 
should be applied. However, such bioassays often require a great 
deal of effort and long experimental periods, which is why simple 
and fast assays are often used to get a general overview of effects 
that are then confirmed by such elaborate assays. 
4. Conclusions 
In this study, a workflow to prioritize effective compounds with 
EDA with 2D HPTLC in combination to HPLC-HRMS was presented. 
Although the workflow is elaborate and involves manual steps, the 
present study reveals its efficiency in prioritizing of signals for 
the identification of effective substances. Investigating samples that 
contain many unknown compounds, a single extraction of the ef- 
fective zones from the HPTLC plate is not sufficient to reduce the 
number of signals to a manageable quantity. Therefore, the EDA 
with 2D HPTLC is required. 
Through application of the developed workflow to water sam- 
ples, several substances could be identified successfully. However, 
in some cases substances have been identified, which have no 
12 L. Stütz, W. Schulz and R. Winzenbacher / Journal of Chromatography A 1624 (2020) 461239 
effect in the bioassay. More available literature data, containing 
toxicity information of the substances may facilitate the identifi- 
cation of effective substances. Despite the successful identification 
of some effective substances, a large number of effects still remain 
unknown in the investigated samples, since the effort required to 
identify only one substance is immense. 
The EDA with 2D HPTLC workflow was performed with the 
AChE assay for the detection of potential neurotoxic effects in this 
study. However, it could be easily adapted to further bioassays in 
the future, such that a wider effect spectrum may be covered. 
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ethylmalonamide 77.3 56.5 101.1 71.4 39.4 28.8 0.40 
Acebutolol 76.6 88.7 72.5 57.2 25.0 29.0 1.19 
Acetaminophen 22.4 87.5 86.4 28.6 1.8 7.2 0.27 
Acetylsulfamethoxazol 98.4 103.2 97.7 48.2 22.9 23.2 1.21 
Alprenolol 94.0 105.0 85.4 65.7 40.6 43.2 2.81 
Amantadin 3.4 52.8 44.0 39.5 0.5 8.3 2.43 
Amisulpride 87.6 84.5 58.3 50.7 22.5 21.7 1.11 
Amisulpride N-Oxide 86.4 97.7 85.6 62.5 33.8 38.2 0.35 
Atenolol 2.6 27.1 59.6 58.1 0.9 9.1 -0.03 
Azithromycin 74.3 59.5 76.4 77.8 45.0 36.0 3.24 
Bentazone 87.9 98.8 105.8 45.0 17.8 20.0 1.67 
Betaxolol 99.0 105.2 84.8 65.7 42.7 43.2 2.98 
Bezafibrate 94.5 100.0 98.4 66.4 41.7 44.1 4.25 
Bisoprolol 86.3 104.8 82.3 65.8 37.3 43.3 1.84 
Bisoprolol M4 15.8 86.1 75.1 61.2 5.9 32.3 0.64 
Bromacil 92.1 110.8 99.3 67.9 42.4 46.1 1.68 
Carbamazepin-10,11-
epoxide 38.8 103.5 100.1 58.8 13.4 34.5 0.95 
Carbamazepine 94.7 101.4 100.3 67.6 43.3 45.7 2.25 
Chloramben 83.9 46.2 94.1 62.0 32.3 17.8 1.90 
Chloramphenicol 86.4 132.2 105.0 66.2 37.9 43.9 0.92 
Chlorbromuron 89.4 97.9 93.0 17.1 2.6 2.8 3.15 
Ciprofloxacin 83.8 81.6 16.3 9.2 0.7 0.7 0.00 
Clarithromycin 40.8 77.7 83.0 76.9 24.1 45.9 3.18 
Clenbuterol 79.0 94.5 88.8 68.3 36.9 44.1 2.00 
Clindamycin 14.1 85.3 81.2 69.8 6.8 41.5 2.01 
Clopyralid 99.0 19.2 89.9 63.8 40.3 7.8 1.63 
Codeine 11.5 85.2 76.3 67.8 5.3 39.2 1.28 
Crotamiton 11.7 88.5 97.4 64.2 4.8 36.5 2.73 
Dapsone 38.6 101.9 94.9 57.3 12.7 32.8 0.77 
Desamino-metamitron 104.3 97.1 101.4 73.5 54.0 52.5 1.43 
Diazepam 98.2 101.1 99.6 70.9 49.4 50.3 2.70 
Diclofenac 90.0 95.9 90.9 41.4 15.4 16.4 4.02 
Dihydrocodeine 9.3 89.0 67.7 57.3 3.0 29.2 1.49 
Dimethenamid M27 87.0 109.7 85.7 56.3 27.6 31.7 - 








































































































































Etofibrat 65.5 50.0 96.9 57.6 21.7 16.6 3.43 
Fenofibrate 75.4 82.3 72.3 66.8 33.6 36.7 5.19 
Fenoxaprop 11.6 93.6 96.8 64.0 4.7 38.3 4.17 
Flecainide 96.3 92.9 93.8 71.9 49.8 48.0 3.95 
Fluazifop 96.1 107.4 98.0 71.8 49.6 51.6 3.58 
Fluroxypyr 86.5 108.5 96.2 67.4 39.3 45.4 1.17 
Gabapentin 2.9 4.1 100.0 68.5 1.3 1.9 -1.37 
Gabapentin-Lactam 57.1 89.4 100.7 71.7 29.3 45.9 1.91 
Haloxyfop(-P) free acid 87.7 101.9 97.9 66.5 38.8 44.2 3.38 
Hydrochlorothiazide 92.4 102.4 84.6 66.8 41.2 44.6 -0.10 
Indomethacin 68.1 92.4 91.4 62.4 26.5 36.0 1.43 
Ketoprofen 85.5 111.6 67.5 1.7 0.0 0.0 3.00 
Lamotrigine 45.9 91.5 101.7 75.0 25.9 51.5 0.99 
Lamotrigin-N2-Oxide 58.1 78.7 94.9 68.9 27.6 37.4 2.91 
Metconazole 91.2 103.3 95.7 74.5 50.7 55.5 4.19 
Methylphenidate hydro-
chloride C II 43.6 88.2 102.2 72.8 23.1 46.8 2.78 
Metoprolol 93.0 90.1 79.8 65.2 39.5 38.3 1.69 
Metoprolol acid 11.6 4.1 95.7 66.2 5.1 1.8 -2.34 
Metronidazol 92.9 33.5 99.2 71.7 47.7 17.2 0.00 
N,N-Diethyltoluamide 21.0 87.4 98.1 68.0 9.7 40.5 2.26 
N-Acetyl-4-
aminoantipyrin 82.4 57.2 101.4 41.3 14.1 9.8 -0.13 
Naproxen 93.5 109.5 115.0 73.0 49.8 53.2 3.10 
N-Formyl-4-
aminoantipyrin 57.8 97.6 103.1 41.1 9.8 16.5 0.50 
NMP 14.2 33.5 79.0 58.5 4.9 11.5 -0.11 
Oxazepam 88.3 104.7 97.3 65.1 37.5 42.4 2.32 
Oxytetracycline 9.0 28.7 12.4 11.6 0.1 0.4 -1.72 
Pentoxifylline 74.7 98.9 85.6 69.1 35.6 47.2 0.56 
Phenacetin 91.7 100.3 99.8 69.6 44.4 48.4 1.67 
Phenazone 87.6 91.1 98.7 57.6 29.0 30.2 0.59 
Phenylalanine 30.8 91.9 89.1 61.2 11.6 34.5 2.89 
Picloram 93.2 45.5 91.1 59.5 33.0 16.1 1.36 
Pindolol 4.1 58.4 2.4 10.0 0.0 0.6 1.48 
Pregabalin 0.5 0.4 94.4 65.1 0.2 0.2 -1.78 
Primidone 94.3 99.5 102.5 72.1 49.1 51.8 0.73 
Propranolol 87.2 100.0 78.4 60.3 31.7 36.3 2.60 








































































































































Quinmerac 93.6 61.9 94.1 66.2 41.0 27.1 2.87 
Ritalinic acid  19.6 11.8 101.6 72.6 10.3 6.2 -1.07 
Ronidazol 85.2 98.1 98.6 70.3 42.1 48.5 -0.37 
Roxithromycin 38.0 63.1 77.4 81.8 25.4 42.2 2.75 
Sitagliptin 33.2 62.5 90.9 68.8 15.7 29.6 1.39 
Sotalol 0.0 51.6 76.1 63.8 0.0 21.0 0.37 
Sulfadiazine 70.8 92.4 97.4 54.6 21.1 27.5 -0.34 
Sulfadimidin 73.6 88.8 96.2 52.2 20.0 24.2 0.76 
Sulfamerazine 70.4 95.6 97.9 49.6 17.3 23.5 0.21 
Sulfamethoxazole 64.8 107.1 91.4 34.2 7.6 11.7 0.48 
Sulfathiazol 47.3 90.4 99.2 72.8 25.0 47.9 0.72 
Sulpirid 6.4 94.2 69.4 65.3 2.7 40.1 0.65 
Sulpiride N-Oxide 11.5 42.9 90.0 76.7 6.8 25.2 -0.12 
Tramadol 53.8 91.8 96.1 69.8 26.2 44.8 3.05 
Tramadol N-Oxide 41.7 94.3 102.3 73.6 22.6 51.0 2.24 
trans-10,11-Dihydroxy-
10,11-
dihydrocarbamazepin 115.4 96.1 102.1 64.2 41.2 39.6 -0.21 
Triclopyr 99.0 105.1 93.3 72.9 52.6 53.2 2.53 
Trimethoprim 53.6 92.1 101.7 76.5 31.4 53.9 0.73 
mean 62.1 81.9 88.2 60.8 24.6 31.7 1.5 
SD 33.9 27.9 18.9 16.0 16.5 16.1 1.5 
1without considering the geometry of the elution head and the band geometry 
2consideration of the geometry of the elution head and the band geometry   
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Table S 2: Composition of the used gradient development in the AMD 2 
Step Methanol:formic acid 







1 100.0 0.0 0.0 11.0 
2 100.0 0.0 0.0 11.0 
3 100.0 0.0 0.0 11.0 
4 70.0 30.0 0.0 16.3 
5 30.0 70.0 0.0 21.6 
6 20.0 80.0 0.0 26.9 
7 15.0 85.0 0.0 32.2 
8 11.0 89.0 0.0 37.5 
9 8.5 91.5 0.0 42.8 
10 6.5 93.5 0.0 48.2 
11 5.0 95.0 0.0 53.5 
12 4.0 96.0 0.0 58.8 
13 3.5 96.5 0.0 64.1 
14 0.0 100.0 0.0 69.4 
15 0.0 50.0 50.0 74.7 





Table S 3: Mobile phases for separation in the 2D 








A [0, 20] Formic acid-methanol-
chloroform (3.3:36.6:60, v/v/v) 
1 70 0.65 ADC 
B ]20, 40] Methanol-chloroform  
(20:80, v/v) 
1 70 0.56 ADC 
C ]40, 60] Ethyl acetate-dichloromethane- 
n-hexane (65:10:25, v/v/v) 
2 70 0.53 AMD 
D ]60, 80] Acetonitrile-chloroform- 
n-hexane (7:70:23, v/v/v) 
3 70 0.40 AMD 





Table S 4: Stability of hRF values of the chromatography control mix  
 Mobile phases mean hRF ± SD 
Substance 
Gradient 
development   
(N = 10) 
MP A 
 
(N = 5) 
MP B 
 
(N = 5) 
MP C 
 
(N = 3) 
MP D 
 
(N = 3) 
1,3,6-Naphthalenesulfonic acid 11.3 ± 0.7 - - - - 
1,5-Naphthalenesulfonic acid 13.2 ± 0.4 10.7 ± 1.2 0.3 ± 0.6 - - 
1-Naphthalenesulfonic acid 18.7 ± 0.9 48.0 ± 1.7 6.0 ± 1.0 - - 
Theobromine 27.8 ± 0.8 73.0 ± 4.0 50.3 ± 1.2 2.3 ± 0.6 - 
Caffeine 30.9 ± 0.8 - 64.7 ± 1.5 13.0 ± 1.0 - 
Thiourea 41.9 ± 1.3 62.3 ± 2.3 30.3 ± 2.5 6.7 ± 0.6 - 
N-Phenylacetamide 56.0 ± 1.0 - 60.0 ± 1.0 66.3 ± 0.6 22.3 ± 1.5 
Benzamide 75.9 ± 0.9 94.0 ± 3.6 76.0 ± 1.0 - 77.7 ± 2.1 
N,N-Dimethyl-4-[(E)-
phenyldiazenyl]-aniline 
































































Figure S 2: Repeatability of extraction, A: without considering geometry of the elution head and the band geom-

































































































































































































































































































































































































































































Figure S 4: Examination of effects and hRF of the candidate substances (concentration 1000 µg/L, application 































































































Zone 1 + 4, hRF = 19 
















Zone 1 + 4, hRF = 61 
Zone 3 + 5, hRF = 58 
